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Depression can be a debilitating illness that affects more than 300 million people 
worldwide. Although there are successful treatments for depression with pharmaceuticals and 
behavioral approaches such as psychotherapy, these approaches are often very costly and may 
carry a stigma of treatment for some individuals. The purpose of this dissertation study was to 
compare results of previously collected data that examine whether a prescribed regimen of casual 
videogame play (CVG) could reduce symptoms associated with depression. This dissertation 
specifically focused on comparing results of a study group and a comparison group on the self-
report instrument, the Patient Health Questionnaire-9 (PHQ-9) as well as objectively measured 
changes in alpha wave, Electroencephalogram (EEG) data. 
Participants in the original study were screened for depression using the PHQ-9. There 
were a total of 57 participants who met the study inclusion criteria. Each participant that met the 
inclusion criteria was then randomized into either the comparison group (n=29) or the study 
group (n=28). Experimental group participants were prescribed to play one of three CVGs three 
times per week (with 24 hours between each session). This process occurred for 30 minutes each 
session, over a 1-month period. Comparison group participants reviewed the National Institute of 
Mental Health’s webpage on depression during a pre-test and a post-test session. The participants 
in this group did not engage in any intervention over the one-month period of time between the 
pre-test and post-test sessions.  
A repeated-measures analysis of covariance (ANCOVA) was completed to examine three 
research questions between subjects at Time 1 and Time 3 to compare changes in depression 
symptoms on both subjective, self-report (PHQ-9) and objective alpha wave EEG measures. The 
CVGs used as the intervention factor were either Peggle, Bejeweled or Bookworm Adventure. 
Study analysis revealed significant decreases in depression symptoms reported in the study group 
on the PHQ-9 self-report scale. Results along the objective, EEG alpha wave scale revealed non-
statistically significant changes. Potential reasons for the non-significant findings along with 
recommendations for future research are also discussed. Conclusions from this study found that a 
prescribed regimen of CVG may have potential as an intervention to help reduce symptoms of 
depression as measured on the PHQ-9 scale. Further research should consider examining 
intricacies of CVG play as a potential intervention to address symptoms related to depression. 
Findings also revealed that while EEG findings were not statistically significant, participants 
self-report responses were significant and may underscore the importance of individual’s 
subjective feelings in the therapeutic process.  
  
 
EXAMINING THE EFFECTS OF CASUAL VIDEO GAMEPLAY AS AN INTERVENTION 




The Faculty of the Department of Addictions and Rehabilitation Studies 
East Carolina University 
In Partial Fulfillment 
of the Requirements for the Degree 
Ph.D. Rehabilitation Counseling and Administration 
by 
Christina M. Brown-Bochicchio  
December 2020 
©Copyright 2020 
Christina M. Brown-Bochicchio 
EXAMINING THE EFFECTS OF CASUAL VIDEO GAMEPLAY AS AN INTERVENTION 
TO ALLEVIATE SYMPTOMS OF DEPRESSION ON BOTH SUBJECTIVE AND 
OBJECTIVE MEASURES 
by 
Christina M. Brown-Bochicchio 
APPROVED BY: 
DIRECTOR OF DISSERTATION: _________________________________________________ 
Paul J. Toriello, Rh.D 
COMMITTEE MEMBER: ________________________________________________________ 
Carmen Russoniello, Ph.D. 
COMMITTEE MEMBER: ________________________________________________________ 
W. Leigh Atherton, Ph.D.
COMMITTEE MEMBER: ________________________________________________________ 
Stephen J. Leierer, Ph.D. 
CHAIR OF THE DEPARTMENT OF ADDICTIONS  
AND REHABILITATION STUDIES: _______________________________________________ 
Paul Toriello, Rh.D. 
DEAN OF THE GRADUATE SCHOOL: ____________________________________________ 
Paul Gemperline, PhD 
DEDICATION 
This dissertation is dedicated to my family. To my parents, Ralph and Marina, you both 
never waiver in your constant and consistent support of my dreams and my passion to pursue a 
career in helping people. I am empowered to achieve success only through your support. This 
dissertation is equally dedicated to my sister Jane. You are my best confidant, advocate, friend 
and support through all the triumphs and tribulations of my work and life. Lastly, I would like to 
dedicate this dissertation to my uncle Kevin and all individuals with disabilities. May we all 
continue to pursue and support treatment that supports individuals’ optimal growth potential.  
TABLE OF CONTENTS 
LIST OF TABLES ......................................................................................................................... xi 
CHAPTER I: INTRODUCTION .................................................................................................. 1 
Introduction to the Study ....................................................................................................... 1 
Background to the Problem ................................................................................................... 4 
Subtypes of Depression ................................................................................................. 6 
Mild depression .................................................................................................... 6 
Moderate depression ............................................................................................ 7 
Major depression .................................................................................................. 7 
Treatment-resistant depression ............................................................................ 7 
Difficulty in Treating Depression ................................................................................. 8 
Traditional Treatment Interventions for Depression ................................................... 10 
Complementary and Alternative Interventions for Depression .................................. 13 
Casual Video Games ............................................................................................................ 15 
Theory of Relationship between Depression and Casual Video Game Interventions ......... 16 
GameFlow Model ....................................................................................................... 16 
Mental-health and Gaming ......................................................................................... 18 
Depression and Alpha Wave EEG Measurement ....................................................... 19 
Statement of the Problem ..................................................................................................... 21 
Purpose of the Study ............................................................................................................ 25 
Research Questions .............................................................................................................. 26 
Definitions of Terms ............................................................................................................ 27 
Study Justification ................................................................................................................ 28 
Significance of the Study ..................................................................................................... 30 
Chapter Summary ................................................................................................................ 33 
CHAPTER II: LITERATURE REVIEW ..................................................................................... 34 
Introduction to Literature Review ........................................................................................ 34 
General Depression and Subtypes ....................................................................................... 34 
Mild Depression ................................................................................................................... 35 
Moderate Depression ........................................................................................................... 36 
Major Depressive Disorder .................................................................................................. 37 
Prevalence ................................................................................................................... 38 
Etiology of Depression ............................................................................................... 39 
Treatment-Resistant Depression .......................................................................................... 41 
Depression Interventions ..................................................................................................... 43 
Pharmacological Interventions .................................................................................... 46 
Antidepressants .................................................................................................. 48 
Psychotherapy ............................................................................................................. 56 
Virtual Psychotherapy ................................................................................................. 60 
Neurostimulation Strategies ........................................................................................ 61 
Aerobic Exercise ......................................................................................................... 65 
Summary of depression treatment interventions ......................................................... 67 
Measuring Depression using EEG ....................................................................................... 68 
Casual Video Games ............................................................................................................ 73 
Gaming History ........................................................................................................... 76 
Puzzle Games – Peggle, Bejeweled, Bookworm Adventures ..................................... 78 
Video Game Research .......................................................................................................... 80 
Negative Effects of Gaming ........................................................................................ 82 
Positive Effects of Gaming ......................................................................................... 84 
Summary of Literature Review ............................................................................................ 86 
CHAPTER III: METHODS .......................................................................................................... 88 
Introduction to Methods ....................................................................................................... 88 
Archival Data Collection Procedures ................................................................................... 88 
Research Design ................................................................................................................... 89 
Treatment Groups: Comparison Group and Study Group .......................................... 90 
Comparison group .............................................................................................. 90 
Study group ........................................................................................................ 91 
Population ............................................................................................................................ 92 
Sample and Sampling .......................................................................................................... 92 
Sampling Procedure .................................................................................................... 93 
Study Setting ........................................................................................................................ 94 
Data Collection Procedures .................................................................................................. 95 
Data Collection Times ................................................................................................ 96 
Data Collection ........................................................................................................... 96 
Treatment Protocol ...................................................................................................... 99 
Instrumentation/Variable Operationalization ....................................................................... 99 
Demographic Profile Questionnaire ........................................................................... 99 
Patient Health Questionnaire (PHQ-9) ..................................................................... 100 
Instrument development ................................................................................... 100 
Scoring ............................................................................................................. 101 
Psychometric properties ................................................................................... 101 
Electroencephalography (EEG) ................................................................................ 103 
Log Sheet .................................................................................................................. 105 
Statistical Analysis Plan ..................................................................................................... 105 
Research Questions ................................................................................................... 108 
Summary of Methods Chapter ........................................................................................... 108 
CHAPTER IV: RESULTS .......................................................................................................... 109 
Introduction to the Chapter ................................................................................................ 109 
Data Handling Procedures ................................................................................................. 109 
Demographic Data ............................................................................................................. 109 
Data Collection Times ....................................................................................................... 114 
Primary Statistical Analysis ............................................................................................... 115 
Chapter Summary .............................................................................................................. 120 
CHAPTER V: DISCUSSION ..................................................................................................... 122 
Introduction ........................................................................................................................ 122 
Study Review ..................................................................................................................... 122 
Interpretation of Results ..................................................................................................... 123 
Sample Size ............................................................................................................... 123 
Sample Demographics .............................................................................................. 124 
Age ................................................................................................................... 125 
Gender .............................................................................................................. 125 
Race .................................................................................................................. 126 
Highest level of education ............................................................................... 127 
Employment status ........................................................................................... 127 
Marital status .................................................................................................... 127 
Experience playing video games ..................................................................... 128 
Discussion of Findings Related to Research Questions ............................................ 129 
Discussion of Findings Related to Research Question One ...................................... 129 
Discussion of Findings Related to Research Question Two ..................................... 133 
Discussion of Findings Related to Research Question Three ................................... 137 
Summary of Research Question Results ................................................................... 139 
Limitations of the Study ..................................................................................................... 141 
Limitations of Study Design ..................................................................................... 141 
Archival data .................................................................................................... 141 
Sample limitations ........................................................................................... 143 
Self-selected intervention ................................................................................. 143 
Limitations of Instrumentation ................................................................................. 143 
Limitations of Study Analysis .................................................................................. 146 
Ethical Considerations ....................................................................................................... 147 
Implications of the Study ................................................................................................... 147 
Implications for Practice ........................................................................................... 148 
Implications for Research ......................................................................................... 150 
Future Research Recommendations ................................................................................... 151 
EEG Right vs. Left Alpha Differentiation ................................................................ 151 
Objectivity in Measuring Mental-Health Outcomes ................................................. 152 
Depression Specific Alternative Intervention and Videogame Research ................. 154 
Chapter Summary .............................................................................................................. 156 
References .......................................................................................................................... 158 
LIST OF TABLES 
1. Data Collection Procedures .....................................................................................................97 
2. PHQ-9 ...................................................................................................................................110 
3. Gender ...................................................................................................................................111 
4. Employment Status Category ...............................................................................................112 
5. Educational Background .......................................................................................................112 
6. Marital Status ........................................................................................................................113 
7. Race .......................................................................................................................................113 
8. Age ........................................................................................................................................114 
9. Gaming ..................................................................................................................................114 
10. Alpha Wave EEG ................................................................................................................116 
11. Mean Differences on Alpha Wave EEG between Control and Experimental Groups .......117 
12. PHQ ....................................................................................................................................118 
13. Mean Differences on PHQ ..................................................................................................118 
14. Correlation Coefficient Matrix on Variables ......................................................................120 
15. PHQ-9 Categorical Distinction ...........................................................................................135 
16. PHQ-9 and Alpha Amplitude Pearson’s Correlation ..........................................................137 
CHAPTER I: INTRODUCTION 
Introduction to the Study 
Over the course of a person’s lifetime, 15% of the US population will experience an 
episode of depression (National Institute for Health and Clinical Excellence [NICE], 2010). 
Worldwide, the prevalence of depression ranges from 4.5%-37.4% (Cao et al., 2019). According 
to the American Psychiatric Association (APA), depression is the leading cause of suicide and 
the carries highest disease burden on society in terms of health care costs, depression’s effects on 
families and caregivers and its impact on productivity in the workplace (Pilling et al., 2009). 
Depression is often disabling and distressing and for many, a chronic condition, especially as it 
becomes difficult to treat (Choi, et al., 2011). Depression in general is associated with high rates 
of health care utilization and severe limitations in daily functioning (DiMatteo et al., 2010).  
The general diagnosis of depression is the leading cause of years of life lost due to 
disability and is responsible for more than 10% of years of life lost across all diseases (World 
Health Organization, 2012). The economics of healthcare alone spotlight the overwhelming 
burden of depression with overall US expenditures topping $200 billion (Greenberg et al., 2015). 
Demographically, women are almost twice as likely as men to have a diagnosis of depression 
(Brody et al., 2018). The prevalence of depression has also been found to decrease as family 
income levels increase (Brody et al., 2018). It is further estimated that 80% of adults with 
depression reported at least some difficulty with work, home and social activities due to their 
depression (Brody et al., 2018).  
Currently, the standard treatment of care for most subtypes of depression is primarily a 
prescribed regimen of antidepressants usually either selective serotonin reuptake inhibitors 
(SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) (Cao et al., 2019).While 
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traditional treatment approaches for depression often recommend strict pharmacological 
interventions, this conflicts with multidisciplinary treatment guidelines which may also include 
non-pharmacological approaches such as counseling and other neurostimulation approaches 
(National Institute for Health and Care Excellence [NICE], 2009). For example, the NICE (2009) 
guidelines state that clients with moderate to severe symptoms of depression should receive a 
combination of psychological and pharmacological treatments. Wiles et al., (2013) evaluated the 
effectiveness of using cognitive behavioral therapy (CBT) along with pharmacological treatment 
in the primary treatment of major depression and found that study participants receiving 
cognitive behavioral therapy (CBT) exhibited a significantly higher response rate at 6 months 
when compared to those receiving pharmacological treatment alone at 46% vs. 22% 
comparatively. Several studies have reviewed the effectiveness of singular psychotherapy 
interventions for use in mild and moderate depression, however, very few studies have explored 
whether psychotherapy alone is effective for clients with chronic major depressive disorder 
(MDD) who have not reached remission of symptoms (Cladder-Micus, et al., 2018).  
Within the category of non-pharmacological, supplemental approaches recent 
applications of video gameplay have grown in popularity for investigating potential effects as a 
mental-health intervention (Kuhn, et al., 2018).  Most of the studies specifically looking at video 
game usage within the context of depression have used custom made games for training that 
have explicitly included elements of CBT and psychoeducation (e.g., SPARX; Kuhn, et al., 
2018). The first evidence for potential positive effects of commercial video games on alleviating 
depression specific symptoms came from the original data collection of this study by Russoniello 
et al., (2013) that asked clients with depression to play one of three different commercial puzzle-
based video games. This innovative approach using commercially available video games serves 
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as the basis for this current replication study which employed similar methodology and 
additionally examined the effects of gameplay on electroencephalogram (EEG) indicators for 
changes in depression in addition to self-reported changes.  
Although non-pharmacological approaches to treating depression in conjunction with 
pharmacological interventions have been studied, psychosocial and behavioral approaches have 
still been insufficiently studied to date (Johnston, et al., 2018). The purpose of the current study 
was to examine if a prescribed regimen of casual video game (CVG) play could reduce 
symptoms of depression in a study group as compared to a comparison group of study 
participants. Additionally, this analysis highlights the potential advancement of using both 
subjective and objective duel report measures to examine the effectiveness of treatment options 
by utilizing both the self-report Patient Health Questionnaire (PHQ-9) and the objectively 
measured electroencephalogram (EEG) data to compare study groups. This study utilized 
archival data collected from a previous, multi-phase study that examined video gameplay as an 
augmentation intervention for individuals with both depression and comorbid anxiety. 
This chapter will provide an overview of the practical and theoretical connections 
between the research questions of this study and the necessity for addressing the gap in treatment 
options for depression (Mrazek et al., 2014).  Topics outlined in this chapter will be expanded 
upon in Chapter two. The purpose of this current chapter is to introduce (a) the background 
issues of this study’s focus (b) theoretical orientation of the study (c) the statement of the 
problem (d) the purpose of the study (e) research questions of the study (f) definitions of 
important terms of the study (g) justification for the study (h) significance of the study. This 
chapter will conclude with a summary of content. 
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Background to the Problem 
Depression symptoms may vary from mild to severe and may include: feeling sad, loss of 
interest in activities once enjoyed, changes in appetite, difficulty sleeping, fatigue, feelings of 
worthlessness or guilt, difficulty in thinking and decision making as well as thoughts of death 
and suicide (APA, 2013). While individuals experiencing depression do not all exhibit the same 
symptoms or intensity and frequency of symptoms, researchers have found some commonalities 
in known risk factors for depression (Russoniello, O’Brien & Parks, 2009). 
Internal and environmental risk factors potentially play a role in the onset of depression 
(APA, 2013). Internally, differences in certain brain chemicals may contribute to symptoms of 
depression (Blanco et al., 2010). Personality characteristics such as low self-esteem, 
overwhelming feelings of stress and pessimistic attitudes of individuals appear to potentially 
yield propensities towards depression (APA, 2013). Additionally, genetic factors including 
specific identified enzymes are increasingly being researched by exploring gene mutations and 
may provide links to depression that may run in families (Serretti, Chiesa, Calati, et al., 2011). 
Environmental conditions such as continuous exposure to violence, neglect, abuse and persistent 
poverty can also potentially make individuals more vulnerable to depression (DiBernardo et al., 
2018). More recently, exposure to environmental pollutants from the air, water, chemically-
based food additives as well as electrical pollution generated from technological increases in 
electromagnetic fields are being researched as potentially compounding causes for increased 
rates of depression (Nemade & Patricelli, 2019).  
Depression is currently the leading cause of disability in the United States and worldwide 
(Anxiety and Depression Association of America [ADAA], 2019). Globally, 322 million people 
live with depression (ADAA, 2019). Within the United States, between 2013-2016, 8.1% of 
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Americans age 20 and older had depression in a given 2-week period (National Center for Health 
Statistics [NCHS], 2016). Demographics of depression vary by age, sex, income and health 
behaviors (Blanco, et al., 2010). While depression can develop at any age, the median age of 
onset is 32.5 years old (ADDA, 2019). Depression is almost twice as common among women as 
men in all countries with global rates at 4.1% and 2.7% respectively for women and men (Brody, 
Pratt & Hughes, 2018).  Rates of depression vary significantly when family income level or 
socioeconomic status is considered. Overall, 15.8% of adults from families living below the 
federal poverty level had depression (Brody et al., 2018). Across all categories of the federal 
poverty level, the prevalence of depression decreased with increasing levels of family income 
(Brody et al., 2018). This prevalence drops to just 3.5% among adults at or above 400% of the 
federal poverty level (Brody et al., 2018).  
Depression has become a commonly used term in society; however, depression is a 
serious condition with particular nuances beyond the broadly popular term (Cherney, 2018). 
There are several criteria indicators for depression. According to the American Psychiatric 
Association (2013), at least five of the nine characteristics must be present including a loss of 
interest and pleasure, persisting for most of almost every day for at least two weeks in order to be 
categorized as major depression. There are several subtypes of depression. The three that were 
discussed in this study are mild, moderate, major and treatment-resistant depression. The exact 
classification of subtypes of depression are based on many factors and defined differently, 
depending on the assessment instrument used during a screening or diagnostic process (Cherney, 
2018). Some of the factors used during consideration of subtype include: symptoms experienced, 
severity of symptoms, frequency and duration of symptoms (Cherney, 2018).  When less than 
five of these symptoms are present, the condition is characterized as minor depression (APA, 
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2013). These symptoms must be independent of physical illness, normal bereavement, and 
alcohol or drug use (Pandarakalam, 2018). The subtypes of mild, moderate and major depression 
have been selected for this study as they correlate with the categories presented on the PHQ-9 
scale, which was used in this study.  
Subtypes of Depression 
Mild depression. Mild depression is generally described as “feeling blue” temporarily 
(Cherney, 2018). Symptoms of mild depression may occur for days and are noticeable enough to 
interfere with typical daily activities. Some of the described symptoms of mild depression 
commonly include: irritability, hopelessness, feelings of guilt, lack of motivation, fatigue and 
insomnia (Cherney, 2018). Though mild depression is noticeable, it is the most difficult to 
diagnose as symptoms may also be easily to dismiss (Cherney, 2018). Despite the challenges of 
diagnosis, mild depression is the easiest subtype to treat (Hu et al., 2016). 
Lifestyle interventions remain one of the most impactful interventions for individuals 
with mild depression (Rejeski & Williamson, 2018). Lifestyle interventions such as exercise, 
adhering to a sleep schedule and practicing stress reduction techniques may boost serotonin 
levels in the brain, which help deter symptoms of depression (Rejeski & Williamson, 2018). 
Other treatments for mild depression include nutritional supplements such as St. John’s Wort and 
melatonin (Cherney, 2018). Antidepressant medications, while often prescribed for mild 
depression, are not the recommended course of action for this subtype of depression (NICE, 
2010). Rather, it is recommended that individuals with mild depression first seek treatment 
through non-pharmacological methods such as group therapy and physical exercise (Pilling, 
2009).  
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Moderate depression. On a scale of symptomatic severity, moderate depression follows 
mild depression. While moderate and mild depression often include similar symptoms, moderate 
depression generally includes a few distinguishing characteristics (Cherry, 2020). These 
additional characteristics include: persistent negative self-esteem, reduced productivity, 
excessive worrying and feelings of worthlessness (Cherry, 2020). The most noticeable difference 
between mild and moderate depression is that moderate symptoms are severe enough to cause 
issues with home and work life (Cherry, 2020). Individuals with moderate depression may also 
experience challenges in their social life, different than in previously memorable years (Cherney, 
2018). Generally, moderate depression is easier to diagnose than mild depression as symptoms 
are severe enough to significantly impact one’s life (Cherry, 2020). Antidepressant medications 
are often described for individuals with moderate depression (Cherry, 2020). Additionally, CBT 
and other forms of psychotherapy are effective and commonly advised for individuals with 
moderate depression (Bekhuis et al., 2018). 
Major depression. Major depressive disorder (MDD) is a serious public health concern 
with 6.7% of United States adults having at least one major depressive episode in 2015 with 
significant impairment on individuals’ quality of life (Johnston, et al., 2018). Major depressive 
disorder is further concerning as there is a strong link between MDD and suicide. It has been 
estimated that up to 60% of individuals who have committed suicide had major depression 
(Pandarakalam, 2018). In particular, treatment-resistant depression (TRD) represents a key 
unmet focus within the management of MDD (Johnston et al., 2018). 
Treatment-resistant depression. Prior to an individual’s MDD becoming defined as 
Treatment-resistant, treatment of MDD most often consists of pharmacological intervention, 
either a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake 
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inhibitor (SNRI) medication and may also include a variety of non-pharmacological approaches 
such as:  psychosocial behavioral interventions, neurostimulatory approaches, exercise and a 
growing array of other complementary and alternative medicines (CAM) (McIntyre, et al., 2014).  
It should be noted that research indicates that failure to respond to pharmacological interventions 
in clients with MDD is not a predictor of non-response to psychotherapy (McIntyre et al., 2014). 
Treatment-resistant depression (TRD) is a specific subtype of major depressive disorder (MDD) 
that is categorized by chronic and persistent failed attempts to achieve remission of major 
depressive disorder symptoms following multiple methods of treatment (Peeters et al., 2016). 
Treatment-resistant depression is often diagnosed after an individual’s reported MDD symptoms 
remain either untreated or treated without remission (Rush et al., 2009). It should also be noted 
that prior to categorizing an individual’s depression as TRD, past and current treatment attempts 
should be carefully evaluated to ensure standards of adequate dosage, treatment duration and 
patient adherence have been met (Shelton, Osuntokun, Heinloth, & Corya, 2010). Age may also 
play a role in the onset of TRD as research has suggested that depression often occurs in older 
adults as this category of individuals may become less responsive to treatment options over time 
(Al-Harbi, 2012). Additionally, research in TRD has found that correlations between high levels 
of stress and noncompliance with medication treatment may contribute to developing TRD (Rush 
et al., 2009). More detailed information regarding potential causes of TRD will be further 
discussed in chapter two of this proposal.  
Difficulty in Treating Depression 
The treatment of depression is quite difficult as the accepted course of treatment heavily 
relies on subjective assessment on the part of a therapist or treating physician (Pilling et al., 
2009). The process of diagnosis and treatment of depression symptoms involves a process in 
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which the client must honestly and fully report all symptoms. In many situations, clients may 
hide the true extent of their feelings, or alter social presentation of their emotions as clients may 
be hesitant due to social stigma or other factors to disclose the severity of symptoms (Solomon et 
al., 2015). While this is an understandable feeling for a client to have, it may prevent decrease 
the probability of receiving an accurate diagnosis and course of treatment from the practitioner 
(Solomon et al., 2015). The National Institute of Health and Clinical Excellence however has 
recommended that when a person is assessed for having depression, a more comprehensive 
assessment should occur that does not simply rely on symptom count reported by the client 
(Pilling et al., 2009). Rather, the clinician should take into account the degree of functional 
impairment and/or disability associated with the possible depression to determine severity and 
help to establish a duration of a depressive episode (NICE, 2010).  
There is no known specific cause of depression, rather, a range of factors may contribute 
to the onset of the condition (Shelton et al., 2010).  Personal factors such as fewer interpersonal 
or economic resources, minority status, lower functional abilities, and chronic depression may 
cause clients to be more likely to experience depression (Thase, 2011). Depression has been 
associated with several negative health and daily functioning outcomes that may impair an 
individual’s overall satisfaction with their livelihood (Knoth et al., 2010). Among adults with 
depression, 50.2% report some difficulty with work, home or social activities because of their 
depression symptoms (Brody et al., 2018). These negative outcomes include: increased 
emergency department visits and hospitalization and poorer overall health-related quality of life, 
greater risk of unemployment and reduced work productivity (Knoth et al., 2010). Clients with 
depression are more likely to incur comorbid physical and mental disorders, marked by greater 
functional impairments than individuals without depression (Fekadu et al., 2009). Some studies 
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have shown that up to 80% of individuals with depression experience recurrent rates of 
symptoms while on a prescribed anti-depressant medication within one year of achieving 
remission (Fekadu et al., 2009). Moreover, research in the treatment of depression has found that 
at least 50% of clients will not achieve and sustain remission following multiple pharmacological 
approaches (McIntyre et al., 2014). In summary, previous depressive illness-related factors, 
personal characteristics, medication variables, and psychosocial stresses may collectively 
contribute to the development of depression with additional research needed in the area of 
treatment (Baud, 2011). 
Traditional Treatment Interventions for Depression 
The treatment and understanding of depression is quite complex and presents major 
challenges for both clients and clinicians (Fekadu, Donocik & Cleare, 2018). Clients that 
experience resistance to traditional pharmacological interventions comprise approximately 10-
30% of the overall number of clients receiving treatment for depression (Al-Harbi, 2012). Clients 
with MDD for example, often undergo a process of receiving several regimens of 
pharmacological treatment, that combine two or more different medications with potential long-
term side effects (Cartwright, et al., 2016). As levels of depression remain suboptimal over time, 
treatment resistance may develop as attempts by clinicians to match an effective treatment 
regimen with clients does not yield effective alleviation of symptoms. Compounding the effects 
of the trial and error process for most clients, risk of relapse of symptoms for clients using 
traditional antidepressant medications increase if a patient decides to stop using the medication 
(Hollon, Cohen, Singla, & Andrews, 2019).  This process can be tiresome for clients and 
clinicians as dosage requirements vary with an array of factors including: age, gender, weight, 
physical health, other medication usage and tolerance to medications and must be prescribed for 
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clients with all of these factors considered (Al-Harbi, 2012). This process creates a burden for 
clients and clinicians not only from dealing with the distressing symptoms but also from the trial 
and error treatment process (Fekadu et al., 2018).  
The process of diagnosing and treating depression also represents a dilemma for 
clinicians (Al-Harbi, 2012). It has been widely accepted that current diagnostic techniques for 
depression have several disadvantages that are associated with patient denial of symptoms, poor 
sensitivity to diagnostic questions as well as medications, subjective bias by practitioners and 
inaccuracy in diagnosis (Li et al., 2016). As depression has become the biggest health burden 
worldwide, effective detection of the diagnosis is a great challenge and requires latest 
technological tools including EEG (Li et al., 2016). Currently, there is a growing focus on 
finding an easy, accurate and practical method of detection depression and exploration of 
methods such as EEG (Li et al., 2016). The cause of resistance to achieving depression remission 
through traditional pharmacological approaches is multifactorial, making etiology of the root 
cause quite complicated to determine for clinicians (Rush et al., 2009). The range of factors that 
a clinician must consider when diagnosing and treating a client with depression may include: 
fewer interpersonal and economic resources, minority status, lower function and quality of life, 
poor social and family support and treatment non-compliance of previously prescribed treatment 
options (Rush et al., 2009). Ideally, treatment options are addressed through a process of 
individualized assessment, examination of psychopharmacological approaches and a complete 
biopsychosocial analysis for each individual case (Popa-Velea, Gheorghe, Trutescu & Purcarea, 
2015) with particular focus from care providers on previous medication outcomes and 
antidepressant history (Al-Harbi, 2012). This diagnostic process may leave room for clinical 
error as misdiagnosis of identifying the correct subtype of depression such as atypical, psychotic, 
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bipolar or melancholic may impact treatment selection or choice of pharmacologic intervention 
(Al-Harbi, 2012). The difficulty in deciphering unique clinical features, response to treatment 
options and measures of physiological function related to MDD diagnosis compound the 
challenges for clinicians to adequately provide treatment to clients when remission is not 
achieved (Casher & Bess, 2010).  
There is no specific, standardized approach for treating depression, with current strategies 
for mental-health experts relying on self-evaluations and subjective opinions of clients for 
efficacy of treatment options (Al-Harbi, 2012). Clinicians must consider several additional 
pharmacological and nonpharmacological treatment options for depression as medications even 
with optimized dosage and durations have not produced a successful outcome, eventually 
causing a client to become classified as treatment-resistant (Shelton et al., 2010). The process of 
finding the best individualized approach to treatment can take both a lot of time and effort for 
both the clinician and the client, creating a need for research to find a more efficient approach to 
the diagnostic and treatment process (Lynch et al., 2011). 
Research for clinical treatment options of depression have predominantly focused on 
pharmacological interventions thus far (Shelton et al., 2010). Within pharmacological literature, 
little evidence exists to show that any one classes of prescribed antidepressant medication is 
more efficacious than another on average (Cipriani et al., 2018). In DiBernardo et al., (2018) 
health related quality of life outcomes in clients with varying levels of depression were 
examined. The study concluded that clients with TRD had significantly lower scores on both 
mental (p <.001) and physical (p = .0126) quality of life scores (DiBernardo et al., 2018). While 
the emphasis treatment in the literature thus far has focused on pharmacological interventions, 
the increased prevalence depression in general and TRD necessitates therapeutic options other 
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than medication including cognitive behavioral therapy and neurostimulation options that may 
additionally offer intervention relief (Al-Harbi, 2012).  
Clients with depression who exhibit mild to moderate symptoms of depression should 
consider other options of low intensity psychosocial interventions aside from pharmacologically 
suggested medications (Pilling et al., 2009). These interventions are guided by the client’s 
preference and may include:  Individually guided self-help based on principles of cognitive 
behavioral therapy (CBT), computerized CBT, a structured, group-based physical activity 
program, or individualized psychotherapy (Pilling et al., 2009). NICE recommendations for mild 
depression do not include antidepressant medications unless symptoms persist for at least two 
years, however antidepressant medications are the most widely used intervention for all types of 
depression ranging from mild to severe (Pilling et al., 2009).  
Complementary and Alternative Interventions for Depression 
Several intervention alternatives to traditional pharmaceutical treatment for depression 
have been explored in combination with antidepressants or as monotherapy (Shelton et al., 
2010).  Psychotherapy has been used as both a primary intervention and as a conjunctive 
intervention for clients with depression (Al-Harbi, 2012). Psychotherapy has shown to be 
effective in combination with medication, but is dependent on the number of sessions, expertise 
of the counselor, the counselor’s adherence to a particular form of therapy, as well as the 
interaction within the client-counselor dyad (Al-Harbi, 2012). These variables make treatment 
efficiency reliant on the adequacy of specific counselor and client treatment adherence protocols 
and guidelines (Al-Harbi, 2012). Other studies have also shown efficacy for including 
psychotherapy as part of a comprehensive treatment plan. Huijbers et al., (2016) compared 
relapse rates between individuals who selected taking antidepressant medications to those who 
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preferred mindfulness-based cognitive therapy and found no significant differences in relapse 
and recurrence rates between the two preference groups. This provides evidence that both 
psychotherapy and antidepressant interventions may be effective. Both antidepressant medication 
and psychotherapy have been shown to be efficacious, however, response rates to any given 
treatment rarely rise above 50% (National Health Service, 2016).  While a systematic review of 
literature found psychotherapy to be useful for clients with depression, there is a lack of quality 
trials with large enough sample sizes to make any significant clinical claims within some subsets 
including TRD (Trivedi, Nieuwsma & Williams, 2011).  
In addition to cognitive therapy and other forms of psychotherapy, several other types of 
complementary therapies may offer relief from depression symptoms. Electrical stimulation of 
the vagus nerve, behavioral activation therapy, neurofeedback, and chronic stimulation of the 
subgenual cingulate region have shown positive results in clinical trials as well (DeRubeis, 
Siegle & Hollon, 2008). These additional complimentary methods may be especially effective 
with individuals with major depression and TRD. For example, electroconvulsive therapy (ECT) 
is recognized as a consistently effective method of treatment for clients with TRD with a 
response rate of 50-70% (Shelton et al., 2010). It should be noted as well that ECT has been 
identified as the treatment of first choice of clients with the most severe cases of TRD (Al-Harbi, 
2012).  Researching the effectiveness of certain complementary approaches, Park et al., (2013) 
conducted a meta-analysis of alternative forms of treatment as opposed to antidepressant 
medication offered in Korea and found that both bibliotherapy and exercise therapy had similar 
treatment results in decreasing symptoms of depression. Regular exercise has also been found to 
positively impact depression symptoms, but further research is needed in this area to show true 
clinical implications (Mota-Pereira et al., 2011).  
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Casual Video Games 
In addition to these complementary treatment options, a growing body of research has 
investigated the use of video games as a newer alternative intervention (Fish, Russoniello & 
O’Brien, 2018). Researchers have stated that video games possess intrinsic qualities that may 
positively effect various mental-health symptoms (Fish et al., 2018). Some of these positive 
outcomes include promoting real-life social relationships (Kowert & Oldmeadow, 2013), 
increasing educational outcomes and increasing skill development (Lamb, Annetta, Firestone & 
Etopio, 2018). Moreover, Kato (2010) found that some types of games categorized as “serious” 
can be valid methods for delivering education and training to clients with physical injuries, pain 
resulting from burns, diabetes, and asthma.  
Casual video games (CVGs) are categorized differently from serious video games as 
CVGs are described as fun, easy to play, and spontaneous and were not created with specific 
educational or training properties in mind (Casual Games Association [CGA], 2008). The Casual 
Games Association states that CVGs do not require previous gaming skills and cab be played in 
small time increments due to the nature of these games that are easy to start, pause and restart at 
any time (CGA, 2008).  Some examples of commonly played CVGs include:  Bejeweled, 
Solitaire, Plants vs Zombies, and Peggle. While few studies have shown efficacy for use of video 
games in reducing stress (Russoniello, O’Brien & Parks, 2009), anxiety (Fish, Russoniello & 
O’Brien, 2014) and depression (Russoniello, Fish & O’Brien, 2013); current research has not 
investigated the changes these games may have on alpha brain waves in addition to self-report 
measures of depression.  
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Theory of Relationship between Depression and Casual Video Game Interventions 
Several theories support the potential use of CVGs as an intervention for alleviating 
depression symptoms, although the field of video game research thus far has faced challenges in 
identifying an agreed-upon theory that explains the positive traits of video games. The discourse 
in game theory may stem from long-held, antiquated negative stigma of video games which 
paints an inaccurate image of those who may identify as “video gamers” (LaFleur, Hebert & 
Dupuy, 2018). The general public perception of the video game community thus far has widely 
been perceived as being primarily male, unhealthy, anti-social and wasteful of their time 
(LaFleur et al., 2018). Although past research supported these stereotypes by putting forth effort 
to focus on the potential drawbacks of gaming, recent scholarly research has shifted to focus on a 
wide range of both of passive and active positive mental-health benefits of playing some video 
games (Granic, Lobel, & Engels, 2014). 
GameFlow Model 
The general industry of gaming has grown into such a universally accepted activity that 
use of games in expanded areas such as mental-health interventions has become the focus of 
recent research (Kuhn et al., 2018). Recent research concluded that across all age groups, more 
than 185 million people play and enjoy videogames within the United States (Entertainment 
Software Association, 2017). The rapid expanse of home-based computer accessibility across 
demographic sectors and expectation of widespread internet access has recently triggered a 
growing area of research into the development of novel and cost-effective technologies for 
general mental-health therapy (Fernandez-A. et al., 2012). Home based, technological 
interventions such as gaming, may assist with mental-health conditions such as depression by 
offering clients an alternative option that may help overcome personal barriers to receiving 
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treatment such as:  personal stigma, high costs, waiting lists and potential shortage of qualified 
providers based on a client’s geographic location (Li, Theng & Foo, 2014). One particular 
gaming theory that may help explain the mechanism behind the positive effects of gaming on 
individuals is the GameFlow model.  
The GameFlow model is a general model used to explain player enjoyment and is 
applicable to all game genres and platforms (Sweetser et al., 2017). GameFlow is a model based 
in explaining player enjoyment. It is comprised of criteria derived from gaming user experience 
literature and includes eight elements (Sweetser et al., 2017). The GameFlow model has been 
used to evaluate a variety of games and applications including mobile games such as Bejeweled, 
Peggle and Bookworm Adventure (Paavilainen, et al., 2009). The eight core elements of player 
enjoyment in games are:  concentration, challenge, skills, control, clear goals, feedback, 
immersion and social interaction (Sweetser et al., 2017). Games that adhere to the GameFlow 
model keep players concentration through a challenging workload but not so challenging that the 
task is no longer enjoyable. These tasks must have clear goals so the player knows how to 
conquer the task and the player must receive sufficient feedback on progress towards completing 
these tasks (Sweetser et al., 2017). If the player and game meet these combined markers, the 
player will feel a total immersion in the game, causing a loss of awareness of daily concerns and 
stressors, producing the result of enjoyment (Sweetser, et al., 2017). While this concept of 
increased gaming enjoyment may not yet be directly linked to lowering reported levels of 
depression, this sensation describes a reduction in rumination, often reported in individuals with 
TRD (Kuhn, 2018).  
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Mental-health and Gaming 
Video game research continues to expand in the area of examining the mechanisms 
behind the positive effects gaming on mental-health outcomes within several domains including 
cognitive, motivational, and social benefits (Ewoldsen et al., 2012; Russoniello et al., 2009; Uttal 
et al., 2013; Ventura et al., 2013). Cognitive based neuropsychological research has suggested 
that positive brain chemical changes may hold therapeutic value as produced by digital 
interventions for depression therapy (Li, Theng & Foo, 2014). Craig et al., (2013) found that 
positive game-playing experiences trigger the release of “feel good” chemicals of striatal 
dopamine and endorphins, that produce feelings of pleasure and well-being (Salamone, 2009). 
Action game-based research that utilizes fast paced gaming have also found increased cognition 
and decreased reported levels of rumination, which can be associated with depression (Kuhn, et 
cal., 2018). These decreased reported levels of rumination are most likely due to improvement in 
executive function caused by focused attention to the gameplay (Kuhn et al., 2018). While the 
mechanism behind what may produce these changes as a result of gaming continues to be 
examined, EEG measurements of brain wave activity support these findings. Alpha-asymmetry 
(AA) occurs when increases in right alpha are present, as evidenced by EEG measurements 
relative to left alpha measurements. This effect may be associated with a reduction in depressive 
symptomatology (Peeters et al., 2014). Objective measures such as EEG have shown that 
cognitive outcomes such as executive function, attention and memory, normally associated with 
decreases in clients with major depression may increase as a result of video gameplay (Kuhn et 
al., 2018).  
Casual video game specific research has rarely been conducted but has thus far suggested 
that that nature of puzzle-like video games may be more rewarding and less frustrating than other 
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types of gaming and thus best suited to entertain clients with an outcome of increased mood 
(Russoniello, O’Brian & Fish, 2013). The potential positive effects of CVGs on reducing 
depression has been described as part of GameFlow Theory and may be due to the immediate 
and concrete feedback in the form of items such as reward points, obtaining coins, flashing lights 
and sounds, etc., built in games that serve to reward continual effort and keep players engaged 
(Sweetser et al., 2017). Philosopher Vygotsky termed this effect the, “zone of proximal 
development” (Granic et al., 2014). This zone is described as the balance of optimal challenge 
and frustration with conscious experiences of success and accomplishment (Sweetser & Wyeth, 
2005). In the most effective video games on the market, this “sweet spot” works so well because 
it dynamically adjusts itself, making the level of difficulty continuous by calibrating the game 
with the players’ abilities and then increasing the difficulty of the levels, eliciting more dexterity, 
focus, quicker reaction times and more complex solutions (Granic et al., 2014). Although several 
studies have targeted the use of video games to encourage general health improvement, most 
studies have not focused on the effects of such treatment on depression (Li, Theng & Foo, 2014). 
In order to begin to investigate the reasons CVGs may effectively reduce symptoms of 
depression, it is first necessary to understand what depression may look like as an EEG 
measurement.   
Depression and Alpha Wave EEG Measurement 
Through several historical and recent research studies, it has been determined that 
depressive symptoms are associated with brain cortical abnormalities, highly involving the 
prefrontal cortex area (Cao, 2019). There are several methods to measure prefrontal cortex 
activity. Among these types of physiological data, EEG measures emotional human brain activity 
in real time (Cai et al., 2018). This measurement is recorded by reading spontaneous, rhythmic, 
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electrical activity of brain neurons through the surface of the scalp (Cai et al., 2018). On an 
electrophysiological level, Davidson et al., (1979) theorized that certain regions of the two 
cerebral hemispheres (left and right) are differentially lateralized (i.e., asymmetrical) for 
processing of positive and negative affective stimuli. The difference in alpha activity between 
both the left and right prefrontal regions is known as alpha-asymmetry (AA) (Peeters et al., 
2014). Early studies of EEG asymmetries examined the left and right hemispheres in response to 
affective stimuli and found that asymmetrical activation to positive versus negative events was 
observed predominantly in the frontal region of the brain (Davidson, Schaffer & Saron, 1985). 
This frontal region is the location in which alpha wave activity is measured. Essentially, this 
early research concluded that greater activation of the left frontal hemisphere occurs, during 
positive affect events, and is associated with positive feelings as opposed to a greater activation 
found in the right frontal hemisphere, associated with an avoidance or withdrawal affect and 
negative emotions (Chia et al., 2016). Thus, individuals with depressive symptoms consistently 
exhibit higher levels of right frontal activation during rest (Schaffer et al., 1983).   
Davidson’s theory that originally explained the alpha-asymmetry observed in clients with 
depression, asserts that depression involves a disorder of emotion. His theory stated that 
individuals experiencing depressive symptoms should display a pattern of both behavioral and 
EEG asymmetry, unique for individuals with depression as compared to clients without 
depression (Davidson, Schaffer & Saron, 1985). Davidson’s theory has been supported by 
numerous experiments, that have concluded observed differences in asymmetry exist when 
comparing samples with and without depression, during times of rest as well as in response to 
cognitive and affective tasks (Chia et al., 2016). A substantial number of EEG studies have found 
a correlation between left-right hemispheric asymmetry in the frontal regions of the cortex and 
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depressive symptoms (Thibodeau, Jorgensen & Kim, 2006). Choi et al., (2011) sought to 
replicate previous findings that frontal asymmetric activation can be an underlying mechanism 
for depression. In their replication study, results showed that following neurofeedback training, 
participants in the experimental group showed improvements of relative right alpha power as 
compared to a control group who did not show any difference (Choi et al., 2011).  In one 
example, Fingelkurts et al., (2006) recorded resting EEG data in a sample of clients with 
depression and a sample of clients without depression to compare changes in brain waves. This 
study found significantly less left-sided activation in the sample of clients with depression as 
compared to the normal subjects. Multiple other studies have similarly concluded that reduced 
left frontal and/or increased right frontal activity exists at rest in clients with depression 
(Thibodeau, Jorgensen & Kim, 2006). Many of these more recent studies, have been interpreted 
within the context of Davidson’s original theory. In one of Davidson’s early experiments, 
increased intensity of happiness was associated with greater left frontal activation (Davidson, 
Schaffer & Saron, 1985). The high correlations (.74) between self-report levels of happiness and 
EEG findings Davidson, Schaffer & Saron’s (1985), work support the focus of this particular 
research that will seek to look for correlations between self-report measures and observed EEG 
data. By examining objective outcome data such as with EEG measurement, there is hope that 
clients may endure a more streamlined approach to treatment through the information provided 
to their clinician’s with EEG, direct brain activity information. 
Statement of the Problem 
The increase in individuals with diagnosed depression poses a significant challenge for 
health care systems worldwide. As the demand to treat clients with MDD increases, additional 
resources to improve overall mental-health quality continues to grow (Cipriani et al., 2018). 
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Traditionally, assessment and treatment of MDD begins with a diagnostic evaluation consisting 
of a subjective interview and potentially a physical examination to make sure depression 
symptoms are not due to a medical condition such as a thyroid problem or tumor (Parekh, 2017). 
During the diagnostic evaluation, a clinician may utilize a variety of self-report assessments such 
as the PHQ-9, to help determine depression diagnosis as well as proper course of recommended 
treatment. The clinician then selects a treatment plan, based on several factors including:  the 
pattern, severity and persistence of depressive symptoms as well as any history of previous 
depression diagnosis and any other co-existing medical diagnoses. While this process remains 
the clinical standard of treatment, there are several challenges presented by this subjective 
process, as assessment of behavior in mental-health practice may be constrained by individual 
subjective observation and lack of real-time, naturalistic measurements (Solomon, et al., 2015).  
Symptoms of depression can vary greatly both within and between individuals, 
compounding the difficulty in assessment, especially as individuals may adapt their behavior to 
meet the context of their social environment (Solomon et al., 2015). Self-report assessments rely 
on the client’s willingness to seek treatment, report symptoms authentically, and the clinician’s 
ability to interpret this client feedback adequately, to formulate a treatment plan (Von Korff, 
Katon, Unutzer, Wells & Wagner, 2001). It is quite logical to reason that in this highly subjective 
process, there may be varying margins of error. This difficulty is only made worse as treatment 
failure and rates of relapse in some clients with MDD increase consistently along with the 
number of attempted treatment steps and the client may become categorized as having TRD 
(Johnson et al., 2018).  
The current guidelines for the treatment of depression do not meet the criteria of 
evidence-based medicine and better-quality research is needed to help inform treatment practices 
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(Pandarakalam, 2018). Due to the limitations of the current, subjective standard of diagnosis and 
treatment, an objective approach to address depression in general is essential (Cai, et al., 2018). 
Clients with moderation and major depression face challenges beyond other clients with MDD as 
this subset of depression has been associated with decreased health-related quality of life, 
increased mortality, and higher rates of relapse, relative to clients with minor depression within 
one year of remission (Fekadu et al., 2009). Several studies have reported clear and consistent 
trends between increasing level of treatment resistance and total medical costs for both clients 
and employers providing medical coverage (Johnson et al., 2018). This cost increase may be a 
result of several factors, the greatest often being the process of trial and error of medications 
(Khandker et al., 2008). These extra costs are not only financial but also cost clients’ time and 
added stress from medical occurrences including:  increased hospitalization, greater returned 
visits to practitioner offices, additional psychiatry visits, laboratory costs as well as other 
outpatient costs (Kubitz et al., 2013). While antidepressant medication remains the recommended 
first line of treatment for moderate, major and treatment-resistant depression, there are several 
concerns related to this approach. Currently, there is no evidence or consensus for the best 
approach to diagnosing depression or agreement on a preferred outcome, other than general 
remission of symptoms and disagreements persist on defining adequate medication dose and 
duration of treatment (McConnell, Carter & Patterson, 2019). There are no standard benchmarks 
antidepressants for treating depression (Pandarakalam, 2018). In the arena of antidepressant 
medication prescription, debate continues regarding both the short-term and long-term efficacy 
of traditionally prescribed antidepressant medications and the benefits and harms of these drugs 
are understudied (Ioannidis, 2008). Concerns regarding side effects of medications are of 
particular concern within the depression subcategory of individuals with TRD, as these clients 
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often take multiple medications, compounding the possibility of dealing with multiple side 
effects from several medications (Thase, 2011). It has been noted that traditionally prescribed 
psychiatric medications to treat TRD may also suppress symptoms at the cost of making the 
underlying depression worse (Whitaker, 2010). Particular videogames may provide opportunities 
not only for use as specific interventions to treat depression but may also provide a data source to 
help identify symptom strength in disorders such as depression and schizophrenia through 
passive data capture (Carras et al., 2018). Specifically, with regards to the treatment-resistant 
subtype of depression, the current method for diagnosing and treatment is associated with 
increased number of treatment steps due to the nature of the currently common trial-and-error 
approach, resulting in reduced patient health related quality of life and overall health status as 
reported across several studies (Johnston et al., 2018).  
The widely practiced process of assessment, diagnosis and management of depression 
contrasts with numerous technological innovations in other fields of healthcare (Solomon, et al., 
2015). The current process of identifying depression symptoms and selection of appropriate 
treatment options may be difficult for primary care providers when there is a difference present 
between the client’s subjectively described experience and objective criteria of diagnosis (Caplan 
et al., 2010). Recent research has suggested attacking the diagnosis of depression from both a 
biological and non-biological approach (Pandarakalam, 2018). Under this advisement, biological 
psychiatrists should give due prioritization to the non-biological aspects of depression and 
psychotherapists should recognize and not overlook biological correlates with depression 
(Pandarakalam, 2018). Finding convenient and effective methods of detecting depression is an 
emerging topic of research (Cai et al., 2018). As advancement in sensors and mobile technology 
increases, exploring physiological measures such as EEG to detect disorders such as depression 
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opens a new opportunity for an objective and accurate tool to help combat depression (Cai et al., 
2018). The continued research and development of using objective methods such as EEG to both 
assess and treat depression are necessary to improve current diagnostic practice since the clinical 
standard for depression diagnosis is subjective and inconsistent (Solomon, et al., 2015).  
Purpose of the Study 
The purpose of this quantitative, ex post facto study was to examine if individuals who 
adhere to a regimen of playing one of three CVGs can reduce symptoms of depression as 
compared to a group of individuals who did not engage in any intervention. The study used an 
experimental design using prescribed CVG play as the intervention in the study group as 
analyzed against a comparison group that did not engage in any intervention to help alleviate 
their symptoms of depression. Comparisons between and within the two groups were examined 
on both the self-report, PHQ-9 scale as well as on objectively measured changes of 
physiological, alpha wave EEG measurement. This research was part of the second phase of a 
multi-part study investigating CVGs effects on various measures of mood, stress, anxiety and 
depression. Results from the first phase of study demonstrated that participants were able to 
significantly increase mood using a variety of CVGs, but did not examine specific mental-health 
diagnostic symptoms such as depression and did not compare the subjective PHQ-9 results with 
objective, EEG alpha wave measures. 
Most of the current literature on depression interventions focus on the treatment options 
of psychotherapy and medication management or a combination of the two, which may carry a 
financial, social and employment cost for many individuals (Amo et al., 2018). While previous 
studies have researched domains associated with depression such as attention (Dye, et al., 2009) 
and information processing (Powers et al., 2013), very few studies have specifically examined 
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the effects of gaming on reducing depression specific symptoms as measured on instruments 
such as the PHQ-9 and EEG data (Russoniello et al., 2013). Generally, CVGs have been found to 
offer several unique qualities to potentially help treat depression but have not often been 
empirically tested. These qualities include the ease of accessibility and low cost of commercially 
available games. Carras et al., (2018) stated that emerging research suggests that commercially 
available video games show promise in preventive and therapeutic medicine but require 
continued research to become accepted in mainstream medical settings.  
Research Questions 
There were three research questions in this study that examined the effects of two 
different interventions on reducing symptoms of depression in a comparison group and a study 
group. In order to address these research questions, a selected activity of browsing the National 
Institute of Mental-health’s consumer website served as the comparison group independent 
variable and one of three CVGs, either Peggle, Bejeweled or Bookworm Adventures served as the 
study group independent variable. The dependent variables for both comparison group and study 
group were alpha wave, EEG measurements and PHQ-9 scores. It should also be noted that 
while it is not the precise focus of this study, advancements in using duel report, both objective 
and subjective measures, used in this study, may promote increased clinical accuracy and 
efficiency of depression treatment. The precise research questions are as follows: 
RQ1: What is the difference between the comparison group (no intervention) and the 
study group intervention (prescribed CVG play) on objective, alpha wave EEG 
measurements between Time 1 and Time 3, analyzed separately? 
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RQ2: What is the difference between the comparison group intervention (no intervention) 
and the study group intervention (prescribed CVG play) on subjective PHQ-9 scores, 
between Time 1 and Time 3, analyzed separately? 
RQ3: Is there a correlation between changes in alpha wave EEG measurements and self-
report PHQ-9 scores? 
Definitions of Terms 
This section contains the definition of terms used in this dissertation that the reader 
should know.  The author defined these terms so the reader can interpret this dissertation using 
these provided descriptions. 
Alpha wave: Alpha waves are EEG activity with a frequency in the alpha range (8-13 
Hz).  
Casual video game (CVG): Video games are operationally defined as fun, entertaining, 
quick to access, easy to learn, and requires no previous video game skills or regular time 
commitment to play (Russoniello, et al., 2019).  
Cognition: The mental activities that include thinking, understanding, learning and 
remembering. 
Cognitive Behavioral Therapy (CBT): Type of psychotherapy based on a cognitive model 
that helps clients connect their thinking to their behavior for improvement of mood and 
functioning.  
Electroencephalography (EEG): The placement of electrodes on an individual’s scalp at 
designated spots in which electrical activity from the brain can be recorded and different waves 
and amplitudes derived and recorded. 
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Depression: Measured using the score from the Patient Health Questionnaire (PHQ-9). 
The nine-item screening instrument asks about the frequency of symptoms of depression 
occurring within the last two weeks. 
Gameplayer: A person who performs the act of playing a digital game under the 
conditions of his/her personal patterns of media usage (Juul, 2010). 
Patient Health Questionnaire (PHQ-9): A commonly used self-administered tool used to 
screen for depression with a score of ten being the recommended cut-off for detecting depression 
(Manea, Gilbody & McMilan, 2012).  
Treatment-resistant depression (TRDS): A type of depression that occurs when medicine 
partly relieves symptoms of depression or does not help at all and requires additional forms of 
treatment (MHA, 2013).  
Study Justification 
Several studies have investigated the use of non-pharmacological forms of treatment for 
depression symptoms including cognitive behavioral therapy (CBT), vagal nerve stimulation 
(VNS), neurofeedback, etc., as an alternative to traditionally prescribed antidepressant 
medications. However, very few studies have investigated the use of CVGs to treat depression. 
While CVG research related to depression is scarce, some studies have reported causal 
relationships between playing preferred video games and improved mood as well as increases in 
positively experienced emotions (Ryan, Rigby, & Przybylski, 2006; Russoniello, O’Brien & 
Parks, 2009). Coincidentally, one of the main symptoms of depression is a lack of interest in 
pleasurable activities and withdrawal (Russoniello et al., 2013). Casual video gameplay may 
support alleviation of symptoms of depression by helping to promote engagement in the 
pleasurable activity of video gameplay. This notion has been supported by research that has 
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found the use of video games to be a contributing factor for positive mental-health outcomes as 
these games may be real enough for users to experience many of the same positive outcomes of 
play in a safe environment (Aldao, Nolen-Hoeksema & Schweizer, 2010). Some of these 
outcomes include: adaptive regulation, problem solving, and reappraisal, which have been linked 
to more social support and lower levels of generalized depression symptoms (Aldao, Nolen-
Hoeksema & Schweizer, 2010). Increasing adaptive regulation strategies for example, may be 
rewarded in video games because of the game’s design that incorporates linking play to goal 
achievement (Granic, Lobel, & Engels, 2014). By contrast, if gameplayers use less adaptive 
strategies such as rumination, a trait linked to depression, players are less likely to be rewarded 
because rumination may impede players from reacting quickly and with flexibility to constantly 
changing challenges (Aldao, Nolen-Hoeksema & Schweizer, 2010).   
Casual video games additionally provide the advantage of convenience for clients by 
allowing them to engage in CVGs in the comfort of their home, workplace, or other convenient 
environments. This advantage provides clients with a level of autonomy of care that does not 
require a visit to a mental-health provider for perceived symptom relief (Fish, Russoniello, & 
O’Brien, 2018). In addition to providing a safe environment for play, research examining CVG 
use for alleviating anxiety found that compliance rates for playing CVGs was nearly 90% as 
compared to prescribed medication adherence rates of 50-60% (Fish, Russoniello & O’Brien, 
2018; Consumer Reports Health Best Buy Drugs [CRHBBD], 2011).    
The emotional, social and economic burden of TRD for clients, their families and society 
are also significant. Additionally, relapse rates of depression which may contribute to TRD have 
been estimated at 50-80% in those who have been depressed previously (Kenny & Williams, 
2007). Due to the high cost of burden as well as prevalence, available treatment options are not 
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always effective for clients, especially with lengthy wait lists for treatment in most healthcare 
settings (Kenny & Williams, 2007). An intervention such as the proposed video gameplay may 
provide relief for some clients through an easily accessible, inexpensive tool for treatment.   
While some studies have shown promise for a variety of therapeutic applications, many 
scientists have strong opinions which have skewed gaming research. These sharp opinions have 
resulted in a lack of unbiased research and an increase in subjective opinions to either support or 
refute gaming interventions (Bavelier et al., 2015). Additionally, the majority of video game 
studies, on both the negative and positive effects, depend on survey assessments, which is 
limiting in the scope of understanding the impact of gaming (Granic, Lobel & Engels, 2014). 
Bavelier et al., (2015) further suggested that methodology which incorporates 
psychophysiological and neural assessments may help better identify the emotional, cognitive, 
and neural changes associated with gaming. While self-report and retrospective assessments are 
useful, there is a need for a more multimethod approach in which objective observations can be 
associated with immediate and long-term effects (Granic, Lobel & Engels, 2014). The aim of this 
current proposal will be to use both objectively measured EEG data and subjectively measured 
PHQ-9 self-report data to contribute to the growing body of literature which seeks to determine 
the overall effects of CVG interventions compared with purely pharmacological treatment for 
reducing symptoms of treatment-resistant depression. 
Significance of the Study 
The purpose of this study was to examine the effectiveness of CVG play in reducing 
symptoms of depression in a study group as compared to a control group not playing a CVG. 
Previous research on the effects of CVG play in rehabilitation settings is new and lacks many 
empirical studies (Bavelier, et al., 2015). Evidence that is strong and based in sound theoretical 
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rationale is needed to provide evidence for the largely unexplored mental-health benefits of 
gaming (Granic, Lobel & Engels, 2014). Thus far, few applications of video game usage in 
rehabilitation settings have been documented, with only a few studies citing video game 
interventions including: helping clients overcome experiences related to PTSD, using games to 
help screen for and rehabilitate clients with dementia, and tracking decreases in some delusional 
thinking symptoms in clients with schizophrenia after eight weeks of gameplay (Han & 
Renshaw, 2015). Gaming studies that specifically focus on decreasing symptoms of TRD 
through CVG play have not been conducted. This particular study will contribute to the growing 
number of clinical applications for video gameplay as well as provide an additional cost-
effective intervention for decreasing symptoms of TRD. Research findings may also provide 
justification for future designs of CVGs that may result in transferrable learning skills not only 
within rehabilitation, but education and other forms of training as well (Bavelier et al., 2015).  
The current standards and process of TRD treatment include:  the diagnosis of 
depression, treatment adherence reporting and follow-up. This process largely if not entirely, 
depends on patient self-report tool. One such self-report tool, the PHQ-9, is utilized for 
determination of successful clinical outcomes. While this process may be effective for many 
clients, the inclusion of a more objective measurement tool such as EEG data may provide 
counselors with a more efficient process for determining changes in depression symptoms. 
Previous research has suggested the treatment of depression would benefit from a broadened 
field of study as multiple etiological causes likely contribute to depression (Jenkins & Goldner, 
2012). Additionally, depression by nature is nebulous in its diagnosis and provides substantial 
room for improvement of definition, diagnosis, prevention and treatment (Jenkins & Elliot, 
2012).  
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Knowledge from studies that utilize psychophysiological measures (EEG) such as from 
this study may help provide a better foundation for designing and confirming the effectiveness of 
targeted interventions and training tools (Bavelier et al., 2015). This study included the use of 
objective EEG data to examine changes in brain wave functioning. In order to compare results of 
self-report measures with objective measures, this research sought to correlate changes in the 
self-reported PHQ-9 measure with changes found in objective EEG measurements. These 
correlations may provide researchers with additional information that may either support or 
refute inclusion of self-report and/or objective EEG measures use for increased treatment 
outcomes.  
Current literature in the treatment of TRD reveals that while research supports the usage 
of cognitive behavioral therapy and other alternative and complementary approaches in addition 
to medication, CVG interventions may be less costly and more time efficient.  The lack of 
widespread medical insurance across diverse populations, high costs and stigma for receiving 
mental-health services may prohibit individuals from receiving adequate care (Popa-Velea et al., 
2015). The use of games in therapy has long been established with positive markers of their use 
(Gottman, 1986). More recently, the previous phase of this research demonstrated that 
individuals experience an increase in mood while engaging in CVG play (Russoniello, O’Brien 
& Parks, 2009). This study looked to further validate the inclusion of CVG as a treatment option 
for decreasing symptoms of depression by demonstrating changes in both self-report measures, 
and objectively measured EEG changes. Thus far, the potential use of CVGs has rarely been 
applied to the area of mental-health, more specifically depression, but may provide a cost-
effective, easily attainable approach to a new mental-health intervention. Findings from this 
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research study can potentially aide counselors and individuals seeking non-pharmacological 
interventions that are cost-effective, convenient and safe.  
Chapter Summary 
This chapter introduced the purpose of this study, which was to compare the effects of 
prescribed CVG play engaged by the study group with a comparison group who did not 
participate in any intervention on changes in self-report and objective measures of depression. A 
brief review of depression prevalence and current treatment options was discussed. The 
statement of the problem discussed the opportunity for efficacy research to explore the 
effectiveness of CVG play on reducing symptoms of depression. A review of the theory and 
design rationale was presented along with study justification, significance of the study, and 
definition of terms.  In the next chapter, a review of literature that examined research related to 
treatment options for depression, including CVG play and potential changes in EEG output in 
clients with depression is detailed. 
 
 
CHAPTER II: LITERATURE REVIEW 
Introduction to Literature Review 
This literature review will provide an examination of depression as well as the subtypes 
of depression including:  mild, moderate, major and treatment-resistant depression. Each 
subgroup will be defined by diagnostic characteristics, treatment options discussed and the 
potential role CVGs play in reducing symptoms of depression. The review will begin with 
information regarding current definitions and prevalence of depression. Next, the review will 
examine current traditional and non-traditional treatments for depression. Then, the review will 
include information regarding this study’s methods of measurement including both subjective 
(PHQ-9) and objective (EEG) and finally, the review will conclude with relevant literature 
involving CVGs and applications for medical treatment. 
General Depression and Subtypes 
Although there is a wide range in both symptoms and severity of depression, the 
Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), generally define 
depression as a common, yet serious medical condition that negatively affects how one feels, the 
way one thinks and how one acts (APA, 2013). Depression largely causes feelings of sadness 
and/or loss of interest in activities once enjoyed (APA, 2013). Depression can also lead to a 
variety of emotional and physical issues and can decrease a person’s ability to function at work 
and at home (APA, 2013). Symptoms of depression vary widely and may include:  feeling sad, 
loss of interest in activities of pleasure, changes in appetite, trouble sleeping, loss of energy, 
increase in purposeless activity such as pacing, difficulty thinking and thoughts of death or 
suicide (APA, 2013). It should also be noted that symptoms must last at least two weeks and 
must represent a change in previous level of functioning for a diagnosis of depression (APA, 
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2013). Depression however, often has a much more significant impact on individuals beyond the 
symptoms listed. Managing depression can be incredibly time consuming and costly to manage 
for individuals as well as a large financial burden for treating medical institutions (Pandarakalm, 
2018). In the United States alone, depression including the treatment of co-morbid diagnoses has 
been estimated to have cost the U.S. economy more than $210 billion in 2010 (Greenberg et al., 
2015). Depression may also affect or be affected by several biological, environmental, social or 
cognitive factors (Solomon et al., 2015). Depression continues to be a very controversial topic in 
mental-health as there are long-standing differences in thought regarding the biological versus 
behaviorally analytical oriented practitioners with associated belifes.  
The PHQ-9 is a widely used nine-item, diagnostic instrument used to detect symptom 
severity in client populations (Spitzer et al., 1994). The PHQ-9 uses checkmarks to ask clients to 
identify symptoms they have experienced related to depression. The checkmarks on the Likert-
scale measure are interpreted as:  0-4 none; 5-9 mild depression; 10-14 moderate depression; 15-
19 moderately severe depression; and 20-27 severe depression (Kroenke et al., 2001).  
Mild Depression 
Mild depression is often overlooked and not widely discusses as there is a pervasive 
assumption that the word “mild” indicates sub-clinical or mild symptoms (Tartakovsky, 2018). 
However, a person with mild depression does meet the DSM-V guidelines for depression, 
however their symptoms are mild in terms of impairment (Tartakovsky, 2018). Mild depression 
is generally characterized by symptoms such as tearfulness, irritability, fatigue and persistent 
negative thinking (Serani, 2018). Individuals with mild depression may describe themselves as 
extra tired, extra moody and achy (Serani, 2018). Some mild depression is short-lived due to an 
event that may be stressful, but it may also be persistent for months or even years (Serani, 2018). 
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Antidepressant medications, while often prescribed for mild depression, are not the 
recommended course of action for this subtype of depression (NICE, 2010). Rather, it is 
recommended that individuals with mild depression first seek treatment through non-
pharmacological methods such as group therapy and physical exercise (Pilling, 2009). College 
students are one of the largest group of individuals often diagnosed with mild depression. Factors 
that may contribute to mild depression among this population include:  poor academic 
performance, lower socioeconomic status and stressful tasks such as exams and interpersonal 
relationships (Hu et al., 2016). In one particular study, Ibrahim et al. (2013) found that 
depression rates among college students ranged from 10% to 85%.  
Moderate Depression 
Moderate depression is distinguished generally by two distinct symptoms, persistent low 
mood and decreased interest in activities (Cherry, 2020). A recent survey found that of the 
United States population with depression, 50% had moderate depression (Cherry, 2020). 
Moderate depression differs from mild depression in terms of severity of symptoms and type 
(Firth et al., 2017). It should also be noted that moderate depression is not a diagnosis listed in 
the DSM-5 (Cherry, 2020). As previously emphasized in this study, there is no official 
determination or consensus regarding number of symptoms or severity that can be used to 
classify depression to distinguish holistically between mild and moderate depression and is 
usually left to the discretion of the practitioner to make this determination (Cherry, 2020). 
Moderate and major depression are associated with social, occupational and physical 
impairments at a more significant rate than mild depression (Pandarakalam, 2018). Some studies 
have stated that up to 15% of individuals who have committed suicide experienced a minimum 
of moderate depression subtype (Pandarakalam, 2018). Depression and reported feelings of 
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hopelessness are among the most commonly known risk factors for suicidal thoughts and 
behaviors (Ribeiro et al., 2018). Moderate depression is also common among college students 
with 37% of university students in Egypt reporting moderate symptoms of depression (Ibrahim et 
al., 2013). Other researchers have found similar rates among college students in Kenya and 
Ghana at 35.75 and 31.1% respectively (Asante & Andoh-Arthur, 2014). Regarding intervention 
selection for mild and moderate depression, psychotherapy and antidepressants may be selected 
depending on an array of factors (Firth et al., 2017). However, individuals who may find 
themselves in the category of either mild or moderate depression may face many barriers to 
treatment (Firth et al., 2017). For example, access to mental-health care remains limited as 
almost half of the world’s population lives in countries where there is only one psychiatrist for 
every 100,000 people (WHO, 2018). Additionally, since many individuals who are thought to 
have either mild or moderate depression are highly functioning in career and home life, many 
individuals carry a burden of stigma which may limit the effectiveness of treatment (Pederson & 
Paves, 2014).  
Major Depressive Disorder 
Major depressive disorder similar to the other subtypes is heterogeneous in nature, which 
has a wide range of etiologies, risk factors and symptoms that may be associated with this 
subtype of depression (Arno et al., 2015). The lifetime prevalence of MDD varies in previous 
research from 11.2 to 16% worldwide (Dold & Kasper, 2017). Approximately 17.3 million or 
7.1% of all adults in the US had at least one major depressive episode in 2017 (NIMH, 2019). 
Within the United States alone, the economic impact of depression totals approximately $210 
billion with 45% of this attributed to direct costs, 5% suicide-related costs and 50% related to 
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workplace cost (WHO, 2018). Compounding the importance of addressing MDD, up to 10% of 
clients with MDD have reported at least one suicide attempt (Holma et al., 2014).  
Symptoms of depression are one of the most common reasons clients seek medical care 
worldwide (Dold & Kasper, 2017). The heterogeneity of the root cause of depression may 
contribute to the variable response to treatment observed that potentially leads to TRD 
(Craighead & Dunlop, 2014). Approximately 30%-40% of clients with depression requiring 
medication, usually MDD, will remain clinically symptomatic, even after receiving a variety of 
treatments and can then be categorized as clients with TRD (Hollon et al., 2014). Risk factors for 
an individual becoming treatment-resistant include:  Suicide risk, melancholy affect, recurrent 
MDD, more than one hospitalization, symptom severity, comorbid anxiety and failure to respond 
to initial antidepressant at the age of 18 or younger (Dold & Kasper, 2019). A person with TRD 
often experiences increases in suicidal thoughts, with an estimated one-third of individuals with 
TRD attempting suicide within their lifetime (Palmisano, 2018). More than 50% of clients with 
depression do not reach remission during initial treatment, with 30-50% of those clients, not 
responding to treatment at all (Mrazek et al., 2014). 
Prevalence 
Depression is the most common, costly and burdensome psychiatric disorders for adults 
worldwide (Cipriani et al., 2018).  All subgroups of depression may affect all ages and can cause 
detrimental loss and burdens to economic systems, as well as, the social, educational and justice 
systems (Solomon, 2015). The prevalence of depression is based on scores from the PHQ-9, 
which allows for criteria-based diagnoses of depressive disorders (Brody et al., 2018). 
Depression affects an estimated one in fifteen adults or 6.7% of the United States population in 
any given year (APA, 2013). It is further estimated that one in six people in the United States or 
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16.6% of the population will experience depression at some point in their life. Depression may 
occur at any time, but on average, first appears during the late teens to mid-‘20s (Solomon et al., 
2015). Between binary genders, women are more likely than men to experience depression 
(APA, 2013). Some studies have shown that up to one-third of women will experience a major 
depressive episode in their lifetime (APA, 2013).  
Depression is not selective with regard to age, gender, environmental factors, etc. 
However, depression rates are lower among non-Hispanic Asian adults, compared with Hispanic, 
non-Hispanic Black, or non-Hispanic White adults (Brody et al., 2018).  Overall, women were 
almost twice as likely to have depression at 10.4% as men at 5.5% (Brody et al., 2018). This 
similar pattern of gender-based occurrence was observed across all age groups (Brody et al., 
2018). Although all subtypes of depression show similar rates of occurrence across age 
demographic categories, the average age of onset for initial MDD episodes is late adolescence, 
with the majority of clients with MDD diagnosed by early adulthood (Craighead & Dunlop, 
2014). Contributing to the prevalence of depression in general, the diagnoses is not only chronic 
and recurrent in nature but frequently occurs comorbidly with other diagnosis (DeRubeis, Siegle 
& Hollon, 2008). Depression is about two to three times more common in individuals with 
chronic physical health problems than in people who are in good physical health (Egede, 2007). 
Chronic physical health problems can both cause depression and make depression symptoms 
worse, while depression alone may also adversely affect physical health such as contributing to 
cardiovascular disease and increasing mortality (Pilling, et al., 2009).  
Etiology of Depression 
There is no one specific root cause of depression, rather, results from a unique interaction 
of social, psychological and biological factors (WHO, 2018). As individuals encounter adverse 
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life events such as unemployment, death of a loved one and psychological trauma, the likelihood 
of developing depression may increase for some people (WHO, 2018). Depression may result 
from any combination of psychological, biological and social conditions (Pandarakalam, 2018). 
These contributions from a variety of root causes are generally thought to be subconscious in 
nature and not of known etiology by the individual (Pandarakalam, 2018). This is important to 
note as there has been a popular misconception and associated stigma that depression is due to a 
lack of will power (Bhugra, 2013). While there is currently no agreed upon cause for depression, 
genetics and biochemical processing are now accepted roots for depression along with 
environmental factors and personality traits (McConnell, Carter & Patterson, 2019). Risk factors 
for specifically developing MDD may also include:  positive family history for a mood disorder, 
early life trauma, prior anxiety disorders, and substance use (Craighead et al., 2013). It is 
unquestionable that depression may come from purely genetic-based, chemical causes, however 
such a medicalization of depression should also be accepted with caution as this approach often 
overlooks important psycho-social factos (Pandarakalam, 2018). 
Clinical depression is largely a recurrent disorder that frequently becomes chronic 
(Craighead & Dunlop, 2014). Treatment-resistant depression results from a progression of 
ineffective treatment of MDD, causing the diagnosis to often require more than one type of the 
same intervention, or a combination of different interventions (MHA, 2013). Treatment-resistant 
depression is quite commonly seen as a progression from MDD in clinical practice and 
constitutes a significant portion of the greater diagnosis of MDD (Peeters et al., 2016). Previous 
research has reported 20%-40% of clients treated for MDD fail to respond to their first 
antidepressant treatment and up to 15% do not respond to multiple antidepressants (Fekadu et al., 
2009).  Due to the progressive nature of MDD resulting from failed first-line treatment 
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approaches, increases in MDD diagnoses are expected to correlate with resulting increases in 
TRD diagnoses as well (Craighead & Dunlop, 2014). Treatment resistance to antidepressant 
medications is one of the most critical clinical challenges in the management of depression  
(Dold & Kasper, 2017).  
Treatment resistance in depression has been historically documented since the 
introduction of the medication, imipramine, in the 1950’s (Kuhn, 1958). Kuhn (1958), observed 
some clients taking imipramine experienced some degree of improvement, although at the cost of 
considerable effort to engage in daily activities, while some clients experienced no effect at all. 
These observations by Kuhn were confirmed with two benchmark studies that followed, both 
also showing poor treatment response at 50% and 62% respectively (Medical Research Council, 
1965). In 1974, the WHO held a conference, specifically to define TRD and attempt to define the 
concept (Lopez-Ibor, 1974). Although significant advances have been made in understanding the 
psychopharmacology and biomarkers of MDD, only 60-70% of clients with MDD respond to 
antidepressant therapy (Al-Harbi, 2012). This disparity leaves up to 30% of people with MDD 
without satisfactory improvement from their symptoms (Fekadu et al., 2018).  
Treatment-Resistant Depression 
Treatment-resistant depression is a subcategory of the larger diagnosis of major 
depressive disorder (MDD) (Ferrari at al., 2013). Currently, there is not one universally accepted 
definition of TRD (McIntyre, et al., 2014).  The term “Treatment-resistant” vaguely describes 
clients who do not respond to antidepressant therapy after one or more adequate trials of 
appropriate dosage and duration (Mrazek et al., 2014). Clients that experience treatment 
resistance to first line interventions are more likely manage comorbid physical and mental 
disorders with increasingly higher health care costs along with other negative effects resulting 
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from ineffective treatment (Fekadu et al., 2018). TRD is associated with significantly high levels 
of personal suffering, considerable functional impairment and monumental medical and mental-
health costs (Gibson et al., 2010).  
Recent research has concluded that most clients with TRD are dealing with a 
combination of risk factors leading to their condition (Al-Harbi, 2012). These risk factors 
include: not adhering to taking prescribed antidepressants long enough (i.e. 6-12 weeks) to 
benefit from the full effect of medications, skipping medication doses, unpleasant side effects of 
prescriptions, or drug interactions with other medical treatments (Al-Harbi, 2012). Other risk 
factors for experiencing TRD may also include:  taking the wrong medicine or improperly 
prescribed dose, genetic predisposition related to speed of metabolizing medications or other 
comorbid medical conditions such as hypothyroidism and anemia (Al-Harbi, 2012). Underlying 
conditions such as eating disorders and substance use may also contribute to a TRD diagnosis as 
each of these conditions may need separate interventions, prohibiting the effectiveness of 
prescribed medications (Al-Harbi, 2012). Despite the seriousness of TRD, evidence now 
suggests that even the most treatment-resistant clients can achieve sustained levels of remission 
when highly specialized, multidisciplinary, intensive and careful intervention programs are 
followed (Wooderson et al., 2014).  Currently, there is little evidence showing that one form of 
treatment for TRD is superior to another. Several studies have compared treatment options 
including: combining antidepressant medications, switching medications, and combining 
medication with psychotherapy as typical first line treatment options (Arnow, et al., 2015). The 
complexities involved with clinically separating the differences between MDD and TRD pose 
challenges to clinicians with regards not only to structuring prevalence statistics but also in 
understanding the point in which a client transitions from having MDD to TRD.  
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In addition to the challenges of simply defining the term, TRD, there is also much debate 
regarding the clinical expectations of defining successful remission of TRD as well. In order to 
meet an expectation of a satisfactory treatment attempt, most clinical definitions of adequate 
antidepressant therapy require minimum thresholds of dose, duration and client compliance 
(Gibson et al., 2010). Other researchers have argued that remission should be the absolute goal of 
treatment and any absence of remission meets the criteria for TRD (Greden, 2010). Additionally, 
other researchers, posit that TRD should be viewed on a continuum ranging from partial 
response to complete treatment resistance as opposed to an all or nothing approach (Jenkins & 
Goldner, 2012). In the largest landmark study examining the effectiveness of treatment options 
for clients with MDD, clients that had progressed to TRD were defined as those who did not 
become symptom free after one or more treatments (Trivedi et al., 2006). In the STAR*D trial, 
72% of clients did not experience remission after treatment with citalopram, a common SSRI, 
used to treat MDD (Trivedi et al., 2006). Additionally, as each subsequent treatment that was 
added the failure to remit rate increased from 79-93% (Trivedi et al., 2006). Further research has 
found that each additional unsuccessful course of antidepressant therapy added is associated with 
lower likelihood of remission and higher relapse rates (Gibson et al., 2010). 
Depression Interventions 
The National Institute of Mental-Health defines treatment for depression as occurring 
within these categories:  Medications, psychotherapies and brain stimulation techniques (NIMH, 
2020). For many clients with depression, alleviation of symptoms often elicits several attempts 
of trying either only pharmacological or a mixture of different types of interventions prior to 
finding symptom relief. Response to treatment is highly variable across all subtypes of 
depression (Arnow et al., 2015).  In addition to variance in treatment outcomes among 
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individuals treated with the same course of intervention, there is also little evidence that one 
treatment is superior to another, whether comparing antidepressant medications, types of 
psychotherapies, or between several other types of interventions (Arnow et al., 2015). Despite 
the belief that depressive symptoms are widely thought of as a confluence of biological, 
psychological and social factors, a scoping review of literature found that the study of treatment 
for depression has historically focused primarily on biologically based treatments in the form of 
pharmacological studies (Jenkins & Goldner, 2012). Given the multifaceted factors underlying 
depression, researchers have hypothesized that the most effective treatment should be equally 
complex and include interventions that address diverse factors contributing to the debilitating 
diagnosis (Jenkins & Goldner, 2012).  
Treatment for depression depends on several factors including an individual’s severity, 
frequency and duration of symptoms (Firth et al., 2017). For example, most individuals with 
mild depression may begin treatment interventions through lifestyle changes, while most clients 
with TRD start with a regimen of antidepressant medication, while some treatment options 
include psychotherapy or a combination of both. Most commonly, the course of treatment for 
moderate or severe depression and TRD begins when a first-line antidepressant medication. If 
this first medication does not alleviate symptoms, a second-line therapy is needed. Selection of 
the initial treatment options should involve numerous factors including:  understanding the 
client’s target symptoms, comorbid medical or psychiatric conditions, concomitant medications, 
previous response to an antidepressant and review of any potentially adverse effects due to drug 
interaction potential (McConnell, Carter & Patterson, 2019). If a client is not receiving adequate 
relief of depression symptoms, guideline recommendations for second-line treatment usually 
include one of three pharmacological options:  increasing the dose of the first medication, 
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switching to a different antidepressant, or adding a second medication (McConnell, Carter & 
Patterson, 2019). The cause for a lack of treatment response in these clients may be due several 
reasons including:  errors in the diagnostic process, inadequate treatment, failure to remedy 
coexisting general medical and psychiatric disorders, or other psychosocial factors (Gautam et 
al., 2017).  Unfortunately, the reported 20-50% of clients who do not experience full remission 
of symptoms are often left to deal with residual functional impairment as well as increased risk 
for relapse and recurrence (Kocis et al., 2012).  
The section that follows will summarize the various types of depression interventions 
typically adhered to in efforts to alleviate depressive symptoms. Currently, there is no precise, 
clinical standard of practice for treating depression (Jenkins & Goldner, 2012). Due to the 
inconsistent nature of defining and treating depression, and the wide spectrum of potential 
interventions and variability of effectiveness of treatments, this literature review of depression 
interventions will briefly examine potential interventions for all subtypes of depression within 
the same section of this review.  
Mild depression as long been treated lifestyle interventions including exercise, sleep 
scheduling, nutritional interventions and mindfulness (Hu et al., 2016). As research in the area of 
MDD and TRD continues to grow, interventions other than antidepressant medications, continue 
to become more widely explored (NIMH, 2019). While causation of TRD research had led to a 
more multifaceted approach, interdisciplinary approaches to treatment of TRD that may address 
reasons for TRD diagnosis such as environmental factors, beyond simply biological determinants 
remain novel and very lightly researched (Jenkins & Goldner, 2012). For example, current 
literature has established the efficacy of psychotherapy as an evidence-based treatment for 
general depression diagnosis, limited research has explored this intervention which may address 
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environmental and social factors of TRD specifically (Jenkins & Goldner, 2012). The main 
adjunctive, nonpharmacological interventions most often used in treating TRD include 
psychotherapy, electroconvulsive therapy (ECT) and vagus nerve stimulation (VNS) (Shelton et 
al., 2010).  
Pharmacological Interventions 
Currently, no pharmacological treatment is universally effective for treating depression, 
yet, antidepressant medications continue to remain the recommended course of continued 
treatment for moderate and severe depression (Gadad et al., 2018). With specific regard to 
treatment for TRD stems, pharmacological interventions come from a progression of an earlier 
diagnosis of MDD, resulting in either combined or altered use of medications typically and 
similarly prescribed for MDD.  
Antidepressant medications are often selected for first-line treatment as they are 
relatively low-cost and easily accessible, however fewer than 50% of clients respond to these 
medications after 14 weeks (Yasinski et al., 2019). In a study reviewing antidepressant 
pharmacologic treatments, Dold and Kasper (2017) concluded that resistance to first-line 
medications is one of the most important clinical challenges in all of disease management. In the 
STAR*D study examining antidepressants for treating MDD, the cumulative remission rate after 
four trials of antidepressants, within a fourteen-month period, was 67% (Rush et al., 2006). Even 
with continued sequenced treatment, 10-20% of participants in the study remained significantly 
symptomatic for two years or longer (Rush et al., 2006). In general, the current accepted thought 
is that although antidepressant medications can be effective in treating depression, the current 
regimens fail to achieve remission in approximately one out of three clients (Voineskos et al., 
2020). There are several categories of antidepressant medications commonly used to treat in 
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medical practice to treat depression including selective serotonin reuptake inhibitors (SSRIs), 
serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), 
monoamine oxidase inhibitors (MAOIs), and others (bupropion and mirtazapine) (Saragoussi et 
al., 2012). A tremendous increase in the use of antidepressant medications occurred when 
selective SSRIs were introduced to the pharmacological market in the early 1990s (Hollon et al., 
2019). This increase occurred as general practitioners felt safer prescribing SSRIs as they are not 
lethal in overdose, compared to previously prescribed tricyclic antidepressants and do not require 
complex dietary restrictions like MAOIs (Olfson, Marcus, Druss & Pincus, 2002). Additionally, 
some studies have cited antidepressants more frequently prescribed than psychological based 
interventions due to inadequate resources to provide alternative interventions and a lack of 
access to care to receive other psychological treatments (Cipriani et al., 2018).  
Since up to 40% of individuals taking first line medications to treat their depression, do 
not achieve symptom relief with the first medication prescribed, it is important to discuss 
strategies used by mental-health physicians when treatment resistance to first-line medications 
occur. These strategies are:  1) increasing the dose of the initial antidepressant, 2) combining two 
antidepressants, 3) switching to another, new antidepressant medication, 4) augmenting the 
antidepressant with another agent such as second-generation antipsychotics (SGAs) or lithium 
and finally, 5) combining the antidepressant with non-pharmacological therapies (Bauer et al., 
2013). Of these preceding strategies, the most commonly practiced are increasing the dose of the 
currently administered antidepressant either through dose escalation or high dose treatment and 
secondly, switching to another, new antidepressant medication (Dold & Siegfried, 2017). Some 
research indicates this may be a result of the heterogeneous nature of depression, in which a 
great diversity of pathologies makes any one course of treatment difficult to determine (Shelton 
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et al., 2010). The complicated nature of clinical evaluation of clients with depression in 
conjunction with the difficulties in determining the root of the depression calls for continued 
research to aide clinicians in deciding the proper course of treatment (Shelton et al., 2010).  
Most often, response to depression symptoms is defined as a notable improvement of 
symptoms and remission as a near absence of symptoms. One of the reported negative traits of 
treating depression with antidepressants alone is the potential threat of symptom relapse. Clients 
who have recovered from depression by use of antidepressants and then discontinue using the 
medication have an increased risk of three to five times the risk of a member of the general 
population experiencing a first episode of depression (DeRubeis, Siegle & Hollon, 2008).  
Consequently, clinical practice guidelines emphasize the importance of maintaining use of 
antidepressants indefinitely for clients in remission of depression, especially for clients with a 
history of chronic depression (DeRubeis, Siegle & Hollon, 2008). There will be two types of 
pharmacological interventions discussed in the section that follows. These two will be 
antidepressant medications and atypical antipsychotics. Additionally, pharmacological based 
strategies designed specifically to address depression symptoms including combining and 
switching antidepressant medications will also be discussed. 
Antidepressants. Antidepressants represent one of the major advancements of modern 
medicine. In 2006 alone, 5 of the 35 medications with top sales in the United States were 
antidepressants with each of these having sales of 1.08-2.25 billion dollars in this one year alone 
(Ioannidis, 2008). Currently, the standard practice for moderate and severe treatment is to keep 
clients with chronic or recurrent depression on antidepressant interventions indefinitely (APA, 
2010). In the past five decades, one of the strongest trends in psychiatry and 
psychopharmacology has been the exponential increase in the number of available medications 
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for treatment of mental-health diagnoses, with antidepressant medications being the largest 
diagnostic category of growth in this area (Popa-Valea, 2015). All of the currently prescribed 
antidepressant medications aim to alter the function of neurotransmitters in the central nervous 
system including:  serotonin, dopamine or norepinephrine (Popa-Valea, 2015). Critics of many 
antidepressants state that there is a danger in prescribed medications as safety, tolerability and 
lethality in overdose are the main drivers of medication choice, rather than efficacy (Archangelo 
et al., 2017). Many researchers have further stated skepticism of effectiveness studies for 
antidepressants as the field lacks comparative double-blind treatment vs placebo vs baseline 
treatment design (Popa-Valea, 2015). 
There are two classes of antidepressant medications that will be reviewed in this section; 
Monoamine oxidase inhibitors (MAOIs) and tricyclics and selective serotonin reuptake inhibitors 
(SSRIs) (Craighead & Dunlop, 2014). These two classes of medications were selected as they are 
most commonly selected in treating clients with TRD (Craighead & Dunlop, 2014). The current 
standard practice for antidepressant prescription recommendations are primarily based on 
tolerability, safety and personal choice, rather than on efficacy (Craighead & Dunlop, 2014). The 
goal of antidepressant treatment is to eliminate symptoms with dosages generally increased every 
2-4 weeks, until either the goal is reached or the FDA maximum recommended dose is reached 
(APA, 2010).  
While many antidepressants have proven efficacy, the side effects of some frequently 
used medications can be serious and may range from increased anxiety, to weight gain, sexual 
dysfunction and suicidal ideations (Cuijpers et al., 2013). Currently, there is not a particular class 
or individual medication that has consistently proven to be superior for the treatment of MDD 
and TRD (APA, 2010). Other researchers further suggest that several negative side effects of 
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antidepressant use may be detrimental to clients. Andershon et al., (2009) found long-term use of 
moderate antidepressants may be associated with development of diabetes. Other researchers 
also suggest using antidepressants cautiously. In a recent study examining treatment options, 
common side effects of antidepressant treatment included:  dry mouth, drowsiness, fatigue, 
sedation, dry mouth, weight gain and increased appetite (McConnell, Carter & Patterson, 2019). 
The specific types of antidepressants currently used for treating TRD will be outlined below.  
Monoamine oxidase inhibitors (MAOIs) and tricyclics. MAOIs and tricyclics are older 
versions of antidepressants. MAOIs include medications such as:  tranylcypromine, phenelzine 
and moclobemide (Voineskos et al., 2020).  MAOIs work by inhibiting MAO-A and B enzymes 
and can be effective antidepressants (Voineskos et al., 2020). While there is no proven course of 
recommended antidepressant for treating TRD, SSRI’s and SNRIs supersede MAOIs as 
recommended first-line therapy (Arcangelo et al., 2017). In most cases, older classes of 
antidepressants, such as MAOIs are reserved for trial-and-error methods of changing medications 
once SSRI/SNRI options are exhausted (Voineskos et al., 2020). 
Selective serotonin reuptake inhibitors (SSRIs). Selective serotonin reuptake inhibitors 
are newest sub-type of antidepressants prescribed for depression. Selective serotonin reuptake 
inhibitors (SSRIs) are the second most widely prescribed medications in the world, following 
statins (Hollon, et al., 2019). SSRI’s became so widely accepted, so quickly, that by the mid-
1990’s they had largely replaced tricyclic antidepressants (TCAs) as the first choice for clients 
with depression (Thase, 2011). The perceived advantages of SSRI’s in both tolerability and 
safety, compared with other medications may have come at the expense of reduced efficacy, 
especially for clients with MDD (Thase, 2011). As initial support for use of SSRIs and combined 
use with other combinations such as TCAs grew, so did the expansion of combining other 
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antidepressants as well such as:  bupropion, mirtazapine and SNRI, venlafaxine (Thase, 2011). 
These medications grew quickly in popularity due to their relatively benign side effects as 
opposed to previous antidepressant medications (Popa-Valea, 2015). Research however, has 
more recently shown that SSRI’s may be neither as safe nor efficacious as commonly believed 
(Hollen et al., 2019). In spite of the advantages of these newer medications, SSRIs may cause 
nausea in the short-term, however tend to also cause sedation and negative sexual side effects in 
the long run (Popa-Valea, 2015). However, SSRIs are currently the most extensively used 
antidepressant medication (Popa-Valea, 2015). SSRIs work by changing levels of serotonin. 
Serotonin is a neurotransmitter, or brain chemical, that allows cells within the brain to 
communicate with one another.  While it was originally thought that SSRIs and SNRIs were 
safer and produced fewer side effects than older tricyclic antidepressants, updated research has 
found conflicting results to this notion. Evidence in recent meta-analysis has found SSRIs to also 
produce side effects of:  dry mouth, gastrointestinal issues, seizure, weight gain, sexual 
dysfunction, and bleeding (Wang et al., 2018). While SSRIs may still be safer and more widely 
prescribed than previous antidepressants, evidence regarding side effects, dropout rate and 
tolerability is inconsistent (Wang et al., 2018).  
As TRD has gained traction as a focus of research, new protocols and treatment strategies 
have been developed to treat this disorder (Perez-Wehbe et al., 2010). While progress has been 
made in these new strategies, there is still no clear or specific protocol recommended to treat 
TRD (NICE, 2009). If first-line medications are ineffective, clinicians working to treat TRD 
often turn to one of two treatment strategies to combat TRD. These strategies are either 
“switching” or “combining” medications (Shelton et al., 2010). Approximately 25% of clients 
with TRD tend to respond to combining treatment paradigms, while up to 50% of clients 
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reportedly respond to switching of medications (Al-Harbi, 2012). Switching involves treatment 
in which medications are changed within and between classes of compounds whereas combining 
involves the addition of adjunctive therapies that may build upon achieved improvements 
(Shelton et al., 2010). Combining medications is generally recommended if partial treatment 
response has been achieved, whereas, switching is recommended when remission of symptoms is 
not evident or when occurrence of side effects elicits a change in medication (Shelton et al., 
2010). Mitchell (2018) however, proposed an algorithm for practitioners to help with treating 
TRD that was composed of three treatment options:  Optimization of medicine, switching and 
augmentation. Optimization was proposed as the first step following unsatisfactory results from a 
single medication as optimization ensures the client is taking the medication exactly as 
prescribed, for the appropriate length of time and in an ideal quantification of dosage (Mitchell, 
2018). After optimization has occurred, Mitchell (2018) recommended pursuing the other 
options of switching or combining.  
Combining antidepressant strategy. When an initial antidepressant is unsuccessful, 
combining antidepressant medications is a common treatment strategy (McIntyre et al., 2014). 
Although widely used and most often safe, the efficacy of combining medications to treat TRD 
has not been established by properly controlled, adequate clinical trials and remains inadequate 
empirically for such widespread use (Thase, 2011). Using this approach, at least two medications 
are administered at the same time, usually of the same class, but not always. Further, research in 
some studies in the area of combining antidepressants supports adjunctive combining atypical 
antipsychotics such as:  lithium, thyroid hormone, triiodothyronine, and buspirone as well as 
with tricylic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs) and SSRI/SNRI 
medications (McIntyre et al., 2014). This strategy is rather common in clinical practice, although 
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there is little evidence supporting these measures (Dold & Kasper, 2017).  Historically, most of 
these combined medication studies have involved TCAs and MAOIs and collectively support 
combining antidepressants and lithium as a first-line treatment option and thyroid hormones and 
buspirone as secondary treatment options (Lam et al., 2009). Thus far, very few RCTs have been 
conducted to look at the effectiveness of this strategy. Blier et al. (2010) conducted a double-
blind RCT examining the responses of 105 clients with MDD to a strategy of combining 
mirtazapine together with fluoxetine, venlafaxine and bupropion as compared to a group of 
participants taking fluoxetine medication alone and found the combined treatment more 
efficacious in terms of remission rates, but not response rates. Additionally, Rush et al. (2011) 
conducted a single-blind study using two different combinations of medication and found that 
these combined treatments were not significantly more effective than escitalopram monotherapy.   
While the approach in combining antidepressant, medications is growing in popularity, it should 
be noted that no antidepressant is FDA approved and/or established as a reliable adjunctive 
treatment strategy for TRD (McIntyre et al., 2014). 
Switching antidepressant strategy. Switching is a method included in both the Canadian 
Network for Mood and Anxiety Treatments (CANMAT) as well as National Institute for Health 
and Care Excellence (NICE) (Voineskos et al., 2020). This strategy is recommended for clients 
with MDD who do not receive adequate response from first-line medications (Voineskos et al., 
2020). Although the efficacy of all officially approved antidepressant medications has been 
verified by positive clinical trials, most of this data has been derived from non- Treatment-
resistant populations with depression. This makes results difficult to be transferred to clients with 
inadequate response to medications and may merit switching medications altogether.  If there is 
less than 50% improvement following 6-8 weeks of maximum tolerable dosage and medication 
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adherence is also good, a switch in antidepressant should be considered (Gautam et al., 2017). 
Switching may be a beneficial strategy as this helps to avoid taking multiple medications that 
may compound side effects, may produce lower costs than multiple medication dosage and 
reduces any risk for treatment-emergent adverse side effects and events (Shelton et al., 2010). 
However, few studies have reported that changing the class of medication after non-response to 
the initial type, for example an SSRI, may significantly increase response rates (Voineskos et al., 
2020). Bschor and Baethge (2010), published a meta-analysis of research-controlled trials and 
reported only three studies, representing 395 clients could meet their meta-analysis criteria and 
no significant differences were found between the switching group and a second group that 
continued taking the same medication. In a follow-up study, Romera et al. (2012) conducted 
research using a double randomized design with non-responders to first line medications who 
were randomized into either a switching group who changed to the medication, duloxetine or 
control group that stayed on the same medication, escitalopram. In this study, no significant 
between-group differences were found in response rates to medications. Additionally, Souery et 
al. (2011) compared non-responding groups taking either citalopram or desipramine medications 
and randomized them into either a group switching to the other respective medication or 
continuation with the first medication and did find significantly higher remission rates among 
only the non-switched clients. Based on these findings, a switching strategy in the case of non-
responders should not be regarded as an evidence-based strategy for clients with TRD (Dold & 
Kasper, 2017). In support of previous findings, a most recent meta-analysis found no significant 
evidence that confirmed that switching antidepressants is effective when compared to simply 
continuing the initial antidepressant (Bschor, Kern, Henssler & Baethge, 2018). While some 
clients may benefit from switching medications, it should be used with caution and preferably 
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with clients who are experiencing absolutely no response or are experiencing adverse effects to 
current antidepressant medications (Dold & Kasper, 2017). If a switching strategy is selected, it 
should be noted that a cross-over titration method is recommended to successfully accomplish a 
medication switch. Using this method of switching, the dose of the first antidepressant 
medication is gradually decreased while the new medication dosage is gradually increased to its 
target dose (Dold & Kasper, 2017).  
Atypical antipsychotics. After inadequate remission of symptoms with either a single or 
multiple SSRIs, atypical antipsychotics have more recently been prescribed as adjunctive agents 
to SSRIs (McIntyre et al., 2014). Atypical antipsychotics are categorized as adjunctive therapy 
that includes the addition of a second medication, not usually considered an antidepressant as a 
first-line pharmacological option (Voineskos et al., 2020). Atypical antipsychotics have been 
increasingly recognized as an important treatment option (Wang et al., 2016).  Three 
antipsychotic agents are Food & Drug Administration (FDA) approved as adjunctive 
medications to antidepressants, aripiprazole, quetiapine or a combination of olanzapine-
fluoxetine (Spielmans et al., 2013). Most of these second-generation antipsychotics have been 
researched as adjunctive therapies in combination, specifically with first-line SSRI and 
serotonin-norepinephrine reuptake inhibitors (SNRIs) medications (Voineskos et al., 2020).  
Recent interest in these medications by large pharmaceutical companies has resulted in 
several large-scale, placebo-controlled research control trials of these medications (Voineskos et 
al., 2020). In these studies, anti-psychotic medications were found to have varying effects on 
serotonin receptors and may therefore show efficacy in combination with SSRI/SNRI 
medications to treat TRD (Voineskos et al., 2020). In one study, quetiapine at a dose of 
300mg/day demonstrated up to 48% response and 24.5% remission in combination with SSRIs, 
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leading to its FDA approval for treatment of TRD (El-Khaliki, et al., 2010).  Results from two 
separate meta-analyses concluded that adjunctive atypical antipsychotics are significantly more 
effective than placebo with approximately double the odds of achieving remission (McIntyre et 
al., 2014). Additionally, Anderson et al., (2009) conducted an open-trial study to explore the 
efficacy of atypical antipsychotics (i.e. quetiapine) as an adjunctive strategy for clients with TRD 
who were taking MAOI medications. While the researchers found the additional atypical 
antipsychotic may be helpful, limitations of small sample size (n = 24) made these results 
difficult to generalize (Anderson et al., 2009). Negatively, atypical antipsychotics also have 
higher odds of discontinuation compared to placed due to akathisia, sedation and weight gain 
resulting in clients desire to stop taking these medications (McIntyre et al., 2014). With some of 
these medications, adverse side effects related to taking atypical antipsychotics, notably weight 
gain, metabolic disruption and sedation are significant barriers for treatment for many clients 
(Cha & McIntyre, 2012).  
Outside of the widespread use of pharmacological treatment options, alternative and 
complementary approaches to treatment employ indirect mechanisms of change that may still 
affect brain physiology, similarly to medications (Gadad et al., 2019). Evidence in recent 
research has suggested non-pharmacological interventions can reduce symptoms of depression 
with varying efficacy (Russoniello et al., 2019). These treatment options with demonstrated 
efficacy in clinical populations include:  psychotherapy, exercise and other somatic treatments 
(Gadad et al., 2019).  
Psychotherapy 
Psychotherapy is a common intervention for treating depression symptoms in all 
categories of mild, moderate and severe depression and is facilitated by a mental-health 
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professional who should be qualified to screen for and treat symptoms of depression. 
Psychotherapy may also be provided in combination with other pharmacological treatments or on 
their own (Voineskos et al., 2020). Many researchers and clinicians advocate for psychotherapy 
as part of a holistic package of treatment of depression that should include the physical, 
psychological and social aspects of care (Pandarakalam, 2018). Additionally, since comorbidity 
is common amongst individuals with TRD, psychotherapy may help in addressing comorbid, 
contributing diagnoses as well (Voineskos et al., 2020).  
There are several varieties of psychotherapy that may provide relief from depression 
symptoms. The efficacy of psychotherapy in clients with TRD is good, with 50% of clients 
reporting benefits from psychotherapy, especially cognitive behavioral therapy (CBT) and 
mindfulness-based cognitive behavioral therapy (Eisendrath, Chartier & McLane, 2011).  
Typically, psychotherapy involves either individual or group counseling for four to six months or 
longer (Blumenthal, Smith & Hoffman, 2012). The APA recognizes three types of 
psychotherapy for the treatment of MDD that have demonstrated efficacy with control group 
studies by at least two investigative teams (Blumenthal, Smith & Hoffman, 2012). The most 
effective psychotherapy treatments include CBT, behavior therapy (BT) and interpersonal 
psychotherapy (IPT) (Blumenthal, Smith & Hoffman, 2012). CBT focuses on identify and 
changing maladaptive thought patterns as compared to IPT, which emphasizes the social context 
in which depression occurs and targets improving communication skills (Blumenthal, Smith & 
Hoffman, 2012). Behavioral therapy focuses on increasing engagement in positive daily 
activities, decreasing previous negative life experiences, and improving adaptive social skills 
(Blumenthal, Smith & Hoffman, 2012). Psychotherapy has been found to be one of the most 
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effective forms of treatment for depression, especially in conjunction with antidepressant 
medications with more severe depression, such as TRD.  
Several efficacy studies support the use of psychotherapy in populations with major 
depression and TRD. A recent Cochrane review publication examined six studies of 
psychological interventions for treating TRD (Ijaz et al., 2018). The psychological interventions 
included in the review were:  dialectical behavioral therapy, cognitive behavioral therapy, 
interpersonal therapy, and intensive short-term dynamic psychotherapy (Ijaz et al., 2018). The 
review found that in combination with a typical course of antidepressant medications, the 
psychotherapy interventions contributed to an overall improvement in depressive symptoms, 
especially when a form of CBT was used in the intervention sessions (Van Bronswijk et al., 
2019). Further, CBT appeared to have good long term, lasting effects following the acute phase 
of therapy at both 12 and 46-month ranges in lowering overall depression scores (Voineskos et 
al., 2020). In a study examining the effect of psychotherapy alone versus combined therapy of 
psychotherapy and antidepressants within a population of individuals with mild to moderate 
depression, the study suppored findings that psychotherapy combined with antidepressant 
medications provided the greatest symptom relief (Bekhuis et al., 2018). However, further 
analysis found the symptoms of blue mood and obsessive thoughts to not be directly connected 
this treatment intervention (Bekhuis et al., 2018). In a randomized controlled study, CBT was 
found to be as efficacious as anti-depressant medications, with both interventions producing 
response rates to treatment at just under 60% (DeRubeis et al., 2005).  Additionally, (Patel et al., 
2017) pointed to the side effects of CBT being things positive, such as improved functioning in 
interpersonal relationships as compared to the often negatively reported side effects of 
medication. With regards to the effects of psychotherapy on traits such as return to work status, 
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CBT was found to produce greater return to work among a group of unemployed participants in 
comparison to a group using antidepressants (Fournier et al., 2015). CBT may have an advantage 
as an intervention over medication alone as it has been found to have a greater enduring effect 
than typical medications (Cuijpers, et al., 2013). Supporting the enduring effect of CBT, Piet and 
Hougaard (2011), researched a subtype of CBT, mindfulness-based cognitive therapy (MBCT) 
and found this form of psychotherapy significantly reduced relapse risk in clients with three or 
more previous depressive episodes and appeared to be at least as effective as a maintenance 
regiment of antidepressant medication in the prevention of relapse episodes (Huijbers et al., 
2016). This study and other similar studies are important as MBCT and CBT may be a viable 
intervention for clients who prefer psychological based interventions rather than pharmacological 
interventions (Huijbers et al., 2016).  In a meta-analysis of nine studies, Cuijpers, et al., (2013) 
compared the effects of acute phase CBT without any subsequent treatment with the effects of 
anti-depressant medication treatment and found that although short-term outcomes of CBT and 
pharmacology were comparable, dropout rates in the CBT group were significantly lower. 
Additionally, clients who received acute phase CBT were significantly less likely to relapse than 
the clients who received anti-depressant medications in the (Cuijipers, et al., 2013). Similarly, in 
a TRD specific population, Wiles et al. (2014), completed a randomized control trial named the 
CoBalT trail among clients who had not responded to antidepressants (Wiles et al., 2014). 
Results of this study found that augmenting antidepressant therapy by adding CBT was effective 
in reducing depressive symptoms that were maintained for over twelve months (Wiles et al., 
2014). Additionally, a follow-up study was completed that found clients who did not respond to 
one or two trials of antidepressants had a 30-50% chance of responding to psychotherapy 
(Kasper & Montgomery, 2013). Group based CBT has also found positive results in treating 
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TRD. Matsunga et al. (2010), researched effectiveness of group-based CBT that addressed 
psychosocial functioning and depressive symptomology in clients with TRD. Following a course 
of 12 weeks of intervention, participants demonstrated significantly reduced symptoms of 
depression and enhanced psychosocial functioning (Matsunga et al., 2010). Further, these results 
appeared to be sustainable as participants demonstrated lasting improvements at the 12-month 
follow-up as well (Matsunga et al., 2010).  
A significant body of research has also investigated combining psychotherapy with 
antidepressant medications. A study that looked at adding CBT to a regimen of prescribed 
medications found that CBT significantly improves response rates for those with TRD with 
lower remission rates of 40% or less (Cuijpers et al., 2010). While few studies have examined 
the effectiveness of combining psychotherapy and medications, the literature indicates that 
utilizing this combination strategy results in superior treatment results as compared to single 
mode approaches (Jenkins & Goldner, 2012). In a review of literature, six studies have explored 
this combination approach and found positive results. Schramm at al. (2008), conducted a study 
with inpatient psychiatric participants with TRD and randomized individuals into either a 
treatment group (medication and psychotherapy) or a control group (medication and clinical 
management, i.e. usual care). Following a five-week intervention, participants who were in the 
treatment group showed statistically significant improvements over the control group. The rates 
of remission among the treatment group was 67% as compared to 32% in the control group 
(Schramm et al., 2008).  
Virtual Psychotherapy  
Progressive interventions that integrate computerized therapy may offer several 
advantages including: many opportunities for younger generations who may be more familiar 
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with computerized services, substantially lower cost than traditional therapy and increased access 
to treatment (McCrone, et al., 2004). Stasiak (2008) completed a pilot study using computerized 
interventions to decrease depressive symptoms and found the intervention showed a significant 
effect when compared with a placebo. Additionally, Fleming et al., (2011) utilized the 
computerized CBT intervention, SPARX (Smart, Positive, Active, Realistic, X-factor thoughts) 
and found this computerized intervention to be significantly more effective than a waitlist control 
group. SPARX was designed as an interactive fantasy game for adolescents seeking help for 
depression that involves the client creation of an avatar to undertake a series of challenges built 
within the game to restore the balance in the fantasy world dominated by GNATs (Gloomy 
Negative Automatic Thoughts) (Merry, et al., 2012). If research and interventions using 
computerized CBT show to be at least as effective as traditional psychotherapy, the potential for 
growth in this area is significant as it may be associated with lower cost and the potential for 
reaching individuals who currently do not access help (Merry et al., 2012).  
Neurostimulation Strategies 
Within the past decade, reversible invasive stimulation methods have been introduced 
and studied for the management of TRD (Mohr, Rodriguez, Slavickova & Hanka, 2011). Modern 
stimulatory techniques such as ECT and  DBS have shown renewed interest in stimulatory 
methods of the 20th century as safer interventions have allowed for the development of precise 
targeting of key structures in the brain, along with a better understanding of the underlying 
mechanisms of several mood and psychiatric disorders (Mohr et al., 2011).  Several different 
neurostimulation approaches have shown effectiveness in treating TRD (Rizvi et al., 2011) and 
may provide a novel approach to precisely target specific brain areas, nuclei and circuits 
implicated in the cause of MDD (Mohr et al., 2011). Clinical practice guidelines are especially 
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critical in applications of neurostimulation strategies to identify clients best suited to benefit 
from these techniques (Mohr et al., 2011). The primary types of neurostimulation techniques 
studied for use with TRD are electroconvulsive therapy (ECT) and repetitive transcranial 
magnetic stimulation (rTMS) (Rizvi et al., 2011). It should be noted that while research 
specifically using rTMS for clients with TRD showed promising results, these techniques are still 
considered experimental and are not widely available (Shelton et al., 2010). 
Electroconvulsive Therapy. Electroconvulsive therapy is recognized as a mode of 
treatment for a variety of mental disorders, including TRD (Al-Harbi, 2012). ECT is considered 
a gold standard for relieving depression by many practitioners, many who believe that by not 
beginning ECT sooner, clients may unnecessarily deal with less effective treatments and risk 
chronic illness (Pandarakalam, 2018).  In one large population study, participants with TRD, 
ECT was an effective treatment for approximately two thirds of cases (Al-Harbi, 2012). ECT has 
been found to be particularly effective in the treatment of geriatric TRD for many reasons, 
including:  older adults’ low tolerance to medication, somatic comorbidity, higher likelihood of 
medication interactions, higher reported rates of treatment resistance and high risk of suicide 
(Kellner et al., 2016). Additionally, the Prolonging Remission in Depression in Elderly (PRIDE) 
study revealed that ECT combined with an antidepressant was effective in preventing relapse in 
clients age 60 and older who had severe depression (Kellner et al., 2016).  However, 
contradicting the appropriateness for older adults alone, in a study of 402 clients, Socci et al., 
(2018), found no significant difference in rates of response to ECT treatment across age 
categories of three groups:  young (18-45 years) at 63.5%, middle (46-64 years) at 55.5% and 
older (³65 years) at 69.6% response rate. Supporting ECT’s widespread effectiveness across age 
categories, in one recent study of adolescents with TRD, continuation ECT and maintenance 
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ECT was found to be a safe and useful treatment strategy for adolescents with severe TRD 
(Ghaziuddin, Dumas, & Hodges, 2011). This study was particularly important as symptom 
remission was achieved without cognitive impairment (Ghaziuddin, Dumas, & Hodges, 2011). 
This study supports evidence that ECT is an effective treatment option, independent of age, 
while older clients may show a faster response (Socci et al., 2018). One of the main reasons ECT 
may not be more widely used is the potential for side effects which may temporarily cause 
memory impairment (Pandarakalam, 2018).  
Repetitive Transcranial Magnetic Stimulation (rTMS). Repetitive transcranial magnetic 
stimulation is a newer alternative for individuals with TRD (Dumas et al., 2012). This is a non-
invasive, well-tolerated technique using high-frequency (> 5 Hz) of the left dorsolateral 
prefrontal cortex or low-frequency (< 1 Hz) of the right dorsolateral prefrontal cortex magnetic 
pules (Lefaucheur, et al., 2011). These pulses produce up to fifty stimuli per second and can 
modify the activity of specific brain areas (Pandarakalam, 2018). For example, since research has 
shown the left prefrontal cortex to be less active in clients diagnosed with depression, rTMS may 
be used to target that particular area as it is accessible by this technology (Pandarakalam, 2018). 
The differences in usage of the high versus low frequency rTMS comes from 
electrophysiological data collected from the motor cortex, showing that high-frequencies may 
produce a stimulatory effect while low-frequencies have been shown to suppress cortical 
stimulation (Dumas et al., 2012). Several research studies examining the effectiveness of rTMS 
have investigated changes in overall depressive symptoms (Berlim et al., 201). Meta-analyses of 
clinical outcomes using rTMS have shown a threshold of nearly 50% decrease in overall 
symptom severity, in up to 76% of clients (Slotema et al., 2010). Additionally, rTMS presents a 
treatment advantage as compared to ECT in that rTMS does not produce any cognitive memory 
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impairment, does not require general anesthesia and is not invasive (O’Reardon et al., 2007). In 
2008, the FDA approved rTMS for use with clients experiencing moderate TRD (O’Rearadon et 
al., 2007).  
Vagus Nerve Stimulation. The mechanism involved with VNS is a stimulation of the left 
cervical vagus nerve, located near the meeting point of the base of the brain and top portion of 
the cervical vertebrae (Mohr et al., 2011). All VNS systems until recently, have required surgical 
implantation. In the newest VNS technique, systems that can sit on the exterior of the body have 
been develop, which show promise, but are not yet approved for use with TRD clients (Howland. 
2014). During this technique, the ascending fibers of the left cervical vagus nerve are stimulated 
using a programmable neurostimulator, or pacemaker-like device that is implanted in the left 
chest wall (Mohr et al., 2011). The battery-powered stimulator sends electrical impulses through 
the subcutaneously located bipolar lead. The associated electrode is wrapped around the left 
vagus nerve in the neck, near the carotid artery (Mohr et al., 2011). This is usually an outpatient 
procedure, performed by a neurosurgeon. Stimulator settings are programmed to deliver 
intermittent stimulation of varying frequencies and wattages in a periodically sequenced protocol 
(Mohr et al., 2011). This technique was originally used for the treatment of epilepsy since the 
1990’s and was expanded for use with depression in the United States in 2005 (Mohr et al., 
2011). Currently, the use of VNS has been FDA approved for clients with chronic or recurrent 
depression who failed to adequately respond to at least four antidepressant interventions (Mohr 
et al., 2011). During the course of VNS treatment, usage of antidepressants, mood stabilizers or 
other psychotropic drugs is also permitted (Mohr, et al., 2011).  
The exact method of the antidepressant action of VNS has not been fully understood, 
however hypotheses are based on the neurobiology of the vagus nerve and overall effect on brain 
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functions involved in mood control (Nemeroff, et al., 2006). Alleviation of depression 
symptoms, may be partially attributed to the projection of afferent fibers to the part of the 
nucleus that relays incoming sensory information to the brain through an automatic feedback 
loop to certain portions of the brain (Mohr et al., 2011). During VNS, the locus coeruleus, which 
is the site of many norepinephrine containing neurons, may be stimulated that connects to 
important regions of the brain responsible for mood regulation including:  the amygdala, 
hypothalamus, orbitofrontal cortex and other limbic regions (Henry, 2002). Several studies in 
both humans and animals have indicated that VNS evokes changes in neurotransmitters 
implicated in the diagnosis of depression including:  Serotonin, norepinephrine, gamma 
aminobutyric acid, and glutamate (Manta, et al., 2009).  
While the US FDA has approved VNS as adjunctive therapy, benefits of this therapy 
have only been documented after prolonged use of up to one year (Shelton et al., 2010). In 
addition, there have only been a small number of clinical trials that have demonstrated steadily 
increasing improvement with full benefits after six-twelve months of treatment, sustained up to 
two years (Mohr et al., 2011). Thus far, VNS is perceived as safe and well tolerated, with no 
documented negative cognitive effects, but continued research is needed in larger, long term 
trials (Mohr et al., 2011).  
Aerobic Exercise 
Physical activity has long been recognized as a key component of a holistic intervention 
for several mental-health diagnoses including depressive disorders (Rosenbaum et al., 2014). The 
potential noted benefits range from an overall reduction in reported symptoms to an increase in 
mental-health service utilization (Rosenbaum et al., 2014). In recent years, formal exercise has 
received considerable attention as an alternative and as an augmentation strategy for treating 
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depressive disorders (Rethorst & Trivedi, 2013). Several research studies have indicated that 
exercise may be a reliable augmentation strategy for individuals with mood disorders who are 
not responding to conventional medication interventions (Kucyi, et al., 2010).   
A recently conducted meta-analysis reported a moderate effect of exercise on quality of 
life outcomes for individuals with mental illness diagnoses, including major depression 
(Rosenbaum et al., 2014). Further research conducted by Greer et al., (2016) examined the effect 
of exercise augmentation within a population of individuals with non-remitted, MDD, meaning 
participants reported some response to their pre-study antidepressant but were still experiencing 
symptoms of impairment. The purpose of this study was to examine two doses of exercise as 
augmentation strategies following SSRI treatment (Greer et al., 2016). The results of this study 
revealed significant improvements in psychosocial functioning and overall quality of life 
following exercise augmentation compared to baseline level of reported functioning (Greer et al., 
2016). These research findings are particularly important as psychosocial impairments are often 
continually reported after pharmacological treatment and may highlight the significance of using 
exercise as an augmentation intervention to improve deficits in psychosocial functioning for 
clients with non-remitted MDD (Greer at al., 2016). Trivedi et al. (2011) also studied the role of 
aerobic exercise as an augmentation to antidepressant therapy in a population of individuals 
insufficiently responsive to adequate duration and dosage of SSRI medication. The two-group 
randomized trial (4 week or 16 week) plan of prescribed exercise showed significant 
improvement in depressive symptoms in both groups at study endpoint with adjusted remission 
rates of 28.3% at week 12 for the longer-term exercise group and 15.5% for the four-week, acute 
group, both groups showing clinically significant results (Trivedi et al., 2011).  
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Other studies, not necessarily directly related to TRD have also indicated beneficial 
results as measured by EEG examination. Woo et al. (2010), examined brain activation in a 
population of college students and found that when compared to baseline measures, resting left 
frontal brain activation and self-reported levels of “vigor” were all elevated following exercise at 
low, moderate and high intensity levels. These results are important to this proposed study as 
findings reinforce an exercise-effect relationship in which exercise induced positive affective 
responses in study participants overall.  It should also be noted that while numerous studies have 
found efficacy of exercise interventions, results may be inconsistent, often due to heterogeneity 
of research participants (Gadad et al., 2019).   
Summary of depression treatment interventions 
Many such studies have shown promise for treatment options beyond medication. In a 
meta-analysis comparing CBT with pharmacological interventions, the CBT group was found to 
have lower rates of depression relapse as well as reporting the CBT group just as likely as the 
medication group to experience relief of depression symptoms (Cuijpers, et al., 2013). When 
specifically examining the impacts of media on mental-health outcomes, (Ruggiero, 2000) found 
that managing one’s mood and enhancing their emotional state were some of the top reason’s 
individuals cite for using diverse forms of media. Within the literature of current conventional 
therapies to depression, an unmet need exists in researching therapies for clients who do not 
adequately respond to typical courses of treatment (Thase, 2017). The majority of clients who do 
not respond to first-line therapies, also do not respond to newer combinations of other 
antidepressants and adjunctive therapies with antipsychotics (Thase, 2016).  The interventions 
reviewed in this section have all been found effective in some capacity and within the scope of 
particular populations. With the continued growth of the videogaming industry, applications of 
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gaming have expanded into healthcare settings. Various applications of CVGs specifically were 
examined in the section following a discussion on measuring TRD.  
Measuring Depression using EEG 
While the human EEG signal was first discovered by psychiatrist Hans Berger in 1926 
(Cai et al., 2018), during the 1960s and 70s it was discovered that brainwave patterns could be 
measured, reconditioned and retrained (Kamiya, 2011). Psychophysiological measures, 
particularly EEG, provide reliable, high resolution measurements of brain activity relaying 
human experience information regarding cognition and emotion (Liu et al., 2018). 
Electroencephalography is one of the primary methods to measure neural activity in the brain 
and is one of the main dependent variables of this proposed study. Using EEG methods, non-
invasive electrodes are placed along the scalp in various locations to measure spontaneous 
electrical activity in the brain (Cao et al., 2019).  Brainwaves occur at various frequencies and 
can be identified by their corresponding names (Hammond, 2011). These brainwaves range from 
very fast to slow and are measured in cycles per second or hertz (Hz). EEG measurements have 
been used for decades in auxiliary diagnosis of several mental-health conditions including:  
depression, seizure and schizophrenia (Li et al., 2016). The main advantages of using EEG over 
other brain activity measures are sensitivity, relatively low-cost, and convenience of recording 
through portability (Li et al., 2016). Recent advances in neuroscience, sensor technology design, 
and an increase efficient signal processing has helped facilitate the understanding and transition 
of EEG from clinical-oriented diagnoses and research to the new potential growth of personal 
healthcare devices and applications (Lin et al., 2017). EEG measurements continue to expand in 
applicability and has recently been used to record video gameplayer experience data and game 
flow during gaming sessions (Berta, et al., 2013). EEG use is growing within the gaming 
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research community as use of sensors and equipment do not interfere with players while 
performing most tasks, with data stemming from involuntary processes (Liu et al., 2018).  
The names for these EEG bands are:  Delta, theta, alpha, beta and gamma. Gamma 
brainwaves are very fast EEG activity above 30 Hz. Gamma brainwaves are still largely under-
researched however, some Gamma activity has been associated with intensely focused attention 
and in assisting the brain to process and decipher information from different areas of the brain 
(Hammond, 2011). Beta brainwaves are small, rather fast brainwaves (above 13-30 Hz). These 
beta brainwaves are associated with a state of mental, intellectual activity and concentration. 
These brainwaves have been described as a “bright-eyed, bushy tailed” state of alertness 
(Hammond, 2011). The activity at the lower end of this range, known as sensorimotor rhythm, is 
associated with a state of relaxed attentiveness. Alpha brainwaves (8-12 Hz) are slower and 
larger. These brainwaves are associated with a state of relaxation. Low range activity in these 
brainwaves represent a considerable and measured degree of a person’s brain shifting into an 
“idling mode”, potentially disengaged and waiting to respond when needed (Hammond, 2011). It 
should be noted these alpha waves will be the specific type of brainwave studied within this 
currently proposed research. Theta brainwaves (4-8 Hz) are generally described as the daydream 
brainwaves and can produce an absent-minded effect, sometimes associated with mental 
inefficiency. The very slow levels are correlated the twilight state between waking and sleep. 
Lastly, Delta brainwaves (.5-3.5 Hz) are very slow, high-amplitude brainwaves and are displayed 
during deep, restorative sleep. When excessive amounts of slow waves are present in the frontal 
parts of the brain, mostly identified for executive functioning purposes, individuals may find 
difficulty controlling attention, behavior, and/or emotions (Hammond, 2011). These symptoms 
may correlate with cognitions and behaviors such including:  difficulty concentrating, memory 
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issues, impulsive behavior or hyperactivity, and in the long term, diminished intellectual 
efficiency (Hammond, 2011). While different brainwaves are associated with different levels of 
awareness, it should be noted that every person always has some degree of each of these various 
brainwave frequencies, present in various parts of the brain (Hammond, 2011).  
The focus of brain activity measurement in this proposed study will be alpha wave 
activity. Alpha activity is commonly measured using a mid-prefrontal placement of sensors 
(Fp1/Fp2) location. This placement allows researchers to measure the potential right and left 
prefrontal asymmetry, often associated with depression (Cao et al., 2019). Since the origins of 
EEG brain activity measurement, brain asymmetry measured from the frontal regions of the 
brain has proven to be a reliable biological marker to understand the processing of affect (Chia et 
al., 2016).  
Specific to depression, researchers have postulated that since depression is a mental 
condition, it is reasonable to believe the brain would be the physical location to look for 
physiological expression of depression (Rosenfeld et al., 1995). Davidson (1984), proposed 
decades ago that the measurements in the anterior EEG alpha band (8-12 Hz) reflected the 
relative differences in affective responsivity between the left and right brain hemispheres. 
Historically, and more specifically, the left frontal regions may be more active during the 
experience of positive emotions (approach-related) and right frontal regions may be more active 
during negative emotions (withdrawal-related) (Gotlib, Ranganath & Rosenfeld, 1998). The 
conceptual basis for Davidson’s findings applied to depression were described by Davidson 
(1992) in relation to neurological literature originally related to the emotional consequences of 
cortical lesions, originally examined in patients who had experienced strokes. During his 
research, Davidson found that lesions in the right frontal area led to positive affective states, 
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while lesions in the left frontal area lead to negative affective states. The findings of these areas 
with lesions were thought to correlate if there were negative and positive affective reactions in 
the right and left frontal areas (Rosenfeld et al., 1995). Previous research had already confirmed 
that lower frequency (alpha activity) is associated with a resting cortex, thus, reduced activity in 
the right alpha state, indicating resulting negative affect (Rosenfeld et al., 1995). By contrast, 
increased activation (reduced alpha) on the left side would coincide with resulting increased 
positive affect (Rosenfeld et al., 1995). Several studies have compared the resting EEGs of 
clients with MDD to “normal” controls and have concluded the clients with MDD have elevated 
resting state EEG alpha power (Jaworska et al., 2012). While sometimes confusing, it is 
necessary to note that power in the EEG alpha band (8-13 Hz) is inversely related to activation of 
the corresponding region of the brain (Davidson, 1993). This can be interpreted by understanding 
that as Hz power increases, activation of that hemisphere being measured decreases (Gotlib, 
Ranganath & Rosenfeld, 1998). This inverse measurement discovery was first reported in 
Henriques and Davidson’s (1991) research that revealed relatively greater left frontal alpha 
power in participants with MDD, indicating left frontal hypoactivity (less cortical activity), 
described as a deficit in the positive affect emotion. This supports the notion that participants 
with asymmetry are more likely to experience negative affective states, such as depression 
(Henriques & Davidson, 1991). Most notably for this particular study, early frontal EEG findings 
paralleled the findings on self-ratings for happiness, showing correlation between self-report and 
objectively measured mental-health outcomes (Davidson, Schaffer & Saron, 1985). This served 
as the basis for more recent and in-depth investigations into specific mood disorders such as 
depression.  
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 Psychopathological states have been studied for decades from the perspective of 
understanding the conditions in various structures of the brain affected by different diagnoses 
(Thayer & Brosschot, 2005). Previous studies have particularly noted that under conditions of 
perceived uncertainty or threat, the prefrontal cortex becomes particularly hypoactive (Thayer & 
Brosschot, 2005). In conditions such as anxiety, depression, post-traumatic stress disorder and 
schizophrenia, correlations associated with prefrontal hypoactivity and a lack of inhibitory neural 
processes have been found (Thayer & Brosschot, 2005).  This early research has long suggested 
that greater left frontal EEG activity is related to positive, approach-related emotion, while 
greater right frontal EEG activity is related to negative, withdrawal-related emotion (Davidson, 
1995). This notion has been confirmed by further research, specifically focused on depression 
that has long reported individuals with depression exhibit greater right frontal EEG activity 
(Schaffer, et al., 1983).  
Currently, the standard method of diagnosis for all forms of depression is a scale-based 
assessment and interview conducted by a mental-health provider, most likely a psychologist or 
psychiatrist (Cai et al., 2018). Self-assessments are most commonly used to diagnose and 
monitor depression as they are a quick and easily accessible method (Solomon et al., 2015). 
While these methods may be flawed due to the reliance on accurate and honest reporting of 
symptoms, they serve do serve as a reasonable and quantifiable standard to use for assessment 
and measurement of depression (Solomon et al., 2015). The PHQ-9 is one of two most 
commonly uses assessments and was used in this study (Solomon et al., 2015).Other 
psychometric questionnaires such as the PHQ-9 that will be used in this proposed study, are 
additionally used as screening tools by mental-health professionals. These current methods of 
depression detection are time intensive, expensive and rely on the doctor or provider’s 
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experience and knowledge (Cai et al., 2018). As a result, many clients with depression may be 
diagnosed incorrectly and do not receive optimal treatment (Cai et al., 2018). Objective forms of 
assessment of TRD may additionally be helpful when combined with subjective questionnaire or 
interview assessments such as the PHQ-9 to add increased opportunity for accuracy of 
assessment (Liu, et al., 2018). As opposed to assessments such as the PHQ-9, EEG indicators are 
neither affected by the participant’s answering style, social preferences, interpretations of 
questions and scale or wording by observer bias (Kivikangas et al., 2011). This EEG 
measurement provides an advantage to both clinicians and researchers as a source of information 
during engagement in a task such as gaming that will not interfere with gaming devices such as 
joysticks, keyboards, mouse, gesture or voice (Liu, et al., 2018). Additionally, the continuous 
nature of EEG data collection provides an opportunity for real-time data analysis and tracking of 
a user within a system (Liu et al., 2018).  
Casual Video Games 
Video games hold immense potential to teach individuals new patterns of thought and 
behavior (Granic et al., 2014). A standard definition for a CVG has not been agreed upon thus 
far, mostly because these games are so diverse in nature, subject matter and objectives 
(Russoniello et al., 2019). Casual Video Games is part of a class of video games labeled, 
“commercial off the shelf (COTS)” games that are designed for entertainment, with no 
consideration of the therapeutic value (Carras et al., 2018). These COTS games contrast custom 
video games that are based on health interventions and game for health applications (Carras et 
al., 2018). It has been suggested that using these COTS games, rather than a game specifically 
created to address a health issue, may be more beneficial as clients are already familiar with 
games used and are thus, more open to learn how to use play interventions to promote well-being 
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(Carras et al., 2018). The structural characteristics of games may provide unique offerings that 
traditional therapies are unable to offer (Carras et al., 2018). The Casual Games Association 
instead offers an operational definition that proposes all CVGs must be fun, quick to access, easy 
to learn and require no previous video game skills, experience or regular time commitment 
(Casual Games Association, 2007). Casual video games have also been described as a break 
from life, promoting escapism and a way to transition between activities or kill time while 
waiting (Morris, 2011). Self-reports “gamers” have also cited CVGs as a method to de-stress and 
relax (Morris, 2011). Russoniello (2011) referenced CVGs process that works on individuals 
subconscious by relaxing the autonomic nervous system, the part of the brain responsible for 
what is commonly referred to as the “fight or flight response (as cited in Morris, 2011). 
Video games have undoubtedly grown to be an accepted part of everyday life for millions 
of people globally (Grooten & Kowert, 2014). In 2017, over 130 million Americans (40% of the 
US population) played commercially available video games (Brown, 2017). The increased 
growth in ownership of multiple digital technologies including devices such as smart phones and 
tablets has contributed to the exposure of most of the population to CVGs and other gamified 
applications (Palaus et al., 2017). The growth of multiple device usage has led to 30% of overall 
tablet users and 70% of smart phone users to be categorized as “casual gamers” to some varying 
degree (Casual Games Association, 2013).  Antiquated stereotypes of “gamer culture” has 
continued to prevail regarding the type of individual engaging in CVG, although demographic 
data actually explains the widespread use of this gaming category (LaFleur, Hebert & Dupuy, 
2017). Recent demographic data on video gaming shows that the current mean age of video 
gameplayers (VGPs) is 31 years old and has continued to rise in recent decades (Entertainment 
Software Association, 2014). The gender divide between men and women is split nearly evenly 
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with the majority of CVG players engaging socially in these games with family members, 
spouses and colleagues (Entertainment Software Association, 2016). Additionally, in a 2010 
study sponsored by PopCap, the manufacturer of all three CVGs of use in this study, results 
found the average CVG user to be 43-year-old women, contradicting typical gaming stereotypes 
(Farooqui, 2010). For many women in this age category, accessibility is the most commonly 
listed appeal to CVG use (Farooqui, 2010). Women who often find themselves multi-tasking can 
find an outlet for competition and social connection through CVGs (Farooqui, 2010).  
The CVG segment of gaming is currently one of the fastest growing segments of the 
gaming industry, with an estimated market share increase of 20% annually (Casual Games 
Association, 2008). The Entertainment Software Association (ESA) reported that 59% of all 
Americans play video games with nearly equal distribution across genders (52% of males and 
48% females) (ESA, 2014). The CVG industry now reports earnings upwards of $55 billion 
yearly (Casual Games Association, 2008).  
As rates of video gameplay continue to grow, a growing number of video game 
manufacturing companies such as Electronic Arts (EA) are creating games that are tackling 
mental-health issues (Parker, 2019). Examples of these mental-health focused games include: 
“Celeste”, a game that explores depression and anxiety through a main character who must avoid 
physical and emotional obstacles, “Hellblade:  Senua’s Sacrifice”, in which a young Celtic 
warrior deals with psychosis and “Night in the Woods” that focused on self-identity, anger issues 
and post-traumatic stress disorder (Parker, 2019). The majority of video games created with a 
mental-health focus have come from independent creators, stereotypically more willing to take 
risks in exploring unusual content (Parker, 2019). Electronic Arts introduction of “Sea of 
Solitude” marks a shift in the gaming industry as one of the largest publishers of video games, 
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better known for “Madden Football” and battlefield war games (Parker, 2019). Within the 
context of mental-health counseling, video games may be a useful tool in psychotherapy 
assessment, building rapport and providing social skills training (Blum-Dimaya, et al., 2010). 
The CVGs used in this study, Peggle, Bejeweled and Bookworm Adventures, are manufactured 
by PopCap Games, owned by parent company EA and is part of the growing industry of utilizing 
mainstream video games to examine mental-health outcomes. 
Gaming History 
In general, games have a rich history for use as general entertainment. A “game” is 
described as an activity with the key features of challenge, motivation and reward (Li, Theng & 
Foo, 2014). Recreational activities including board games and cards have shown reduced cortisol 
levels, improved mood and stress reduction when compared with a matched control in a study 
group of client participants with alcoholism (Russoniello, 2008).  While video games have been 
played in homes and arcades since the late 1970’s, gaming had been identified mostly as 
harmless entertainment, increasingly common in the 80’s and early 1990’s (LaFleur, Hebert & 
Dupuy, 2017). In 1992, the advent of the game, Mortal Combat, began to shift this identification 
of gaming as innocuous to a new identity of something potentially harmful to play (LaFleur, 
Hebert & Dupuy, 2017). Midway Games released the first version of Mortal Combat, a game 
focused on competing in a martial arts tournament, with the final goal of killing one’s opponent 
in multiple gruesome ways (LaFleur, Hebert & Dupuy, 2017). As games have expanded and the 
demographics of those who play them has grown, a gradual shift has taken place to normalize 
and accept new gaming opportunities such as CVGs (LaFleur, Hebert & Dupuy, 2017). 
Casual video gaming has undergone a progressive evolution of normalization of digital 
play from the early 1990’s through recent years (Chiapello, 2013). Some gaming historians look 
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to Windows Solitaire (Microsoft, 1990) as the game that introduced the casual gaming movement 
to daily life, leading the way for the current boom in CVGs (Chiapello, 2013). Many CVGs are 
based on other popular traditional games including:  chess, Sudoku and pinball (Pine et al., 
2020). These games have been modified for delivery through electronic platforms (Fish & 
Russoniello, 2013). Typically, CVGs are categorized into several groups including:  casual 
action games (focused on motor skills), casual puzzle games (logic focused), idle games 
(observation focused), and casual strategy games (strategy focused) (Pine et al., 2020). The 
diversity of games offered in CVGs allows players to increase their level of choice so they can 
select a game that best matches their mood and level of interest (Pine et al., 2020). The 
framework of CVGs specifically values elements of:  Acceptability, accessibility, simplicity and 
flexibility in game design (Kultima & Stenros, 2010). In recent years, gaming experiences have 
expanded to include fluid experiences between devices allowing a person to play games on 
multiple devices away from the home (Hisatsune, 2010). This expanded model of multi-device 
accessibility now allows players to seamlessly transition from a PC console to their mobile 
phone when leaving their home, increasing overall usage (Hisatsune, 2010). Gaming designers 
also include the necessity of challenge to have a central role in designing a video game (Kultima, 
2009). Other necessary descriptors for CVGs include the necessity of games to be provided in 
short play sessions that can be interrupted and restarted as necessary (Chiapello, 2013). Surveys 
of CVG players have indicated feelings of reduced stress and improved mood following CVG 
play (Russoniello, O’Brien & Parks, 2009). While some recent studies have focused on internet-
based psychological interventions for depression disorders, few have specifically focused on 
using digital interventions with a gaming component (Li, Theng & Foo, 2014). 
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Puzzle Games – Peggle, Bejeweled, Bookworm Adventures 
The specific CVGs used in this research are Peggle, Bejeweled and Bookworm 
Adventures. All three of these games are categorized as puzzle games. Puzzle games meet the 
criteria of CVGs by being described as:  highly popular, easy to learn and play, and liked by a 
wide range of demographics (Chesham et al., 2019). Puzzle games are also non-threatening, 
enjoyable and easy to access (Chesham et al, 2019). Puzzle games have also been described as 
cognitively engaging, which is a benchmark of leisure activities and may play a role in overall 
cognitive decline (Chesham et al., 2018). 
All three of these puzzle games were designed by PopCap Games, Inc., a subsidiary of 
Electronic Arts. PopCap Games, Inc. was founded in 2000, with the intent to provide widely 
appealing games for all demographics to enjoy (Morris, 2011). The first game PopCap released 
was Bejeweled, one of the games included in this current proposal. Bejeweled quickly grew in 
popularity to become the company’s flagship game (Morris, 2011). Bejeweled is a puzzle game, 
most easily comparable to the Nintendo game, Tetris (Morris, 2011). The concept of Bejeweled 
is that the player must match three or more of the descending jewels to make them disappear. 
The appearance of the jewels are colorful, visually appealing and create opportunities in game to 
earn coins and buy bonus jewels to enhance gameplay. Bejeweled quickly exploded in popularity 
with over 500 million downloads and an estimated 10 billion hours of play since 2000 (Edwards, 
2014).  
Peggle is the second game included in this current proposal. Peggle has been described as 
“equally addictive and playable to Bejeweled” (Morris, 2011). The premise of Peggle involves 
zapping pegs or dots on the user’s screen that form in an increasingly complex layout (Morris, 
2011). As the player increases their level of play, the puzzles become more difficult to conquer. 
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Part of the psychological reward that may be effective in Peggle are the cute animals and 
characters that appeal Anecdotally, players have described the effect of playing Peggle as a form 
of meditation and relaxation for the brain (Morris, 2011). Peggle also rewards successful 
completions of levels with the playing of the popular song “Ode to Joy”, contributing to 
validating player efforts (Morris, 2011).  
Bookworm Adventures is the third game included in this current proposal. Bookworm 
Adventures was developed by PopCap Games Inc., in 2006. It is also categorized as a puzzle 
game and utilizes word formation as its game mechanism (PopCap Games Inc., 2007). During 
gameplay, the object of the game is to guide “Lex the Bookworm” through a series of stages, 
battling creatures along the way, largely based in Greek Mythology (PopCap Games Inc., 2007). 
Enemies are damaged along “Lex’s” journey as the character forms words with the letters given 
by the game. The words are formed from a grid of available letters. The longer the formed word, 
the more damage that is done to the opponent characters. Similarly, to PopCap’s other games, 
Bookworm Adventures also features gems, generated by spelling words. Each gem earned has a 
different effect, with properties such as healing “Lex” and inflicting damage on enemy 
characters. Once all the battles are won by “Lex” a treasure item is rewarded. Treasures provide 
special abilities to “Lex” for future battles.  
The formula for all three of the games is very similar using a variety of different visuals 
and sounds that correspond with the plot of each game. During each of the games design, 
developers built each game to increase its difficulty concurrently with the player’s developing 
abilities (Russoniello et al., 2019). Each game was also designed to be appealing to a player’s 
time constraints in a typically busy day by requiring completion of a level to be finished within 
5-15 minutes on average. As a player completes a level, they are challenged with increased 
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difficulty in the next level. One example of this progression may be presentation of different 
obstacles with new abilities as well as new game assets with abilities not seen before as well. The 
game presentations are enhanced similarly by including appealing visuals, sounds and 
animations throughout each game and at the end of each level. As a player reaches their goal, 
positive feedback is provided in the form of earning badges, praise and unlocking additional 
game modes. The game achieves the developers’ goals by facilitating a sense of control and 
accomplishment for the player, but does not specifically aim to improve health outcomes 
(Russoniello, 2019). Further, all three CVGs meet the criteria of a CVG as a game that is 
described as fun, easy to access, simple to learn and does not require previous video game skills 
(Casual Games Association, 2007).  
Video Game Research 
Literature in the area of video game research is often divided sharply by researchers, 
strongly believing in either the negative or positive effects of gaming. In the past decade, interest 
in video game research has grown significantly as many of the early adopters of gaming forty 
years ago, have now become active scientists in this area (Thorens et al., 2016). As a result of the 
increased focus on gaming research, a shift from gaming as a niche leisure activity to an 
accepted social, commercial, cultural, medical and psychiatric discipline in research has begun 
(Thorens et al., 2016). Prior to 1990, little substantive research was published related to video 
games and mental-health outcomes (LaFleur, Hebert & Dupuy, 2017). By nature, video games 
vary tremendously across categories, which makes them difficult to compare equally across 
genres. (Palaus et al., 2017). Mass media also often reports both positive and negative health 
claims related to video games in general, contributing to consumer confusion (Palaus, et al., 
2017). Undoubtedly, video games have become more complex, mostly due to improvements in 
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computer hardware and software capabilities, catering now to larger audiences of both children 
and adults as a normal entertainment option (Palaus et al., 2017). Current estimates report that 
collectively, video gameplayers in the United States spend approximately 3 billion hours per 
week in front of screens playing (Nichols, 2017). This widespread use has prompted scientists to 
examine how video games affect the brain and behavior. 
The use of video games in research has grown significantly in recent decades as such 
games have shown to increase participants’ motivation better than other traditional tasks used in 
neuropsychology research (Lohse et al., 2013). Further, video games intrinsically include 
features that offer a high degree of control over in-game variables make them good for use in 
experimental procedures in both commercially available as well as video games made for 
specific purposes (Palaus et al., 2017). The use of video games in research has recently grown in 
popularity. The number of publications that either study or use video games in research has 
increased at a rate of 20% per year since 2005 (Palaus, et al., 2017). During the 90’s, 
approximately 15 video game-related articles were published yearly, while over 350 video game 
articles were published in 2015). Several factors affect the behavioral and neural correlates 
related to the use of video games depending on variables such as the type of video game, the 
components of gameplay (hours of play, age of beginning of play, etc.) as well as the individual 
demographics of each player (Kuhn & Gallinet, 2014; Vo et al., 2011).  
Although game-based approaches for mental-health disorders are still in the early stages 
of development and validation, several recent studies have focused on the neural and behavioral 
effects of video games, providing an increased amount of data on video game correlates with 
brain activity (Palaus et al., 2017). Thus far researchers have found data driven results for each 
side, both negative and positive of the gaming debate. With regards to CVGs specifically, 
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Holmes et al., (2010) investigated use of the game Tetris as a cognitive vaccine in a population 
of healthy individuals, exposed to violent, traumatic material. Findings showed that the group 
who played Tetris had significantly less flashbacks than the group who did not engage in a task 
(Holmes et al., 2010). Granic et al. (2014) has found effects that are positive in the areas of 
cognitive, emotional, motivational and social benefits. Conversely, Ivarsson et al., (2013), Turel 
et al, (2016) and others have found gaming to result in negative outcomes such as normalization 
to exposure to graphic violence, contributions to obesity, addiction and cardiometabolic 
deficiencies. The vast majority of these studies are unlike this currently proposed research 
however, as most subjects of previous studies have not been screened for mental-health 
diagnoses such as major depression. In order to complete a well-rounded presentation of gaming 
research, literature in both the negative and positive effects of gaming will be discussed. 
Additionally, the Game Flow model will be discussed as the contextual framework for using 
games in therapeutic settings.  
Negative Effects of Gaming 
As popularity of violent games such as Mortal Combat rapidly grew in the 1990’s, 
especially within teenage populations, the community of mental-health professionals began to 
question video games as entertainment (LaFleur, Hebert & Dupuy, 2017). Since then, the 
majority of video game studies have focused on the negative effects of gaming and their 
potential harm, which is not likely to diminish anytime soon (Ferguson, 2013).  As games have 
become more realistic, a robust amount of research has shown that playing particular violent 
games can lead to several mental-health issues including:  decreased empathy, desensitization to 
violence and impulsivity (Connolly et al., 2012). This focus on the possible detrimental aspects 
of gaming is largely due to the popularity of video game genres in which graphic violence is 
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prevalent in game categories such as: first shooter, survival horror and fantasy (Palaus et al., 
2017). Due to this spotlight on detrimental effects of gaming, a large amount of literature is 
directed towards the study of violent behaviors and violence desensitization as a consequence of 
violence in gaming (Engelhardt et al., 2011). Other negative effects of gaming-based research 
has centered around detriments of sedentary screen time, excessive gaming internet addiction 
(Aarseth, et al., 2016). The focus on negative effects of gaming research was emphasized after 
Congress allocated $10 million to specifically study the effects of violent media, especially video 
games, following the tragedy of the Sandy Hook Elementary School shootings (Obama & Biden, 
2013). Thus far, the emphasis of gaming research has been centered on first-person shooter or 
action-adventure games. Combined, these two types of games contribute 49% of the overall 
gaming market (Nichols, 2017). While research has focused on examining if these shooter and 
action games in fact stir aggression, cause violence and addiction, decades of video gaming 
research has failed to find a causal link between playing video games and acts of violence in the 
real world (Nichols, 2017). However, a growing body of evidence has shown that video gaming 
may affect the brain and cause changes in some specific regions of the brain (Nichols, 2017).  
Although gaming has gone through a historically negative biased past, mental-health is 
becoming a more central narrative in gaming culture as the industry attempts to normalize 
mental-health challenges through gaming discussion and design (Parker, 2019).  While there is 
no disputing the necessity to study negative effects of gaming, especially in the aftermath of such 
horrific devastation such as in school shootings, a more balanced perspective on gaming 
research, one that considers not only negative effects, but also the potential benefits should be 
considered (Ferguson & Olson, 2013). While the line of research regarding negative impacts of 
gaming is necessary, gaming researchers must also consider the evolution of gaming and also 
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grow to investigate potential positive effects and ways that clinicians may approach gaming 
(LaFleur, Hebert & Dupuy, 2017).  
Positive Effects of Gaming 
Several studies are beginning to emerge to examine the potential video games may have 
as a treatment intervention in both rehabilitation and education (Bavelier, et al., 2015). The field 
of gaming research is still rather new and has thus far often stated that the benefits of gaming are 
quite distinguishable in cooperative play, promoting prosocial behavior both in gaming and in 
real life (Gentile et al., 2009).  McGonigal (2011) also noted that youth who spend time playing 
games that require the player to help each other are significantly more likely to help friends, 
family, neighbors and strangers.  
The growth of interest in non-pharmacological interventions for mental-health conditions 
has promoted an increase growth in specific research targeting mental-health outcomes. Li, 
Theng & Foo (2014), completed a meta-analytic review to examine the effects of game-based 
interventions on depression disorders using four types of games:  Psycho-education and training, 
virtual reality exposure therapy, exercising and entertainment games. From a game design 
perspective, many CVGs provide users with a method to socially connect with family members 
and friends as part of their online experience (Gomila & Frederick, 2010). Social connectedness 
and positive interactions with others have long been associated with lower rates of depression 
(Seabrook et al., 2016). Thus, casual video games may help use the component of social 
connectedness to elicit positive emotions in individuals with depression. The analysis of nineteen 
studies showed a moderate effect size of the game interventions for depression therapy post-
treatment (d = -.47 [95%CI-0.69 to -0.24]). Other researchers have inferred that research 
showing individuals with mental-health issues benefit from pleasurable activities (Layous, 
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Chancellor & Lyubomirsky, 2014), which may include CVGs for some individuals (Pine et al., 
2020). In addition, results of previous phases of this proposed study found that in a randomized 
controlled study, “normal” participants reported playing CVGs could significantly improve their 
mood and decrease stress (Russoniello, O’Brien & Parks, 2009). The positive changes that 
resulted from the CVG play were evidenced by physiological measures that supported the self-
reported psychological findings (Russoniello, O’Brien & Parks, 2009). EEG monitoring was 
similarly used to determine mood changes and followed protocol for collecting alpha wave data 
(Davidson, 1988). Russoniello, O’Brien & Parks (2009) hypothesized that playing CVG’s would 
result in decreases in left frontal alpha which would indicate improved mood. Results of this 
study confirmed that playing the CVG, Bejeweled II changed brain waves with a shift towards a 
more positive mood when compared to controls. Further, these results correlated with self-
reported improvements in mood on the Profile of Mood States (POMS) subjective assessment 
(Russoniello, O’Brien & Parks, 2009).  
Additionally, recent video game studies have looked at the effects of exposure from 
gaming on the nervous system and cognition and support the notion that gaming can influence 
behavioral aspects, therefore supporting future studies that look for changes in neural activity 
such as this particular study (Green & Seitz, 2015). Augmented reality games are starting to 
emerge as the next application of use with commercially available gaming. Recently, the 
augmented reality game, Pokemon Go, was studied as a potential intervention to improve 
physical activity levels of individuals who are normally reluctant to participate in exercise with 
encouraging results for increasing engagement (Althoff, White, & Horvitz, 2016). In order for 
clinicians to consider using video games as a therapeutic tool in research as well as in practice, 
the clinician must be familiar with the game to be used as well as the broader concepts of the 
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modality of gaming (LeFleur, Hebert, & Dupuy, 2017). These studies which indicated CVG 
effectiveness in improving mood and reducing symptoms of depression was the basis for 
continuing this line of research that supports this proposed study.  
In addition to gaming studies, non-profit organizations have recently emerged to support 
healthy gaming and mental-health outcomes. iThrive Games Foundation for example, aims to 
improve mental-health in teens by providing clinician guides as educational resources to use 
video games as treatment (iThrive Games, 2020). These guides are created by mental-health 
professionals who have used games in therapeutic settings and reviewed by a licensed mental-
health provider. “Take This” is also a non-profit founded in 2013 to focus on responding to 
concerns over gamer mental-health. The organization focuses on providing resources and 
mental-health support for the unique needs of the game development community. While these 
two organizations differ in their missions, the hope of such groups is to provide support to those 
involved with gaming as needed, while promoting the potential applications for positive 
outcomes in game usage. 
Summary of Literature Review 
Depression is associated with significant disability and substantive economic and societal 
burden due to its high prevalence (Jenkins & Goldner, 2012). Recent estimates report 50-70% of 
individuals being treated for depression are not responding adequately to current treatment 
approaches (Jenkins & Goldner, 2012). Traditional pharmacological and non-pharmacological 
interventions for treating depression can be effective, but can often be costly, often produce 
several side effects and cause multiple rounds of trial-and-error treatment. As the burden of 
depression on interpersonal factors, medical expenses and societal demands in general increase, 
development of new treatments, especially in non-pharmacologic ways are especially important 
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(Thase, 2016). Each individual with depression presents a unique set of traits, risk factors, etc. 
and should receive a detailed evaluation to identify antidepressant responses (Al-Harbi, 2012).  
Casual video games, including Peggle, Bejeweled and Bookworm Adventures may offer a low 
cost, low risk possibility for alleviation of TRD symptoms. This specific study will examine if 
adding a regimen of CVG play has an effect on symptoms of TRD. In addition, this study will 
seek to determine if changes in measured right and left alpha brain waves correlate with changes 
in self-reported PHQ-9 scores. 
 
 
CHAPTER III: METHODS 
Introduction to Methods 
The purpose of this chapter is to discuss the methodological approach used to examine 
potential effectiveness of CVGs in reducing symptoms of depression between two groups; a 
comparison group and a study group.  This chapter will include the research questions of the 
study, a description of the data source, an explanation of the research design, as well as 
population description, sample and sampling method, study procedures and instrumentation. The 
chapter will conclude with a description of the statistical analysis that were used to examine the 
included research questions, as well as a discussion on the limitations of this study findings and 
finally, ethical considerations of the study. 
Archival Data Collection Procedures 
This section will outline the procedures that were used to examine the archival data of 
this study, that served as the data source for this present research. This study utilized data 
collected from a university in the southeastern United States. The original data collection was 
completed between July 2010 and November 2010. This doctoral candidate, did not collect this 
data and conducted only secondary analysis of this existing data. The original data was collected 
by researchers at the same university. Recruitment for the original study began following 
approval from the University Institutional Review Board. In order to complete statistical analysis 
of data, demographic and PHQ-9 data from the original forms as well as EEG data measured 
using physiological software were entered into SPSS version 26.0.0.1 program (IBM 
Corporation, 2019).   
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Research Design 
This study that was completed using secondary analysis of existing data, was originally 
collected as part of a larger study. It should be noted that the terms “original data collection” and 
“present study” are the terms used to distinguish the differences between the originally collected 
data set and this current study. The members of the original research team that collected this data 
examined other variables not included in this present analysis of existing data. This data driven 
approach is common in health-based research (Cheng & Phillips, 2014).The use of these terms of 
distinction were selected based on the data usage guidelines of the National Institute of Health 
(NIH) (Cheng & Phillips, 2014).  
This study utilized a non-experimental design to examine archival data collected from a 
university in the Southeastern United States. The original study utilized a randomized controlled 
experimental design with individuals who utilized CVGs as a prescribed intervention in 
comparison to a group that did not receive any treatment. The intent of this research design was 
to examine if individuals who played the prescribed CVGs had a decrease in symptoms of 
depression on the PHQ-9 as well as on measured changes in alpha brain wave activity. Grouping 
of study and comparison groups was completed by the original research team and was unchanged 
during this present study. The original study design lacks random selection of subjects but 
includes random assignment to groups. A statistical random number generator was used to 
randomize participants into either the study or comparison groups. Once participants were 
randomized into either the study or comparison group, the individual was given a choice of three 
popular CVGs to play. This element of choice was designed into this study as previous research 
has shown that freedom of choice is an important element to experiencing the full benefits of 
interventions (Russoniello et al., 2013). It should be noted all participants met the criteria for 
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positive depression screening along the PHQ-9 scale but were not precisely diagnosed with 
depression at the time of the primary research.  
When primary data was collected, participants who met inclusion criteria were randomly 
assigned into one of two group options. These two groups will be discussed in further detail 
within the “Population” section of this chapter. However, in summation, the first group option is 
called the “comparison treatment group.” This group consisted of a group of participants who did 
not receive a treatment intervention. The second group is called the “study treatment group.” 
This group consisted of a group of participants who were randomly assigned to the group 
participating in the prescribed CVG gameplay regimen. The original research team continued to 
recruit for the study until two separate groups of comparable size were formed to create the two 
groups included in this current study. 
Treatment Groups: Comparison Group and Study Group 
Comparison group. Participants who were assigned into the comparison group did not 
receive an intervention and returned one-month later to complete follow-up assessments. During 
each of the two sessions meeting with a member of the primary research team (pre and post 
assessments), each participant engaged in a 30-minute NIMH web browsing session consisting 
of reading the NIMH consumer website on depression. While this group’s task during sessions 
did not involve gameplay, the NIMH website was selected as valuable information on depression 
and suggested ways to overcome symptoms was presented to the participant. The NIMH website 
included comprehensive information about depression including:  causes, signs and symptoms, 
risk factors, diagnostic criteria, treatment options and research references. The purpose of 
selecting this activity to complete during the two sessions meeting with a researcher was to 
provide a psychological experience comparable to the study treatment group, with the exception 
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of the gameplay. The physicality of visiting the computer-based website also provided a similar 
environment with close proximity to a monitor involved in computer use, similar to gameplay. 
During each session a member of the research team was present. While the data was collected, 
the comparison group participants were asked to refrain from playing any CVGs for the one-
month period of data collection and to continue with their prescribed regimen of two 
antidepressants.   
Study group. Participants who were randomly assigned into the study group participated 
in a prescribed regimen of CVG gameplay choosing either Bejeweled, Peggle or Bookworm 
Adventure as the game for their intervention. Each participant was given a choice of which of the 
three games they would like to play. This method was selected by the original research team as 
research has demonstrated that freedom of choice is an essential component of experiencing the 
full benefits of recreation participation (Csikszentmihalyi, 1975). Following random assignment 
into the group, participants were asked to play one of three CVG options; Bejeweled, Peggle or 
Bookworm Adventures to attempt alleviation of symptoms of depression. Following the initial 
meeting with researchers, the study group participants each followed a prescribed protocol that 
consisted of 30-45 minutes of CVG play at home, 3 times a week, for a total of 16 sessions (4 
weeks). Participants were asked to allow for at least 24 hours of time between sessions. 
Participants in this group were provided instructions by a member of the original research team 
who was present during each session. During data collection times, study group participants 
could play more than the minimum amount of prescribed gameplay and were asked to record the 
duration of each gaming session in a journal.  It should be noted that participants in both groups 
completed baseline assessments that included 6-minute physiological data during which EEG 
data was measured.  
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Population 
The participants included in this current study consisted of 57 participants from the 
southeastern United States. All participants met the cutoff minimum of a 5 on the PHQ-9. The 
criteria for inclusion of the primary study as well as this secondary analysis consisted of:  a) 
being at least 18 years of age, b) being able to read and speak English, and a score of at least a 5 
on the PHQ-9. These stated criteria ensured that participants included in the study met the 
minimal level of symptom criteria for depression as defined by the Diagnostic and Statistical 
Manual of Mental Disorders, 5th Edition standards, (2013). Comparison non-qualifying 
participants were given a free CVG of their choice.  
Eighty-five (85) potential participants were assessed by the original research team and 
screened for depression using the PHQ-9. Twenty-six (26) participants were excluded from the 
study for not meeting entrance criteria, representing a rejection rate of 44%. In total, there were 
thirty (30) females and twenty-nine (29) males included in original study. Two participants were 
later eliminated from the data analysis portion of the study as follow-up assessments at session 2 
were not completed. These fifty-seven participants met the entrance criteria and completed all 
sessions and assessments.  
Sample and Sampling 
Recruitment for the original data collection began following approval from the University 
and Medical Center Institutional Review Board (UMCIRB) at a university in the southeastern 
United States. The study’s methodology and logistical plan was developed between July 2009 
and August 2010. The clinical state of the original study was conducted over four-month period 
(July 2010-November 2010). The data collection portion of the study was conducted during a 
one-month period. Recruitment was completed by word of mouth and distributing a recruitment 
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flier to possible referral resources including:  local mental-health agencies, family medicine 
practitioners, and local newspaper outlets. A recruitment flyer was also posted at various 
university campus locations including:  main university campus, nearby community college 
campus and student recreation centers.  
Sampling Procedure 
In order to determine a desired minimum sample size for the original study, several 
factors were considered. In particular power was examined to determine desired sample size. 
Power indicates the likelihood that the influence of an independent variable on the dependent 
variable will be accurately determined when this influence is actually do to the independent 
variable (Trochim, 2006). This can also be explained by describing power as related to the 
probability of making a Type I error (McLeod, 2019). A Type I occurs when data leads the 
researcher to reject the null hypothesis when the null hypothesis is actually true (McLeod, 2019). 
There are several methods for determining power. Power for this study will be established based 
on the original data collection procedures, on the entire sample size of 57. This will be based on 
the contrast between the pre vs. post changes between groups. In order to accurately derive the 
intended sample size for this study, nQuery 5.0 was selected by primary researchers to decide on 
a sample size. NQuery is a web-based application employed in clinical research industry for use 
in determining intended sample sizes for research studies (nQuery, 2019). Based on a two group 
Satterthwaite t-test of equal means with unequal variances (equal Ns), a sample size of 30 per 
group was determined to be needed in order to result in 95% power to detect size differences 
(a=0.05, two sided).  
However, the desired, predicted sample size of 30 per group to detect changes of 1 
standard deviation between groups with at least 95% power at the a level = 0.05, two sided tests 
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were not met during the original data collection. The entire sample size of 57 was reduced from 
the originally screened size of 85 due to several reasons including participants not meeting 
inclusion criteria and drop-out rate. There are several methods to address a smaller than desired 
sample size in data analysis. The simplest solution to meet the desired 60 participant expectation 
would be to sample more of the intended population. However, since this is not a practical option 
in archival data research, this analysis employed a statistical adjustment technique to address this 
study limitation. The researcher addressed this smaller than desired sample size by examining the 
literature of previous, similarly designed studies with regards to effect size. Effect size is 
described as the strength of an association or difference between the independent and dependent 
variables (Ary, Jacobs & Sorenson, 2010). Cohen (1988) describes effects sizes as: .2 considered 
small, .5 considered moderate and .8 considered large. These effect sizes suggest sample size 
cutoffs based on the number of participants needed in order to achieve a minimally accepted 
power of .80 (Cohen, 1988). Variations to the required sample size that are needed to meet the 
accepted power of .80 are related to the nature of the study and type of statistical analysis used in 
the study. Primary research results as well as related studies were reviewed to help determine 
acceptable effect sizes for this study. In order to address the smaller than desired sample of 57, 
potential changes to effect size determinations will be discussed following statistical analysis in 
the results section as well as discussed in final study limitations.  
Study Setting 
This study used data previously collected at a university in the southeastern United 
States. During any study that includes a clinical population, such as this one, confidentiality is 
the utmost priority for both participants and researchers. In order to ensure confidentiality, the 
primary researcher met with participants in a secured laboratory room. The researcher and 
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participant were seated side-by-side at a table during data collection. The researcher had a 
desktop computer sitting on the table to collect all of the physiological data. This physiological 
equipment was responsible for monitoring and recording EEG data. The positioning of the 
researcher and participant as well as physiological equipment is critical as this allowed for data 
to be clean of artifact. Artifact is defined as recorded activity that is not cerebral in origin 
(Zhang, et al., 2015).  
In physical relation to the primary researcher, study participants sat to the left of the 
researcher. Participants had a computer similar to the researcher in front of them on the table. All 
participants used the computer to complete any pre-test assessments available electronically on 
the computer. Participants in the study group played either Bejeweled, Peggle or Bookworm 
Adventures and those in the comparison group read the NIMH’s website on depression.  The data 
collection room remained locked during each session. The researcher stayed in the data 
collection room with the participant for the duration of each session. 
Data Collection Procedures 
Diagnosis and treatment for depression can be a lengthy process that usually includes 
several rounds of trial and error efforts to provide symptom alleviation, most commonly utilizing 
an antidepressant medication. Along with an evaluation psychiatrists and mental-health providers 
generally consider several factors that helps identify specific symptoms, side effects, reviews 
medical and family history, cultural factors and environmental factors to help decide on a proper 
treatment plan. The diagnostic tool used in this study to quantify self-reported changes in 
depression symptoms was the PHQ-9. The PHQ-9 is a nine-item scale that is widely used to 
measure depression symptom severity (Lowe, Spitzer, & Grafe, 2004). The tool uses a Likert-
type scale to quantify depression symptoms. The PHQ-9 was selected as it has good 
96 
psychometric properties including good construct validity when compared with other self-reports 
on depression, sick days reported and recorded clinical visits (Spitzer, et al., 1994). The PHQ-9 
was further selected as this instrument is commonly used by psychiatrists and recommended for 
use in this study by mental-health professionals.  
Data Collection Times 
An overview of the data collection process and times is presented in Table 1 on the page 
that follows. Data collected at Time 1, initial baseline, was gathered before participants began 
playing either Bejeweled, Peggle or Bookworm Adventures for the study group or reading the 
NIMH website for depression for the comparison group.  Data collected during Time 2 (post-
session 1), was completed at the end of the first session.  Data collected at Time 3 (pre-session 
2), took place one-month post the initial baseline and prior to the beginning of session 2.  Time 4 
(post-session 2), was collected at the end of session 2. The study and comparison groups had the 
same data collected at matching times and sessions. 
Data Collection 
During the first session (Time 1 and Time 2), the researcher screened participants for 
entrance into the study, explained the purpose of the study including inclusion criteria and data 
collection procedures. During the entirety of this process, the researcher remained in the room to 
monitor all physiological signals for integrity, to monitor any potential artifact as well as to assist 
with and provide answers to any questions regarding data collection procedures. Following 
completion of the informed consent, participants were asked to fill out pre-intervention 
demographics and PHQ-9 questionnaires. The PHQ-9 and EEG data were collected at four 
different times as illustrated in Table 1 below. Data collection during session 1 was obtained 
prior to playing either Bejeweled, Peggle or Bookworm Adventures for the study group and prior 
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to beginning their reading of the NIMH website in the comparison group. Data collected at time 
3 was collected 1 month after baseline and compared with time 1 in order to answer the study’s 
main research question. The standard PHQ-9 guidelines were followed at time 1 and time 3. Data 
collected during time 2 was used to compare changes pre- and post-CVG play or NIMH website 
sessions to determine the impact of a single session. Approximately 4 weeks (1 month) later, 
participants of both the study and comparison group returned to meet with a researcher to 
complete time 3 and time 4 measurements. All participants were asked to complete the PHQ-9 
questionnaire again using standard guidelines as well as to have EEG data measured. Upon 
completing the study, participants received a free copy of a CVG of their choice and a $100 Visa 
gift card for their participation.  
Table 1 
Data Collection Procedures 
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The PHQ-9 was used to measure self-reported levels of depression.  In addition to PHQ-
9, participants also completed a demographic profile that included information regarding age, 
gender, ethnic background, and previous experience in gameplay. Following completion of 
questionnaires, participants were connected to a Nexus 10, physiological and data acquisition 
system, utilizing sensors placed on the skull to measure changes in brain activity in the form of 
an EEG. Utilizing the software program included within the Nexus 10 system, researchers 
developed a physiological (EEG) computer screen template that visually displayed the collection 
of 6 minutes of baseline data and 30 minutes of intervention physiological recordings. This data 
provided a measure indicative of changes in overall alpha brain wave ratio measures, used for 
data analysis. 
During the four weeks between session 1 and session 2, comparison group participants 
were asked to refrain from any CVG play. The study group, was asked to record each CVG 
session played on a log sheet. Using the log, participants in the study group recorded the date 
they played, duration of each CVG session, and initialed all logs.  After the four weeks between 
sessions 1 and 2 (approximately 12 sessions), participants returned to meet with the research 
team to complete their participation in the study. During this session 2, participants were 
connected to physiological monitoring equipment again, using the same software from the first 
session, while 6-minutes of baseline and 30-minutes of intervention data was collected.  
Following the completion of the intervention, the PHQ-9, previously administered during pre-
intervention was completed again by both the study and the comparison groups. In order to 
protect the individual identities of participants, all forms used in this study were coded and kept 
in separate folders. 
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Treatment Protocol 
Study group participants were prescribed to play their choice of either Bejeweled, Peggle 
or Bookworm Adventures and were given instructions regarding frequency and duration. During 
time 1 in the first session participants played the CVG for 30 minutes, while physiological data 
was collected.  During the next four weeks, participants were required to play the CVG for a 
minimum of 30-45 minutes per session. Participants were further permitted to play additional 
sessions and were asked to document any extra gameplay on their log sheet.  Each participant 
was also required to play their CVG for a minimum of three times per week over the one-month 
period. By the end of the four-week period, participants were required to have completed a 
minimum of 12 sessions of gameplay. 
Instrumentation/Variable Operationalization 
This section describes the instruments that were used in collecting the archival data that 
was analyzed in this current study. This dissertation utilized a portion of data from a larger study 
that contained several additional instruments not under review in this current study. For the 
purposes of this particular research, there are two instruments that will be examined, the PHQ-9 
and EEG data. Additionally, in order to collect demographic information, a demographic profile 
sheet was administered during the initial session along with the PHQ-9 and EEG, physiological 
data.  The instruments utilized in this study are listed below in the order they were administered 
to participants. 
Demographic Profile Questionnaire 
During the first session, prior to Time 1, participants completed a demographic profile 
that asked each person to provide relevant demographic information. The questions included 
asked participants to identify:  gender, race, educational status, occupational status, how many 
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hours per week worked if employed, marital status, and amount of time spent playing video 
games in the last week. This information was gathered in order to describe the study’s population 
as well as in order to discern participant’s previous gaming experience. 
Patient Health Questionnaire (PHQ-9) 
Instrument development. The brief Patient Health Questionnaire (PHQ-9) was utilized 
in this study as the main, subjective dependent variable. The PHQ-9 is a subtest used to detect 
depression and part of the larger, Patient Health Questionnaire (PHQ) that measures the five 
common types of mental disorders: depression, anxiety, somatoform disorders, alcohol and 
eating (Spitzer et al., 2014). The PHQ-9 was originally created in the mid 1990’s as an 
improvement to the lengthier Primary Care Evaluation of Mental Disorders (PRIME-MD) which 
included data from 6,000 clients from primary care facilities in its development (Solomon, 
Valstar & Crowe, 2015). Since its original development, this assessment has been studied in a 
wide range of adult populations and conditions including spinal cord injury, stroke, cardiology, 
primary care, general medicine, oncology and traumatic brain injury (Kroenke et al., 2010). The 
PHQ-9 has subsequently been adopted as a standard measure for depression screening across a 
variety of health care systems including the Department of Defense and Department of Veterans 
Affairs (Spitzer et al., 2014). The PHQ-9 is available in several languages and often used among 
racially and ethnically diverse populations, although few versions aside from English have been 
psychometrically validated (Rancans et al., 2018; Spitzer et al., 2014). The PHQ-9 has also been 
administered in several formats including automated telephone-based administration and touch-
screen computer (Beard et al., 2016). The brief questionnaire consists of nine items that focus on 
the diagnostic criteria for major depressive disorder, based on the DSM-IV criteria and have 
remained unchanged in the DSM-V update, making the assessment theoretically consistent with 
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the revised manual (APA, 2013). This self-administered measure will be used in this study to 
quantify self-report changes in the severity of depression symptoms throughout the study. 
Scoring. The PHQ-9 is a nine-item scale that asks clients to check off the number of days 
they have experienced each of the listed symptom over the previous two weeks. The PHQ-9 uses 
a self-report, Likert scale to report symptoms of depression and is interpreted as follows:  0-4:  
none, 5-9: mild depression, 10-14:  moderate depression, 15-19:  moderately severe depression; 
20-27:  severe depression. The standard cut-off scores for screening were established in the 
original PHQ-9 study consisting of a population of 580 participants and a major depression 
population n= 41 (Spitzer, Kroenke & Williams, 1999). Major depression is diagnosed if 5 or 
more of the 9 symptoms have been present for at least “more than half of the days” in the past 
two weeks as well as one of the symptoms being depressed mood (Spitzer, Kroenke & Williams, 
1999).  The scoring of the PHQ-9 is straightforward and is widely used due to its simplicity, 
efficiency of time to take in approximately one minute and is free (Spitzer et al., 2014). The 
PHQ-9 was developed and has been empirically validated as a screening and diagnostic 
instrument to detect depression. 
Psychometric properties. 
Validity. The PHQ-9 was selected as the instrument has been validated in approximately 
18 studies conducted in various clinical settings (Manea, Gilboy & McMillan, 2012). During its 
original validation study, a score of “10” or higher had a sensitivity of 88% and a specificity of 
88% for detecting MDD and 78% and 96% specificity for any depression diagnosis (Manea, 
Gilbody & McMillan, 2012). For this reason, a cut-off score of “10” was originally 
recommended for diagnosing MDD (Kroenke, Spitzer & Williams, 2001). Criterion validity was 
established by comparing responses from over 500 mental-health professionals (Lowe, et al., 
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2004). Construct validity was established for the PHQ-9 by comparing this assessment with other 
longer self-report tools, used to screen for depression as well as self-reports of sick days and 
clinical visits (Russoniello, Fish, O’Brien, 2019). The PHQ-9 was chosen over the QIDS and 
other depression inventories for measuring changes in depression symptoms due to is sound 
validation as an outcome indicator when measuring changes in symptoms of clients taking 
antidepressant medications as well as overall generalizability (Martin, et al., 2006). 
Reliability. The PHQ-9 is often administered repeatedly to document improvement or 
worsening of depression symptoms in related to treatment (Williams et al., 2014). Reliability has 
been assessed through internal consistency as well as test-retest research techniques. In general, 
self-report instruments should have Cronbach’s alpha of at least .70 to be considered reliable 
(Streiner & Norman, 1995). Internal reliability has been reported as “excellent” with a 
Cronbach’s alpha coefficient range of .89 to .86 in primary care and obstetrical clinical studies 
(Spitzer et al., 2014). Test-retest reliability has also been reported as excellent with a kappa of 
.84 over the time span of 48 hours within primary care settings (Spitzer et al., 2014). Reliability 
within some European populations has also been reviewed with resulting Cronbach’s alpha of 
.82 for the Latvian version of the PHQ-9 scale and .79 for the Russian version, with both 
versions determined have very good reliability. Maroufizadeh et al. (2019), further examined 
psychometric properties of the PHQ-9 in a population of clients managing infertility and 
determined the PHQ-9 to have good internal consistency with Cronbach’s alpha reported of .85. 
The inter-item correlations of items on the assessment were also found to be statistically 
significant, ranging from .2 to .6 within this study (Maroufizadeh et al., 2019). To further 
examine reliability, Daray et al. (2019) compared internal consistency of the PHQ-9 with the 
following other assessments that are also widely used to screen for depression:  The Beck 
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Depression Inventory-II (BDI-II), the depression subscale of the Hospital Anxiety and 
Depression Scale (HADS) and the total HADS (anxiety and depression subscales together). The 
PHQ-9 internal consistency resulted in a Cronbach’s alpha of .86 while the other assessments 
had Cronbach’s alpha values of .90, .74 and .84 respectively (Maroufizadeh et al., 2019). These 
results showed excellent comparative values for the PHQ-9. 
During the study, the PHQ was administered at pre-assessment and post-assessment for 
both sessions. Participants were instructed to answer questions based on their previous two 
weeks and four-week time periods that correlated with the section of the PHQ being completed.  
For both post intervention sessions, participants were instructed to answer questions based on 
how they felt at that moment.  
Electroencephalography (EEG) 
Brain activity changes were recorded using the NEXUS-10, a 10-channel physiological 
data acquisition and sensor system that can record EEG measures. In general, EEG examination 
of asymmetry in the brain has been used for several decades to examine the effects of stimuli and 
conditions on the brain (Olbrich & Arns, 2013). EEG has been widely used to study 
antidepressant treatment responses in many previous studies as well as in clinical settings due to 
its broad availability and cost effectiveness (Olbrich & Arns, 2013). Several researchers dating 
back to the 1970’s have reported EEG findings in clients with depression that show a greater 
proportion of right versus left sided asymmetry (Abrams & Taylor, 1979). Additionally, it has 
long been hypothesized that frontal EEG data should parallel behavioral data to reveal greater 
right front activation in depressed clients (Davidson, Schaffer & Saron, 1985). The particular 
EEG variable of interest for this research is alpha power. Alpha activity has an inhibitory effect 
on neural activity in the brain, thus indicating, increased alpha power observed in depressed 
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patients who respond to antidepressant treatments, is expected following the intervention in this 
research study. Further, studies have reported antidepressant treatment responses in association 
with hemispheric asymmetry, as a relative measure of the difference in EEG alpha power 
between the right and left prefrontal regions of cortical activity (Cao et al., 2019).  
In order to record participants’ EEG data, a software screen was created to collect 6 
minutes of baseline and 30 minutes of intervention physiological data. The purpose of these 
recordings was to provide EEG alpha brain wave scores. In order to collect these data, 
experienced EEG researchers were required to inspect the collected data to ensure that the raw 
EEG data did not have interference from artifact. Despite the fact that wearable EEG devices 
have a built-in function to remove artifacts through real-time EEG signal enhancement, manual 
review of raw data scores were also examined. Prior to analysis, the EEG data was bandpass-
filtered from 1 to 12 Hz using a zero-phrase finite impulse response filter. The specific protocol 
utilized in this study for recording participants EEG was as follows: 
1. The researcher located and marked F3, F4, and CZ placements using a 10/20 
standardized measurement cap. 
2. The researcher prepped skin by cleaning connection sites using alcohol pads and 
Nuprep. 
3. The researcher placed EEG sensors labeled with #1s on the left and #2s on the right.  
Active leads (red) were placed at F3 and F4.  Reference leads (black) were placed at 
CZ.  The ground lead was placed on the center-backside of the participant neck. 
4. Researcher checked impedance to determine if it was at an acceptable level (between 
-25,000 and 25,000).  If not, sensors were adjusted or replaced until impedance was in 
an acceptable range. 
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5. Researcher visually inspected the EEG signal to determine if it was free of signal  
Log Sheet 
The participants in the study group took a log sheet home during the one-month period 
between sessions.  The items included on this log were:  title of their CVG, amount of sessions 
player, and amount of time played per session. The log sheet data was used to ensure that 
participants meet minimum requirements for the intervention. 
Statistical Analysis Plan 
This study examined the influence of CVG play on reducing symptoms of depression in 
subjective and objective measures of depression. Following data collection, primary researchers 
coded data, immediately scored PHQ-9 assessments, and electronically entered data into SPSS 
version 22.0. As a preliminary execution, descriptive statistics were run on all demographic 
variables for each of the two groups. Each participant in the original research study completed a 
demographic profile that asked for demographic information relevant to this study. The questions 
included asked for information regarding: gender, race, educational status, occupational status 
and amount of time spent playing video games in the previous week. This gathered information 
was helpful in describing the study population as well as in discerning if participants had any 
previous gaming experience. Demographics were also analyzed to identify any covariance with 
the dependent variable of changes in symptoms of depression. Pearson correlations were utilized 
to examine covariance with the continuous variable of depression scores.  After this initial 
description of the data, the main statistical analyses were examined. 
Prior to beginning the main statistical analysis for this current analysis, frequency tables 
and cross tabulations were run on all included variables. This initial step helped provide 
information to this current researcher regarding any issues with coding patterns for each variable 
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as well as information to identify the profiles of any missing data for each variable. This 
procedure was critical to the analysis plan for this research as the current researcher was not 
present during the primary data collection and is therefore, unable to account for any variances to 
variables or potentially missing data that occurred during the data collection process.  
The main statistical analysis used to address the five research questions in this current 
secondary analysis proposal were completed using a repeated measures ANCOVA. An 
ANCOVA analysis is an extension of ANOVA that additionally provides a way of statistically 
controlling for the effect of covariates in the study (Vogt, 1999). ANCOVA analysis allows the 
researcher to remove covariates from the group of potential explanations of variance in the 
dependent variable. With regards to this current analysis, pre-test scores of EEG and PHQ-9 are 
the covariates. This is done in ANCOVA analysis by using statistical analysis techniques rather 
than direct experimental methods to control for covariates (Green & Salkind, 2003).  
Since ANCOVA was used to address two of the three research questions, an examination 
of ANCOVA assumptions and whether the data meets the assumptions for this statistical method 
was required. There are four main assumptions that should be met for the results of an ANCOVA 
to be considered valid. These assumptions are:  1) independent observations; 2) normal 
distribution of the dependent variable across all levels of the independent variables; 3) 
homogeneity of variance; 4) linearity of data. In order to assess the assumption of independent 
observations it is ideal to use random sampling to ensure observations are independent. Random 
sampling was not used in this study and may be a limitation to the study. However, at the time of 
original data collection, no known relationships existed among participants in the study 
(Russoniello et al., 2013). Additionally, all participant identifiers were removed from collected 
data to prevent any potential participant identification. In order to assess homogeneity of 
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variance, Levene’s test of equal variances was completed with non-significant findings at a=0.05 
indicating homogeneity of variance. Further, tests of between subjects’ effects for each level of 
independent variable was examined to look for statistically significant findings at a=0.05 along 
dependent variables while controlling for the pre-test covariate. The assumption of linearity of 
data was determined by examining scatter plots to look for linear relationships between the 
dependent variable and the covariate for each level of independent variable. In order to assess 
homogeneity of regression slopes univariate tests of between subjects’ effects were used with 
non-statistically significant findings at a=0.05. These assumptions have been met, so ANCOVA 
analysis was used to address the research questions. 
ANCOVA, a=0.05 was administered to determine if significant changes occurred during 
any data collection times (Time 1-Time 3). Specifically, baseline (Time 1) and one-month, post 
intervention (Time 3) will be used to determine responses to research questions. The use of this 
ANCOVA method allowed for testing hypotheses regarding changes over time within each 
group, as well as, to test for changes at each specific time point. The ANCOVA analysis was 
selected as this type of analysis accounts for changes to the response variable of symptoms of 
depression by both a factor and a continuous variable. An ANCOVA compares the dependent 
variable of changes in depression scores by both a factor and a continuous variable. Separately, 
partial eta squared, which is a measure of effect size was included to determine treatment effect 
and describe any differences in means relative to common variance (Lakens, 2013). Partial η2 
squared was selected to measure effect size as it is recommended in the literature for use with 
ANCOVA research design (Lakens, 2013). In regards to this study analysis, partial eta squared 
was calculated as the difference between the means divided by the pooled standard deviation. 
Lakens, (2013) classifies effect size changes by the following categories:  small (0.02), medium 
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(0.13), and large (0.26). To answer research question three, a Pearson’s-product correlation was 
conducted to determine if a relationship exists between the instruments used to collect the 
objective EEG alpha wave data and the participant’s subjectively reported PHQ-9 data.  
Research Questions 
There were three research questions stated in this dissertation research:  
RQ1: What is the difference between the comparison group (no intervention) and the 
study group intervention (prescribed CVG play) on objective, alpha wave EEG 
measurement between Time 1 and Time 3? 
RQ2: What is the difference between the comparison group intervention (no intervention) 
and the study group intervention (prescribed CVG play) on subjective PHQ-9 scores, 
between Time 1 and Time 3? 
RQ3: Is there a statistically significant correlation between changes in alpha wave EEG 
measurements and self-report PHQ-9 scores? 
Summary of Methods Chapter 
This research design and data collection methods frame the purpose of this study which 
was to examine the effects of prescribed CVG play on participants with symptoms of depression, 
as evidenced by their EEG measured physiology and self-report PHQ-9 scores. From a 
physiological viewpoint, changes in EEG data may show if participant’s physiology is indicative 
of reduced symptoms of depression following the one-month intervention period. Separately, 
changes on the PHQ-9 self-report scale, were examined to determine if these subjective 
responses demonstrate reduction in symptoms of depression. Lastly, the goal of this analysis plan 
was to investigate whether prescribed CVG play significantly decreased participants’ symptoms 
of depression from both an objective, physiological perspective and a subjective perspective. 
 
CHAPTER IV: RESULTS 
Introduction to the Chapter 
The primary purpose of the current study was to examine the effects of playing one of 
three CVGs on reducing symptoms of depression when used as a prescribed intervention as 
compared to a group of individuals who do not engage in prescribed CVG play. Comparisons 
between the two groups were examined on both the self-report, PHQ-9 scale as well as on 
objectively measured changes of physiological, alpha wave EEG measurement. Provided in this 
chapter are the results from this study. These results include demographic data and statistical 
analyses of research questions. The chapter concludes with a summary of results. 
Data Handling Procedures 
All data collected in the original study was collected by trained researchers. All 
demographic and PHQ-9 assessment sheets were scored immediately and turned into the study 
coordinator for a quality assurance review. Once the study coordinator reviewed the collected 
data and promptly entered the data into the computer. Data were coded and directly entered into 
SPSS version 20 software. It should be noted this data analysis was completed using SPSS 
version 26. This study analysis required further review of de-identified data to examine 
completeness of all study variables. Two additional participants from the original study did not 
complete Session 2 (Time 3 and Time 4) assessments so were eliminated from this analysis, 
bringing to total number of participants to 57. 
Demographic Data 
There were 57 subjects in the research for this dissertation. All participants in this study, 
were individuals who met the PHQ-9 screening criteria for depression with a minimum score of 
5 or greater. Participants in the study group had a mean PHQ-9 score of 11, while participants in 
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the comparison group had a mean score of 10.7. As a measure of severity of symptoms, the 
PHQ-9 scores can range from 0 to 27 since each item can be scored from 0 (not at all) to 3 
(nearly every day). PHQ-9 scores of 5, 10, and 15 represent separate screening cut-off categories 
for depression. A score of a 5 denotes mild depression, while a 10 categorizes major depression, 
a 15 moderately-severe and a 20, severe depression (Kroenke, Spitzer & Williams, 1999).  
Table 2 
PHQ-9 
  Group   
  0 1 Total 
  N % N % N % 
Change PHQ 9 Level -4.00 0 0.0% 1 3.6% 1 1.8% 
 -3.00 0 0.0% 1 3.6% 1 1.8% 
 -2.00 4 13.8% 8 28.6% 12 21.1% 
 -1.00 17 58.6% 14 50.0% 31 54.4% 
 .00 6 20.7% 4 14.3% 10 17.5% 
 1.00 1 3.4% 0 0.0% 1 1.8% 
 2.00 1 3.4% 0 0.0% 1 1.8% 
Total  29 100.0% 28 100.0% 57 100.0% 
Frequency tables as shown in Table 2 were examined to note total numbers of 
participants in each category of depression along PHQ-9 measures, as well as movement 
between categories between Time 1 and Time 3. At Time 1, 25 participants met the cutoff 
criteria for mild depression, 18 for moderate depression, 9 for moderately severe and 5 for severe 
depression. Following the intervention phase of the study at Time 3, a remarkable 26 participants 
dropped below the threshold of 5 for minor depression, with 3 participants reporting no 
depression symptoms any longer. Additionally, 15 participants met the cutoff for mild 
depression, 13 for moderate depression, 1 for moderately severe and 1 for severe depression.  
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These participants were divided as, 29 were in the comparison group while 28 were 
participants of the experimental group. The following data profiled the sample on various 
demographic characteristics by group membership. Also, statistical analyses were performed to 
determine if the comparison group differed significantly from the study group prior to the 
treatment intervention, a regimen of playing one of the CVGs.  
The gender breakdown for the sample was 51% male and 49% female. These statistics 
were similar for the comparison group as well as for the study group, as Table 3 reports. There 
was no statistically significant difference between the two groups on gender breakdown.  
Table 3 
Gender 
Group Male Female 
 N (%) N (%) 
Comparison 15 (52%) 14 (48%) 
Study 14 (50%) 14 (50%) 
Total 29 (51%) 28 (49%) 
Note. Chi Sq=.02, df=1, p=.90 
In terms of employment status, most of the subjects (42%) were full-time employees.  
Thirty percent were students and twelve percent were part-time workers. The remainder were 
unemployed (7%), categorized as disabled work status (3.5%), retired (3.5%) or homemakers 
(2%).  There were no significant differences in occupational breakdown between the comparison 














        
Comparison 4 (14%) 10 (35%) 4 (14%) 1 (3%) 1 (3%) 8 (28%) 1 (3%) 
Study 3 (11%) 14 (50%) --- 1 (4%) --- 9 (32%) 1 (4%) 
Total 7 (12%) 24 (42%) 4 (7%) 2 (3.5%) 1 (2%) 17 (30%) 2 (3.5%) 
Note. Chi Sq=5.85, df=6, p=.44 
There was also similarity between the two groups on educational backgrounds. Most of 
the sample had some college (47%) while a large segment was composed of college graduates 











     
Comparison 2(7%) 16 (55%) 7 (24%) 4 (14%) 
Study 7 (25%) 11 (39%)    5 (18%) 5 (18%) 
Total 9 (16%) 27 (47%) 12 (21%) 9 (16%) 
Note. Chi Sq=4.13, df=3, p=.25 
The marital status of the subjects reflected a large segment that was never married (55%), 
while almost a third reported being married.  Fourteen percent was divorced or separated. There 
were no statistically significant differences in the distribution between the comparison and study 





Group Married Separated Divorced  Never Married 
 
Comparison 10 (36%) 1 (4%) 1 (4%) 16 (57%) 
Study 7 (25%) 4(14%)    2 (7%) 15 (54%) 
Total 17 (30%) 5 (9%) 3 (5%) 31 (55%) 
Note. Chi Sq=2.70, df=3, p=.44 
The racial composition of the sample was predominantly White (68%), while 23% were 
African American. Latinx (4%), Asian (2%) or another ethnicity (4%) were of minority. There 
were no statistically significant difference in the distribution between the comparison and study 












Control 19 (66%) 2 (7%) 6 (21%) --- 2 (7%) 
Experimental 20 (71%) ---    7 (25%) 1 (4%) --- 
Total 39 (68%) 2 (4%) 13 (23%) 1 (2%) 2 (4%) 
Note. Chi Sq=5.09, df=4, p=.28 
There were no statistically significant difference in the distributions on age. The 
comparison group had a mean age of 31 while the study group’s average age was 29. An 
independent samples t-test determined there were no statistically significant differences on this 





Group N M SD 
Comparison 29 31 15 
Study 28 29 11 
Total 57 30 13 
Note. t-test=.59, df=55, p=.56 
In terms of gaming experience, the majority of the subjects were identified as being 
gamers (70%). This was true for the comparison group (76%) as well as for the study group 




Group Gamer Non-Gamer 
Comparison 22 (76%) 7 (24%) 
Study 18 (64%) 10(36%) 
Total 40 (70%) 17 (30%) 
Note. Chi Sq=.91, df=1, p=.34 
Data Collection Times 
The PHQ-9 and EEG (alpha wave) data collection methods followed the administrative 
guidelines outlined in Chapter 3. The PHQ-9 is a well-researched, valid and reliable instrument 
used often for screening the level of severity of symptoms of depression (Kroenke et al., 2001). 
It is a self-administered nine-item scale that asks participants to rate their symptoms of severity 
of depression as “0” (not at all) to “3” (nearly every day). EEG (alpha wave) activity is one of 
five brain waves and is commonly found in the 8-12 hertz range (Schwartz & Andrasik, 2003). It 
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is one of the brain waves which changes are often witnessed in individuals with depression 
(Schwarts & Andrasik, 2003). Alpha brain waves are often described as producing an alert, but 
relaxed state. The demographic questionnaire included in this study was administered along with 
consent to participate during session 1, pre-collection Time 1. The PHQ-9 assessment as well as 
EEG (alpha wave) data collection was completed pre and post session 1 and session 2. The data 
collected at Time 1 (during session 1) at initial baseline, was collected before randomizing 
participants into either the comparison or study group. Data collected during Time 2, post-
session 1, was completed at the end of session 1. Data collected at Time 3, pre-session 2, took 
place one-one post initial baseline and prior to the beginning of session 2. Time 4, post session 2, 
was collected at the end of session 2. Both the comparison and study groups had the same data 
instruments administered at matching times and sessions. A table containing the sequencing of 
data collection is located in Chapter 3.  
Primary Statistical Analysis 
The dissertation empirically tested three research questions: 
RQ1: What is the difference between the comparison group (no intervention) and the 
study group intervention (prescribed CVG play) on objective, alpha wave EEG 
measurement between Time 1 and Time 3? 
RQ2: What is the difference between the comparison group intervention (no intervention) 
and the study group intervention (prescribed CVG play) on subjective PHQ-9 scores, 
between Time 1 and Time 3? 
RQ3: Is there a statistically significant correlation between changes in alpha wave EEG 
measurements and self-report PHQ-9 scores? 
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The first research question used a repeated measures Analysis of Covariance procedure to 
test the difference between the comparison and study groups on the dependent variable of alpha 
wave EEG measurement (Testing Time 3). 
RQ1: What is the difference between the comparison group (no intervention) and the 
study group intervention (prescribed CVG play) on objective, alpha wave EEG 
measurement between Time 1 and Time 3? 
The preliminary statistic of Levene’s Test of Equality of Error Variances was required to 
determine whether the error variance of the dependent variable was equal across both the 
comparison and study groups. This was the case and the assumption was met. (F=1.37, df=1,55, 
p=.25).   
The descriptive statistics on the dependent variable (Time 3) and the covariate (Time 1) 
were executed and are presented in Table 10. The mean amplitude, measured as microvolts (µV) 
of EEG alpha waves for the comparison group (N=29) was 5.98 µV (SD=4.46) at Time 1 and 
5.97 µV (SD=4.13) at Time 3. The mean amplitude of EEG alpha waves for the study group 
(N=28) was 4.37 µV (SD=2.15) at Time 1 and 5.19 µV (SD=2.93) at Time 3. 
Table 10 
Alpha Wave EEG 
 Time 1 Time 3 
Group N M SD M SD 
Comparison 29 5.98 4.46 5.97 4.13 
Study 28 4.37 2.15 5.19 2.93 
The results showed that the comparison and study groups were alike at the beginning of 
the treatment on Alpha Wave EEG (Time 1) and at the end of the treatment at Alpha Wave EEG 
(Time 3) as well. Please see Table 11.  
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Table 11 






    
Time 1 1.61 .93 .09 
Time 3 .78 .95 .42 
Given the statistics in Table 9 and 10, the findings on the Repeated Measures ANCOVA 
showed there were no differences on the Time 3 alpha wave EEG when the Time 1 alpha wave 
EEG was held as a covariate. F (1,54) =.50, MSE=13.10, p=.48. Specifically, the comparison 
group and the study group were not statistically different on the alpha wave EEG measure at 
Time 3.  This means that the intervention for the study group (subjects who engaged in 
prescribed CVG play) had no statistically significant impact on alpha wave EEG data.  
The second research question used a repeated measures Analysis of Covariance 
procedure to test the difference between the comparison and study groups on the dependent 
variable of PHQ measurement (Testing Time 3).  
RQ2: What is the difference between the comparison group intervention (no intervention) 
and the study group intervention (prescribed CVG play) on subjective PHQ-9 scores, 
between Time 1 and Time 3? 
The preliminary statistic of Levene’s Test of Equality of Error Variances was required to 
determine whether the error variance of the dependent variable was equal across both the 
comparison and study groups. This was the case and the assumption was met. (F=1.30, df=1,55, 
p=.26).   
 The descriptive statistics on the dependent variable (Time 3) and the covariate (Time 1) 
were executed and are presented in Table 10. The mean score, on the PHQ-9 for the comparison 
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group (N=29) was 10.66 (SD=4.81) at Time 1 and 7.48 (SD=5.64) at Time 3. The mean score 
for the study group (N=28) was 10.86 (SD=5.23) at Time 1 and 4.54 (SD=3.74) at Time 3. 
Table 12 
PHQ 
 Time 1 Time 3 
Group N M SD M SD 
Comparison 29 10.66 4.81 7.48 5.64 
Study 28 10.86 5.23 4.54 3.74 
ANCOVA statistics were then executed. The results showed that the comparison and 
study groups were alike at the beginning of the treatment on PHQ (Time 1) but not alike at the 
end of the treatment at PHQ (Time 3).  In fact, there was an almost three-point decline in PHQ 
scores for the study group at the Time 3.  Please see Table 13.  
Table 13 






    
Time 1 .20 1.33 .88 
Time 3 2.95 1.27 .02* 
The findings on the Repeated Measures ANCOVA underscored the treatment 
intervention as a success.  The differences between the comparison and study group at Time 3 
were significant and there were statistical differences on the Time 3 PHQ when the Time 1 PHQ 
was held as a covariate. F (1,54) =8.21, MSE=16.18, p<.01). This demonstrates a decrease in the 
self-reported symptoms of depression for participants following one-month of CVG play. The 
strength of the relationship between the factor and the dependent variable at Time 3 PHQ was 
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strong, as assessed by the partial h2 with the factor accounting for 13% of the variance in PHQ, 
holding constant the Time 1 PHQ covariate.  
 Specifically, the comparison group and the study group were statistically different on the 
PHQ measure at Time 3. Results show that the intervention for the study group (subjects who 
engaged in prescribed CVG play) had a statistically significant impact on PHQ scores. When 
examining the data in Table 11, the mean score declines from Time 1 to Time 3 for the study 
group signified a successful intervention.  
To examine the third research question, a Pearson Product Moment Correlation Matrix 
was computed to determine if there was a correlation between changes in alpha wave EEG 
measurements and self-report PHQ-9 scores.  
RQ3: Are there statistically significant correlations between changes in alpha wave EEG 
measurements and self-report PHQ-9 scores? 
There were no statistically significant correlations for each of the two dependent 
variables and the two times of measurement. This would indicate that the EEG (alpha wave) data 
and self-reported PHQ-9 instrument did not both collect statistically significant correlated data 
on symptoms of depression. There may be several reasons that explain the lack of correlation and 
will be further discussed in Chapter 5. Each of the correlation coefficients were low to 




Correlation Coefficient Matrix on Variables 
 Alpha Wave 
EEGTime1 
Alpha Wave 
EEG Time 3 
 
PHQ (Time 1) -.04 -.01 
PHQ (Time 3) .05 .01 
Chapter Summary 
This study sought to determine the effect of CVG play on symptoms of depression along 
two dependent variables, self-report PHQ-9 assessment and objectively collected EEG (alpha 
wave) variables. Additionally, a third research question sought to investigate potential 
correlations between the self-report PHQ-9 instrument and the objectively collected, EEG alpha 
wave data.  
Overall, the repeated measures analyses of this study did show changes in the study 
group from Time 1 to Time 3 in one out of two dependent variables. Data obtained in this study 
confirmed significant differences in self-reported symptoms of depression along the PHQ-9 data 
with significant changes reported from Time 1 to Time 3. Using Time 1 (initial baseline) and 
Time 3 (1 month later) as comparison points, the experimental group saw significant reductions 
in depression. However, data obtained in this study for EEG (alpha wave) data showed no 
significant differences in changes based on EEG (alpha-wave) measures from Time 1 to Time 3. 
With regards to the third research question, there were no statistically significant correlation was 
found between the PHQ-9 instrument and collected EEG alpha brain waves. Based on this data, 
there is strong evidence for the potential use of CVG’s as an intervention option to lessen 
symptoms of depression as results showed on average, a greater than three-point decrease in 
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PHQ-9 scores in the study group, before and after CVG play. Additional discussion regarding the 
results of this study will take place in Chapter 5 that follows this summary.  
 
 
CHAPTER V: DISCUSSION 
Introduction 
This chapter contains a discussion of results from examining changes in symptoms of 
depression in a study group who engaged in a regimen of CVG play as compared to a control 
group who did not participate in an intervention. First, this chapter will provide a review of the 
study. Next, findings are discussed with respect to descriptive statistics, research questions, and 
instruments used in the sample. Lastly, this chapter contains an overview of the study’s 
limitations, implications for practice, and recommendations for future research.  
Study Review 
Depression can be a debilitating condition ranging from mild symptoms to severe and 
treatment-resistant (World Health Organization [WHO], 2020). The WHO (2020), stated there 
are currently 264 million people living with depression worldwide. Depending on the duration 
and severity of symptoms, depression may significantly and negatively impact an individual’s 
quality of life (Russoniello et al., 2013). Although there has been some success in treating 
depression with antidepressant medication and other therapeutic interventions such as cognitive 
behavioral therapy, these treatments are often costly and may carry associated stigma and other 
barriers to treatment (Russoniello et al., 2013). The purpose of this study was to examine 
whether a prescribed regimen of CVG play could reduce symptoms of depression on both the 
self-report PHQ-9 assessment instrument as well as on objectively measured EEG (alpha wave) 
measures. The relationship between depression and prefrontal EEG dynamics, the location of 
alpha wave activity, has also attracted significant interest recently (Cao, 2019). The novelty of 
this particular study involved the dynamics of examining changes in prefrontal EEG (alpha 
123 
waves) as compared to changes in self-reported PHQ-9 measures to investigate the responses of 
participants who participated in a prescribed regimen of CVG play. 
The results of this randomized control study demonstrated that playing CVGs can 
facilitate decreases in depression symptoms along one of two measures, the PHQ-9 self-report 
measure. There were no other interventions used in this study, other than CVG play, lending 
support to the findings that particular CVGs may hold promise for providing symptom 
alleviation for individuals with varying degrees of depression. Further, there were no reports of 
any negative or adverse side effects during CVG play, supporting the notion that CVG play is 
safe.  
Interpretation of Results 
This section provides a discussion of the results of the statistical analyses reported in the 
previous section, Chapter 4. First, a descriptive summary of sample size and all demographic 
variables included in this study will be discussed. Secondly, the findings of research question one 
are discussed to explore the results of changes in symptoms of depression along the dependent 
variable of the alpha wave EEG. Thirdly, the findings of research question two are discussed to 
explore the results of changes in reported symptoms of depression along the subjective, PHQ-9 
dependent variable. Lastly, the findings of the correlation comparing the objective and subjective 
variables are discussed.  
Sample Size 
This current research study analyzed data previously collected from a larger, original 
research study that examined several dimensions of changes in symptoms of anxiety and 
depression among a study group and a comparison group. All participants were screened for 
depression using the brief Patient Health Questionnaire-9 (PHQ-9) and met the criteria score for 
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inclusion of a score equal to or greater than 5. According to the PHQ-9 instrumentation, a “5” is 
the criteria score for a screening of “mild depression.” There were 85 people screened for 
participation in the original study. Of these 85 screened, 26 did not meet the entrance criteria, 
representing a rejection rate of roughly 31%. A total of 59 participants were included in the 
original study. Following data transfer to this study’s researcher, a visual review of study 
variable data revealed two incomplete sets of participants post-assessment data. These two 
original study member’s data was additionally rejected, bringing this study’s total number of 
participants to 57. 
Sample Demographics 
Demographic data was originally collected using a questionnaire. Demographic data was 
reported to describe the sample (N=57) of participants who screened for a minimum threshold of 
mild depression symptoms, rated as a “5” on the PHQ-9 scale. The demographic variables 
collected on the study’s questionnaire were used to describe the study sample. These variables 
were: age, gender, race, highest level of education achieved, occupational status, marital status, 
experience playing video games. The purpose of this section is to discuss the findings related to 
these descriptive statistics.  
From a demographic perspective for this study, the study group and comparison groups 
were very similar on the variables of gender, occupation, and race, while varying slightly on the 
demographics of education and previous game experience.  Each of the similarities or differences 
within each demographic category will be discussed in-depth under each of the subtitled 
categories outlined in this section. Implications regarding the role each demographic variable 
may have on study results will also be discussed. In order to understand the implications of this 
study’s demographic variables regarding depression and CVG play, comparisons were made 
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between study demographics and national-level data on age, gender, race, education as well as 
within the context of similarly designed research studies.  
Age. According to the Anxiety and Depression Association of America (2020), the 
overall mean age of depression in the United States is 30.5 years of age. Although ages of this 
current sample ranged from 18 to 56 years old in the study group and 18 to 74 in the comparison 
group, the mean age of the total sample (N= 57) was 29.75, rounded up to 30 years of age which 
is very similar to the mean age of depression in the United States. Therefore, the findings of this 
study with respect to age among this current sample are largely consistent with what is reported 
in the literature about the target population of individuals with depression. Further, ANCOVA 
analysis determined there were no statistically significant differences on this demographic 
variable between groups, at the p <.05 level. Levine’s Test for Equality of Variances confirmed 
equal variances assumed (p=.395). This confirmation of equal variances assured that each group, 
comparison and study group, were homogeneous or approximately equal and thus able to be 
compared equally on age. This is important in quantitative research as participants in the study 
group’s age ranged from 18 to 56 years old, with a mean age of 29. The comparison group ages 
ranged from 18 to 74 years with and had a mean age of 31. The average age of a CVG player is 
now 33 years old (Williams et al., 2013). Consistently, previous studies have similarly found the 
average age of gamer to be in the 30s range (Williams et al., 2008; Russoniello et al., 2018). 
While video game play in the 1980s and 1990s was largely engaged by teenagers, video 
gameplay has now become mainstream in adulthood as well with approximately 40% of adults 
now reporting regular gameplay.  
Gender. The gender breakdown for the sample was 51% male (n=29) and 49% female 
(n=28). These statistics were similar for the comparison group as well as for the study group, as 
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Table 1 in Chapter 4 reports. This gender breakdown of equality among binary identified genders 
is similar to what is found in the literature, that indicates both male and female genders enjoy 
CVG play (Liu et al., 2018). For decades a widespread, false stereotype existed that individuals 
who identified as gamers were largely teenage males. (Lopez-Fernandez, 2019). This stereotype 
has proliferated by the fact that traditionally games have been designed by males and targeted for 
males (Kuss & Griffiths, 2012). Similarly, most of the professional and highly visible figures in 
gaming culture are usually males, which helps to promote the continued stereotype that most 
gamers are male (Paaben et al., 2017). According to recent demographics, over 45% of 
international gamers from Western countries are now female (Entertainment Software 
Association [ESA], 2018). Similarly, national averages within the United States estimate 49.1% 
of players who self-identify as gamers are male while 50.1% are female (Lopez-Fernandez et al., 
2019).  
Race. The racial composition of the sample was 68% White (n=39), while 23% (n=13) 
were African Americans, 4% (n=2) Latinx, 2% (n=1) Asian/Pacific Islander or 4% (n=2) another 
ethnicity were of minority.  There were no statistically significant differences between the 
comparison and study groups on racial breakdown, as Table 5 in Chapter 4 depicts. In terms of 
the intervention of CVG play, there are mixed results in the literature regarding racial 
distribution across the United States of individuals who identify as gamers. For example, the Pew 
Research Center reports that respondents to a survey regarding gaming habits were divided 
among racial groups as 19% Hispanic, 11% black and 7% white who self-identified as gamers 
(Pew Research Center, 2017). However, other studies have shown that white video gameplayers 
are identified as 81% over overall video game market as compared to 7% identified as Latinx 
and 2% Black/African-American (International Game Developers Association (IGDA, 2019). 
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The mixed findings in the literature as compared to this study’s racial demographic do not 
support any assumptions that can be made on the relationship between race and CVG 
interventions for reducing symptoms of depression.  
Highest level of education. The majority of the sample had some college education 
(n=16; 47%) while a large segment was also composed of college graduates (n=7; 21%). There 
was a smaller percentage of participants with either post graduate degrees (n=4) or high school 
diploma holders (n=2) totaling the remaining 16% of participants. According to this research 
study, the largest sample segment of the study were individuals with some college education 
(n=16; 47%) which does not correspond with the national data in this category (Morris, 2018). 
Employment status. In terms of employment status, most of the subjects (n=24; 42%) 
were full-time employees.  Thirty percent (n=17) of participants were students and twelve 
percent (n=7) were part-time employees. The remainder of the participants were unemployed 
(n=4; 7%), disabled in terms of work classification (n=2; 3.5%), retired (n=2; 3.5%) or identified 
as homemakers (n=1; 2%).   There were no significant differences in employment status 
breakdown between the comparison and study groups, as Table 2 indicates in Chapter 4. The 
demographic of employment status in this research compared similarly to previous research. For 
example, Russoniello et al., (2018) conducted research related to a specific video game and 
symptoms of depression in which 24 participants or 40% were full-time employees and 10 
participants or 17% were part-time employees. Similarly, to the factor of education level, 
researchers have found that employment status is also commonly one of several factors lumped 
into the complex identifier of socioeconomic status (Eaton et al., 2010). 
Marital status. The majority of participants indicated that they were never married 
(n=31; 55%), while 30% (n=17) reported being married.  Fourteen percent were either divorced 
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(n=3) or separated (n=5). There were no statistically significant differences between the 
comparison and study groups on this variable of marriage status, as Table 4 in Chapter 4 
displays. Within the state of North Carolina, 48% of the adult population is classified single 
people. Therefore, the results of this study based on the sample somewhat aligns with the 
population of the geographical area as well as statistics on rates of depression and marriage 
status.  
Experience playing video games. Reporting of gaming experience was a demographic 
variable that may be examined in future studies. This demographic variable was simply collected 
to describe the sample population within this particular study. In terms of gaming experience, the 
majority of the participants identified as being gamers (n=40; 70%), with (n=17; 30%) reporting 
identification as a non-gamer. This was true for the comparison group (76%) as well as for the 
study group (64%). 
Overall, findings from the demographic data of this study are generalized and profiled as 
participants who were generally white, evenly distributed between binary male and female 
genders, full-time employee, with at least some college education, never married and profiled on 
average between late 20s to early 30s in age. This general portrait of this study’s participants 
similarly aligns with the Casual Games Association, (2012) demographics report on the typical 
profile of a CVG player on the variables of gender but not age. This report lists the gender 
breakdown of average CVG player to be 51% female and 49% male (Casual Games Association, 
2012). The age division of a CVG player however was listed as 62% over the age of 35 and 38% 
under the age of 35% (Casual Games Association, 2012). Additionally, 56% of respondents of 
the Casual Games Association (2012) report identified as being a gamer, while 70% of this 
study’s participants identified as a gamer. Upon analyzing these demographic findings, data 
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indicated that this study’s demographic was generalizable on certain factors discussed in this 
section but not all factors. This makes it very difficult for the researcher to make any sound 
inferences on these individual variables in this study in relation to other similar studies utilizing 
socioeconomic status as a variable. However, previous research completed by members of this 
study’s original research team showed similar demographics related to CVG play, rates of 
depression and demographic factors (Russoniello et al., 2018). This study provides a point of 
comparison for this particular study analysis. 
Discussion of Findings Related to Research Questions 
The primary purpose of the research questions that follow was to examine the effects of 
CVG play on reducing symptoms of depression on both subjective (PHQ-9) and objective (alpha 
wave EEG) measures. The participants in this study (N=57) were divided as, 29 were in the 
comparison group while 28 were participants of the experimental group. In order to answer the 
repeated measures Analysis of Covariance (ANCOVA) procedure was used to test the difference 
between the comparison and study groups on the dependent variables each of PHQ-9 and alpha 
wave EEG measurements based on the data obtained from the original research team. The third 
research question examines correlation statistics between the two instruments, PHQ-9 and EEG 
measures. The following section discusses data analyses for each of the three research questions 
including interpretation of statistical procedures and possible explanations of these findings. 
Discussion of Findings Related to Research Question One 
The first research question was:  What is the difference between the comparison group 
(no intervention) and the study group intervention (prescribed CVG play) on objective, alpha 
wave EEG measurement between Time 1 and Time 3? Specifically, this research question 
examines the objective, physiological alpha wave EEG measures obtained before the 
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intervention phase at baseline (Time 1) and after the intervention (Time 3) of playing one of 
three CVG’s for the study group or engaging in no intervention for the comparison group. The 
comparisons between Time 1 and Time 3 conducted for this variable was overall changes in  
amplitude of alpha wave EEG measurements. To complete this process, a Repeated Measures 
ANCOVA was completed to test the difference between the comparison group and the study 
group. Results from this analysis were measured by examining overall changes in amplitude of 
alpha wave EEG signals. In efforts to contextualize alpha wave amplitude it should be noted that 
overall, an EEG measure is a continuous recording of waves of differing frequencies and 
amplitudes. These terms are both commonly used to describe EEG findings. The number of wave 
cycles or peaks that a occur over a set period of time is the wave frequency measured in Hertz 
(Hz). The amplitude of the EEG pattern is the strength of the pattern in terms of microvolts (µV) 
of electrical energy (Schwartz & Andrasik, 2003). The findings from this particular research 
question indicated no significant difference found between the control or experimental groups 
along Time 3 when Time 1 alpha wave EEG amplitude was held as a covariate (p=.48). This 
means the comparison group and the study group were not found to be statistically different at 
Time 3. As a result, statistically, it was found that the intervention of prescribed CVG play for 
the study group had no statistically significant impact on alpha wave EEG amplitude. However, 
statistically insignificant results may not equate to clinical changes reported. For example, 
previous research found that participants who played Peggle as an intervention to increase mood 
reported significant changes in their feelings of mood increases on the Profile of Mood States 
scale, however statistically, alpha power while playing did not show statistically different results 
between a control group and experimental group due to the very large variations in individual 
brain waves (Russoniello et al., 2009). These findings are difficult to compare to previously 
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completed research studies have not specifically identified changes in alpha wave EEG 
measurements related to symptoms of depression along the independent variable of prescribed 
CVG play. Previous studies however have examined changes in alpha wave EEG measurements 
in relation to overall changes in mood, which may relate to feelings of depression (Russoniello et 
al., 2009). In this comparison study, increases in alpha power were predicted to improve mood 
and increase approach/engage behaviors. In this repeated measures study, individuals who 
participated in CVG play produced changes in alpha EEG brain waves consistent with improved 
mood (Russoniello, et al., 2009). These results support the results of this current study which 
indicated significant differences in subjective reporting of decreases in symptoms of depression 
while not confirming statistically significant EEG data. However, other studies have also found 
insignificant data along changes in alpha wave EEG results (Li et al., 2016). In this particular 
study, it was found that the complexities of instrumentation pertaining to ensuring well-trained 
technicians operate expensive equipment may have contributed to insignificant findings along 
alpha wave EEG in their study. Future recommendations by Li et al., (2016) included re-
evaluating the selection of EEG equipment used as well as collecting data from a larger sample 
size as factors to consider in future studies. In an additional recent study, Choi et al., (2011) 
examined changes in alpha band EEG measures in relation to the other four types of EEG bands 
and found that similarly, results were found to be statistically insignificant, while 50% of study 
participants indicated clinically meaningful changes that were not found in the comparison 
placebo control group. These results may similarly relate to this study’s results in that 
statistically significant results were not found, however results on self-report measures were in 
fact, found to be statistically significant as well.  
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There are several reasons why insignificant statistical findings of alpha wave EEG 
amplitude may be dissimilar from clinical self-reports of depression symptoms as was the case in 
this study. The measurement of EEG waves is a very precise, controlled procedure requiring 
specific steps and protocols to be followed to ensure accurate collection of data. This is an 
inherent limitation of conducting secondary analysis of data (Cheng & Phillips, 2014). Further, 
an examination of raw data prior to analysis would further ensure that proper data cleaning 
techniques have followed and that confounding issues including what is termed EEG “noise” 
was properly accounted for through use of filters and proper data collection techniques. 
Additionally, results for this research question may also be not statistically significant due to the 
singular variable of individual EEG alpha wave extrapolation. In previous research studies, brain 
waves are collected and measured in terms of right/left sided ratios or as part of an overall brain 
map comparing changes along all types of brain waves. For example, Li et al. (2016) measured 
changes in alpha waves within a population of individuals with depression, however this research 
was conducted in comparison to Theta waves, which is a different brain wave, often used as a 
comparison ratio in research related to depression. These results also found insignificant findings 
along the alpha wave EEG band suggesting perhaps other brain wave bands would be more 
sufficient in finding significant changes in depression symptoms (Li et al., 2016). An 
examination of data collection procedures was similarly advised in this study. 
In another study that looked at changes in brain waves within a population of individuals 
with depression, a similarly designed study used an ANCOVA statistical analysis to also account 
for time as in this current research. However, this Choi et al. (2011) study utilized a more 
sophisticated type of EEG brain wave collection that allowed for all five brain waves of delta, 
theta, alpha, low beta and mid beta to be collected. In collecting EEG data in this way, rather 
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than along a single wave such as alpha alone, comparisons between relative overall brain 
function were able to be inferred across the totality of brain wave function among a population of 
individuals with depression. However, even with such sophisticated data collection procedures, 
changes along alpha waves were statistically insignificant in this study (Choi et al., 2011). This 
research was similarly first of its kind as researchers stated this was the first attempt to examine 
the efficacy of asymmetry training in depression by adopting an experimental design. This is 
aligned with this current research in which previous studies have not involved the same 
intervention and data collection procedures combined. Lastly, alpha brain waves, similarly to all 
brain waves are relative compared to the overall picture of a person’s brain functionality. In 
future studies, it is recommended that an overall idea brain functionality should be included to 
make further inferences regarding functionality. Clinical implication of the findings for this 
research question one will also be discussed in a section that follows.  
Discussion of Findings Related to Research Question Two 
The second research question was:  What is the difference between the comparison group 
intervention (no intervention) and the study group intervention (prescribed CVG play) on 
subjective PHQ-9 scores, between Time 1 and Time 3? Specifically, this research question 
examined the subjectively reported PHQ-9 data obtained before the intervention phase at 
baseline (Time 1) and after the intervention (Time 3) of playing one of three CVG’s for the study 
group or engaging in no intervention for the comparison group. Following ANCOVA analysis, 
the results showed that the comparison and study groups were alike at the beginning of the 
intervention phase (Time 1) but not alike at the end of the intervention (Time 3). In fact, there 
was an almost three-point decline in PHQ scores for the study group at Time 3. This three-point 
decline resulted in 24 participants (42%) even reporting dropping below the minimum threshold 
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of a “5” for mild depression. As the findings in Table 2 shown, individuals reported downward 
shifts in several occasions to a lesser category of PHQ-9 depression category. The findings on 
the Repeated Measures ANCOVA underscored this treatment intervention as a success. The 
differences between the comparison group and study group at Time 3 were significant with 
statistical differences on Time 3 measurement of the PHQ-9 when Time 1 was held as the 
covariate (p<.01). These results demonstrate a decrease in the self-reported symptoms of 
depression for participants following one-month of CVG play. The strength of the relationship 
between the factor of CVG play and the dependent variable (PHQ-9) at Time 3 was strong as 
assessed by the partial 𝑛! with the factor accounting for 13% of the variance in the PHQ-9 
scores, holding constant the PHQ-9 Time 1 covariate. Specifically, the comparison group and the 
study group were statistically different on the PHQ-9 at Time 3. This is understood as the 
intervention of CVG play had a statistically significant impact on PHQ-9 scores. When 
examining individual changes in reported PHQ-9 scores, categorical changes were also noted for 
the purposes of interpretation of changes. In looking at categorical changes in symptom severity 
along the PHQ-9 measure, a total of 17 participants in the study group shifted to a categorical 
score of 0-4 at Time 3, which detects a score of no depression. It should also be noted that 
among participants in the comparison group, a total of 9 participants shifted to a categorical 
score of 0-4 at Time 3, which indicates no longer reporting of symptoms great enough to be in a 
category of depression (Russoniello et al., 2013). While not all participants in the study group 
moved downward to a category of no reported symptoms of depression, 6 participants 
experienced a large enough shift in symptoms that they categorically met the criteria for a lesser 
category of depression. For example, a participant with a score at Time 1 of an 11 indicating 
moderate depression, had a follow-up score of a 6 at Time 3. This indicates the participant 
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shifted from a category of moderate depression to mild depression. It should also be noted that 4 
participants in the comparison group reported an increase in symptoms of depression at Time 3 
as compared to Time 1. No participants in the study group reported increases in symptoms of 
depression from Time 1 to Time 3. Table 13 included below shows the categorical cutoffs for the 
PHQ-9.  
Table 15 
PHQ-9 Categorical Distinction 
Total Score Depression Severity 
1-4 Minimal depression 
5-9 Mild depression 
10-14 Moderate depression 
15-19 Moderately severe depression 
20-27 Severe depression 
Note. PHQ-9 Copyright© Pfizer Inc. 
Results from analysis of this research question should also account for the fact that some 
participants that identified in each category of PHQ-9 scores ranging from mild to severe 
depression experienced categorical shifts to less severe categories of reported depression 
symptoms.  
These study results are similar to previous studies that have examined changes on self-
report measures for interventions to help alleviate symptoms of depression. In a study that 
examined the specific video game called Plants versus Zombiesä, Russoniello et al. (2019) 
examined self-report changes on the same measure used in this study, the PHQ-9. Results from 
that study support the self-report findings of this study as changes between groups on the PHQ-9 
were indeed significant (p<.001, h2=.254). These supportive results are especially remarkable as 
there were no reports of negative side effects or adverse reactions to prescribed CVG play 
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indicating this as a potentially safe method of supporting reduction in symptoms of depression in 
either study.  Findings related to significant changes along self-report measures, utilizing CVG 
play, may be explained through the application of the GameFlow model proposed in this study as 
a theoretical basis for positive outcomes involving gameplay. In a study examining engagement, 
a questionnaire related GameFlow to positive feelings of engagement in the gameplayed (Kiili & 
Lainema, 2008). These reported feelings include experiences of intensive, interesting, motivating 
as well as engaging and immersive experiences. These described feelings are relevant to this 
research measuring alpha wave EEG measures as the descriptors of alpha waves are similar. 
Alpha waves have been described historically as relating to alertness and task engagement 
(Schwartz & Andrasik, 2008).  
While these findings show promise for the use of CVGs in reducing symptoms of 
depression, they should be interpreted with caution as there are several potential unknown factors 
that may confound these changes. Further research would need to investigate questions regarding 
things like changes in environmental, social, financial factors that may also be responsible for 
some of the variance in significance. Additionally, participants were not questioned regarding 
medication or health changes that may also significantly impact these results. Lastly, individual 
differences in CVG specific game was not included in this analysis. However, it should be noted 
that 60% of participants in the study group selected Bejeweled over either Peggle or Bookworm 
Adventures. The further research section of this chapter will examine indications to investigate 
differences in nuances between games that may also contribute to changes in PHQ-9 self-
reported scores.  
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Discussion of Findings Related to Research Question Three 
The third research question was:  Is there a correlation between changes in alpha wave 
EEG measurements and self-report PHQ-9 scores? The final research question used a Pearson’s 
Correlation Matrix to determine if there was a correlation between changes in alpha wave EEG 
amplitude and self-report PHQ-9 scores. The findings are reported in Table 16 below. Findings 
on this research question found no correlation for each of the two dependent variables, the PHQ-
9 and alpha wave EEG measurements and the two times of measurement at Time 1 and Time 3. 
However, the PHQ-9 did show statistically significant correlations between Time 1 and Time 3. 
Alpha amplitude scores were not statistically significant within at Time 1 and Time 3.  
Table 16 
PHQ-9 and Alpha Amplitude Pearson’s Correlation 




































































Note. **. Correlation is significant at the 0.01 level (2-tailed). 
There may be several reasons that can explain the lack of correlation between instruments. 
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Previous research has analyzed changes in PHQ-9 scores using similar CVG-based 
protocols aimed to reduce symptoms of depression and found significant results (Russoniello et 
al., 2013; Russoniello et al., 2019). This previous research similarly found significant differences 
in results between Time 1 and Time 3 along the PHQ-9 scores (Russoniello et al., 2013). While 
recent EEG based affective computing studies, similarly to this study design have recently grown 
in popularity, there is still little published research in this field comparing self-report and 
objectively measured data. Recent examinations of this concept by previous researchers have 
addressed the challenges is comparing self-report and objectively measured data (Hu et al., 
2019). The core of affective computing involves using computational devices such as EEG to 
measure affective states such as depression and physiological responses to stimuli. Along this 
theory of the benefits of measuring physiological responses such as using EEG, it is the thought 
of researchers that this physiological data could overcome issues in self-report bias, stigma, 
coherence, etc. This theory posits the physiological data provides direct measurement of human 
conscious and subconscious activities that may otherwise be concealed in self-report data (Hu et 
al., 2019). While the enticement of measuring physiological data to infer affective states has 
grown tremendously in popularity as evidenced by the increase in recently published articles, 
there is some reluctance to fully adopt EEG-based affective computing in practical settings as 
EEG signals may not be sensitive enough to pick up behavioral changes in affective state as the 
relationship between brain waves and human emotion could be very complicated and should not 
be oversimplified by researchers (Hu et al., 2019). The non-significant in correlation between the 
self-report PHQ-9 data and the EEG data may similarly be connected to the difficulty in 
accurately relating one singular psychological element such as depression to one physiological 
signal, such as alpha wave amplitude. Hu et al., 2019 calls this a one-to-one relationship and 
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advises research along these lines may find insignificant results between instruments, such as 
with this study due to the complexities in sensitivity between EEG data and self-report PHQ-9 
assessments. These researchers further support the results of this study by stating the one-to-one 
relationship may provide an ideal theoretical basis for measuring affective outcomes, but are 
difficult to validate and rarely reported in existing literature (Hu et al., 2019). 
Summary of Research Question Results 
Objective and subjective measures of symptoms of depression were measured in this 
research study. Objective data consisted of analyzing previously collected alpha wave amplitude 
EEG measures. Subjective data consisted of analyzing previously collected PHQ-9 self-report 
scores. Differences at Time 1 before any intervention and at Time 3, following intervention were 
examined to indicate any changes in both the subjective and objective instrumentation. This data 
was used to examine the primary purpose of this research study which was to examine the effects 
of CVG play on reducing symptoms of depression along both alpha wave EEG amplitude and 
self-report PHQ-9 scores.  
Research question one was examined along changes in Repeated Measures ANCOVA 
analysis for alpha wave EEG amplitude changes. This analysis was selected as it accounted for 
the covariate of Time in this research. Results indicated no significant differences between Time 
1 and Time 3 along measured changes in alpha wave EEG data. There were several reasons 
listed regarding potential explanations for the lack of change detected. Research question 2 was 
examined similarly along changes in Repeated Measures ANCOVA analysis for PHQ-9 self-
report scores. Results indicated significant differences between Time 1 and Time 3 along self-
report changes in PHQ-9 scores. This analysis showed that scores between the study group and 
the comparison group did not differ at Time 1, however differed by an almost three-point decline 
140 
at Time 3, making these changes statistically significant. Using Time 1 (baseline) and Time 3 
(one month later) as comparison points, the experimental group saw significant reductions in 
reported PHQ-9 scores, indicating reduction in depression symptoms. The third research 
question examined correlations between the alpha wave EEG amplitude measures and PHQ-9 
scores. Upon completion of research analysis, it was concluded that no significant correlation 
was found between the PHQ-9 instrument and the collected EEG alpha brain wave amplitude 
measures. Based on this data, however, there is strong indications for the potential use of CVGs 
as an intervention option to help reduce symptoms of depression. This conclusion can be made as 
results showed on average, a greater than three-point decrease in PHQ-9 scores in the study 
group before and after CVG play. While significant evidence was not found in measured EEG 
alpha wave data, previous video game research has reported participants associating feelings of 
engagement, calmness and focus while engaging in video gameplay (Carras et al., 2018). These 
emotions have been described previous as the emotions measured in alpha waves and may 
indicate that a relationship does occur between gaming and alpha wave EEG measures, even if 
not found to be statistically significant. Further theoretical limitations to measuring statistically 
significant changes along one EEG variable, such as alpha wave amplitude has been discussed. 
For example, a recent review of literature by Palmiero & Palmer (2017), indicated that the 
psychological implications for changes in measured EEG signals has reported mixed reviews 
when such one-to-one measures have been conducted such as with this study. This review of 
literature indicated that validity of such one-to-one studies should be reviewed with caution 
(Palmiero & Palmer, 2017). Recently, a study similar to this one have also attempted to compare 
affective states measured by EEG along with self-report psychological data and similarly found, 
non-statistically significant results. In this study, participants were asked to watch a video on 
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gratitude while being connected to EEG measurement equipment (Hu et al., 2017). Given the 
nature of the emotion of gratitude, it was later determined that participants may also experience 
feelings of intense hope and love while watching the video which is very difficult to separate and 
detect the differences between these emotions on an EEG measurement reading (Hu et al., 2017). 
Similar complications in instrumentation may be a reason correlations between EEG data and 
PHQ-9 were insignificant as emotional outcomes may be too complicated and interwoven to be 
precisely measured and compared on these instruments. 
Limitations of the Study 
As with all research, the current study includes several limitations. These limitations 
mostly pertain to elements of the research design, sampling, instrumentation, and statistical 
analyses. Each of these limitations are discussed prior to discussing the clinical implications of 
study findings and future research recommendations. Limitations are an inherent component of 
any research study. No single study is completely flawless or inclusive of all possible aspects of 
research for any singular topic, resulting in expected limitations to research.  
Particular to this study, the data used is an ex post facto investigation using analysis of 
existing data from a larger archival study. The use of secondary data, particularly in health 
research is growing, however, use of such data comes with several limitations. These limitations 
include items related to research design, instrumentation and statistical procedures of this study. 
These primary limitations are discussed in this section.  
Limitations of Study Design 
Archival data. The use of archival data poses a limitation to this study’s research design. 
Specifically, the data analyzed in this study was not collected only to address the specific 
research questions in this study but were part of a larger study that examined several other 
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variables including anxiety. This technique while common in research, limits the variables of 
study and does not potentially account for other confounding study variables that affect these 
study variables (Cheng & Phillips, 2014). A further limitation is that the members of the original 
research team were not the same individual(s) involved with this study analysis. This is a 
limitation as the researcher analyzing this data is unaware of the procedures and techniques used 
to acquire and clean data prior to analysis (Cheng & Phillips). For example, procedures 
necessary to collect psychophysiological data such as prepping skin, sensor placement, staff 
training and issues with data collection are unknown to this study’s researcher. Additional 
limitations regarding EEG specific protocols will be discussed in the implications section of this 
chapter. This human-made error limitation applies to this study. Under this limitation, the 
researcher conducting this analysis may be unaware of study-specific nuances in the data 
collection process. These potential glitches may be vital to the interpretation of specific variables 
in the dataset. In order to mitigate this problem, succinct documentation and communication of 
important information about the validity of the data by the data collection researchers and careful 
examination of all relevant documentation was completed by the analysis researcher.  
Due to the nature of using archival data, this type of study prohibits the accuracy in 
suggesting any cause-effect relationships between variables. Due to the nature of secondary 
analysis, there are many nuances of using archival data that lead to cautious interpretation of 
results (Cheng & Phillips, 2014).   Although data analyzed in this study showed significant 
evidence for the use of CVG play in reducing symptoms of depression, cause-effect relationships 
cannot be drawn from this data as there are potential confounding variables and unknown factors 
that may affect this study’s data. This prohibits this study’s researcher from claiming that any 
decreases in depression symptoms resulted directly from CVG play. This is an issue inherent to 
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the use of secondary analysis of existing data as this available data was not originally collected to 
address the particular research questions of this study or to test any particular hypothesis (Cheng 
& Phillips, 2014).  
Sample limitations. This study utilized volunteers elicited through several methods of 
community-based recruitment to participate. This may be a limitation as a convenience sample of 
volunteers does not accurately represent the population of individuals outside of the study. This 
creates a threat to external validity. Further, inducement may be a limitation of this study as 
participants were offered a $100 Visa gift card for completing the study as well as a free CVG of 
their choosing. The enticement of these incentives to participate may contribute to skewed data 
in favor of study compliance.  
Self-selected intervention. An additional limitation of the study’s experimental research 
design poses threats to internal validity. This is due to the procedure of each participant in the 
study group, self-selecting the CVG they desired from the choices of either Peggle, Bejeweled or 
Bookworm Adventure to play. There was a disproportionately large selection of the game 
Bejeweled as compared to either Peggle or Bookworm Adventure. The CVG each participant 
chose leads to an element of selection bias which may have influenced the dependent study 
variables. Additionally, the design elements of CVGs are largely unresearched but may be 
influential in the participant outcomes, motivation to play and may create a potential for placebo 
effect if the participant had a particular affinity towards the selected CVG.  
Limitations of Instrumentation 
There are also limitations in regards to the instrumentation and data set selected for this 
current study. First, it is unknown if any or all participants were actively taking any 
antidepressant medication or other interfering medications as this data was not collected in the 
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original research study.  If any medications were taken, factors such as dosing, medication type 
and brand were not recorded and as a result cannot be reported or analyzed while potentially 
affecting study variable outcomes. Previous studies of similar constructs appropriately excluded 
participants with pre-existing comorbid conditions such as: bipolar disorder, depression which 
includes delusions and hallucinations, paranoid ideation or schizophrenia or delusional disorder 
(Solomon et al., 2015). These and other co-occurring conditions and disorders may significantly 
impact accurately accounting for depression symptoms alone. Questions on the demographic 
questionnaire did not address potential comorbid disorders that may significantly impact reported 
symptoms of depression as well as covariates of statistical analysis.  
The next limitation involves one of the two main study dependent variables, the PHQ-9. 
These PHQ-9 scores rely on self-report methods of measurement. Self-report methods of 
assessment may be inaccurate and highly influenced by conscious or subconscious adherence to 
reporting socially desirable responses (Cheng & Phillips, 2014). While in this study, PHQ-9 
results showed positive change based on the study group’s CVG play, participants may have 
either under-reported or over-reported symptoms of depression. While little may be done to 
ensure accurate self-reporting, the consistency of administration methods through use of manual 
guidelines as well as policies and procedures for instrument administration ensured best possible 
scenarios for accurate delivery of the self-report assessment.  
One of the assumptions in using a technological based intervention such as CVG play, is 
that participants in the study are proficient in computer usage skills. In this particular study, one 
of the limitations involved technological barriers as some participants experienced difficulty 
connecting to the CVG they selected, connecting to WIFI and general difficulty with computer 
usage. Further, this was a technology-based intervention. While the ages of participants ranged 
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from 18 to 74, most participants were in their early 20’s and may have more game and 
technology knowledge than older adults. This presents a limitation as participants may become 
frustrated in trying to use technology to complete the study, which may exacerbate their 
symptoms of depression and may also result in inaccurate reporting of study outcomes based on 
their negative experience with technology.  
The next limitation of instrumentation involved the additional use of the objective EEG 
measurement. There were limitations in the procedure to use EEG both to look for correlations 
between self-report and objectively collected indications of symptoms of depression and to look 
at study group changes. While this technique of dual-reporting of assessment (PHQ-9 and EEG) 
meets the recommended guidelines for ethical obligations of counselors under the American 
Counseling Association (ACA) Code of Ethics (ACA, 2014), there were issues in this study with 
accurately collecting the correct depression related alpha amplitude of EEG instrumentation. The 
use of physiological data in analysis is accompanied by inherent limitations for accuracy in data 
collection. The precise use of EEG electrodes, placement of electrodes, and procedures to ensure 
the most accurate data was collected was not supervised by the current researcher. This creates a 
limitation of a potential unforeseen error in data collection procedures as small changes in 
procedure and sensor placement may make a significant impact on data collected. Brain wave 
changes in the alpha band (8-12 Hz), specific to depression have been clinically and empirically 
researched when alpha waves are examined as a ratio between right and left-brain hemispheres, 
also known as alpha asymmetry. These brain waves and asymmetry principles have been 
extensively researched in previous studies. While the researchers of the original study collected 
EEG alpha wave data that was analyzed in this particular study, no distinction between right and 
left alpha was able to be made due to a lack of sophistication in equipment instrumentation. This 
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is a study limitation as overall changes in EEG (alpha waves) was not determined to be 
significant in this study. However, without distinguishing between right and left alpha ratios, it is 
impossible to determine if in fact changes did occur which may have been significant enough to 
impact overall amplitude changes. Rather than an overall total amplitude measure of both right 
and left-sided alpha combined, right and left side measurements should be taken separately and 
distinguished in the data as separate figures so that proper right/left alpha ratio could be 
examined, which is the measure indicated in similar studies. 
 Additional limitations to the data set and instrumentation include the use of volunteers as 
participants, inducement to participate and flaws with accurately reporting time spent playing 
CVGs at home. The participants included in this archival data set were recruited by several 
methods and included in the study following read of an approved IRB script to the participant. 
Upon completion of study, all participants received a $100.00 Visa gift card and a free CVG for 
their time involved in the study. These perceived rewards for participation may have influenced 
self-selection into the study.  
Limitations of Study Analysis 
A final set of limitations that threaten the validity of these study results involve the 
selected statistical approach of analysis. An initial limitation of analyzing data occurs if any 
archival data includes any coding or typing errors. Data was reviewed before conducting the 
study analysis to ensure any incorrect data was not entered. In this study, two participants were 
missing study variables upon data examination and were eliminated from study analysis. In order 
to mitigate this limitation, data was evaluated along ANCOVA statistical assumptions, to ensure 
normality of data and homogeneity. There were several limitations involved with this study’s 
data analyses. Firstly, participants in the study group were offered a choice of three CVG 
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options:  Bejeweled, Peggle, and Bookworm Adventure. While all three of these CVGs operated 
under similar principles, rules and game design, it is unclear at this time if there were intricacies 
between or within each of the games that may have potentially made one game more appealing 
over another. This information of determining which game produced the greatest reduction in 
depression symptoms for example, may help future game developers use specific game qualities 
for targeted intervention use. Further determining what game qualities or game actions produce 
positive health effects may further provide insights into the underlying mechanisms of change to 
assist both game programmers and clinicians better maximize the effectiveness of video games 
and gaming outcomes.  
Ethical Considerations 
The researchers involved with this study have obtained Institutional Review Board (IRB) 
approval to perform this research, listed as a research team member under the IRB submission. 
In respect of participant privacy, ethical considerations were employed throughout analyses and 
reporting of data. Coded identifiers were used in this study with no identifiable information 
included.  Additionally, all forms completed were coded by the original research team and were 
not revealed to this researcher. This dataset includes self-report information regarding mental-
health, namely self-report depression scores. It should be noted that by using archival data, direct 
participant contact did not occur for this particular study. This is important to note as some 
participants may require additional follow-up related to their depression symptoms based on high 
PHQ-9 self-report scores. 
Implications of the Study 
The purpose of this study was to examine the potential effects of prescribed CVG play on 
reducing symptoms of depression along both objective and subjective measures. The results of 
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this study have revealed potential implications that will be discussed for practice. A section of 
recommended future recommendations will follow this section to conclude this research. 
Implications for Practice 
Although this study included several study limitations as discussed in the previous 
section, findings from this research may have several implications for the fields of counseling 
and recreational therapy. These implications mostly pertain to practical applications for working 
with clients who show signs of depression and other mental-health diagnoses. The potential 
implication for including both subjective and objective assessments for mental-health related 
conditions such as depression will be the focus of this section. 
Over the course of the last decade, practitioners have drawn their attention to introducing 
more objective methods of measurement to improve clinical standards for diagnostics and 
management of optimal course of treatment for many diagnoses (Solomon et al., 2015). Recent 
studies examining brain function as a byproduct of technological advances have allowed 
practitioners to expand the emphasis on brain-based treatment, including rehabilitation 
counselors (Dadashi et al., 2015). Clients with depression may greatly benefit from new 
objective measurement opportunities as so often there is internal as well as social and 
environment pressure to alter self-reporting for a myriad of potential reasons (Solomon et al., 
2015).The current standard of focus on symptom-based definitions of depression can make 
accurate diagnoses challenging as it has previously been thought that psychological based needs 
as opposed to physiological needs are difficult to measure objectively (Solomon et al., 2015). A 
strong argument cannot for the inclusion of objective measurement in clinical practice based on 
this study’s research findings, however the non-statistically significant findings of the alpha 
wave EEG readings have been explained by limitations of instrumentation in previous sections. 
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Other research studies on the other hand do support the notion of including objectively measured 
outcomes in counseling practices and other health care services. Historically, back to the 1980s 
researchers have found correlations between subjective reporting and objectively measured brain 
waves. Davidson, Schaffer & Saron (1985) found early frontal EEG findings that paralleled the 
findings on self-ratings for happiness, showing correlation between self-report and objectively 
measured mental-health outcomes (Davidson, Schaffer & Saron, 1985). More recently, Potvin et 
al., (2016) examined assessment of cognition within a population of individuals with depression 
along self-report and objectively reported data and similarly found correlations. These historical 
studies along with a critical examination of data collection techniques in this original study 
indicate further examinations should be conducted to consider implementation of integrating 
both objective and subjective assessment tools into practice.  
Further, reduction of reported symptoms along the PHQ-9 indicate the potential use of 
non-pharmacological interventions for reducing symptoms of depression. Many pharmacological 
based interventions do not include the client in the treatment process, rather simply provides 
medication as an approach to treat a chemical deficit. While this approach may be necessary and 
effective for some individuals, research has shown that up to 40% of clients with depression do 
not receive adequate reduction in their symptoms after use of antidepressant medications 
(Cuijpers et al., 2014). While it is not known at the time of this research the factors involving 
medication use, comorbid diagnoses and other factors that may affect the effectiveness of some 
antidepressant treatments, the evidence in the reduction of PHQ-9 scores at Time 3 after 
intervention are significant enough that CVG play should at a minimum be considered for 
potential use along with other complementary and alternative treatment options for depression. 
Additionally, rehabilitation counselors working in areas of focus such as addiction may consider 
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CVG play as part of their toolkit of treatment interventions as CVG play does not require the use 
of potentially harmful antidepressant medications and include actions by the participant in the 
treatment process.   
Implications for Research 
Proper examination of changes within the alpha wave amplitudes was limited in this 
study by issues with instrumentation. In order to properly assess brain wave changes related to 
depression, it is critical to first examine the totality of an individual’s brain function and resulting 
brain waves. This is relevant to this research as only alpha wave activity was examined without 
understanding the context of each individual’s medical history, mental-health conditions and 
overall brain function. This may potentially be the root cause of the insignificant changes in 
alpha brain wave findings between Time 1 and Time 3. Additionally, it should be considered that 
alpha functioning in general is relative to several factors within an individual. For example, 
certain conditions such as PTSD already produce a high amount of alpha waves as a factor of the 
condition (Group & Heller, 2016). Therefore, it would not be ethical or correct to train for 
increases in alpha waves as is typical in EEG depression protocols when as many people with 
PTSD already overproduce alpha. This is one example of several conditions that should be 
further investigated prior to engaging in EEG alpha wave measurement or training. On the other 
hand, individuals dealing addiction may already have very low alpha waves so small gains in 
recordings may still result in large gains in anecdotal data (Wang & Bulanova, 2018). 
Precise examination of changes related to alpha waves further requires measurement of 
frontal asymmetric activations. In this study, asymmetric activation measures were limited by the 
strength and complexities of available EEG equipment as well as potential issues with data 
collection methods. While overall changes in alpha brain waves were measured, precise 
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differences between right and left-brain hemispheres were not determined for this study. The use 
of more sophisticated EEG ratio comparisons would be able to detect changes between the right 
and left alpha which has generally been advised in the literature as the EEG ratio to examine 
within populations of individuals with depression (Schwartz & Andrasik, 2003). Although the 
overall changes in alpha are important to measure, clinicians should focus on looking for relative 
hypoactivation in the left prefrontal area, which differs from that found in individuals without 
depression who show hyperactivation in the left prefrontal area. As compared to the right frontal 
area. Equipment that measures EEG changes separated by left and ride sided alpha measures 
would enable clinicians to examine more precise clinical intake information.   
This study and previous studies now indicate the potential effectiveness of video game 
use as a demonstrated intervention to address clinical conditions such as depression. Based on 
this data, healthcare professionals such as counselors, recreational therapists may consider 
prescribed CVG play to clients who are experiencing symptoms of depression. The data from 
this study indicated that CVG play by the prescribed protocol of three times a week, 30 minutes 
per session, for four weeks may be effective for reducing symptoms of depression. Due to the 
low-cost and availability of CVGs, counselors and other allied health professionals may consider 
use of CVGs as a simple, effective tool for relief of symptoms of depression, similarly to other 
complementary and alternative approaches such as exercise and general physical activity. 
Future Research Recommendations 
EEG Right vs. Left Alpha Differentiation 
It has long been established that EEG measured frontal brain asymmetry has implications 
related to depression, however few studies have compared results of subjective self-report with 
objective EEG measures. In one early study (Schaffer, Davidson & Saron, 1983), high and low 
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scores on the Beck Depression Inventory were compared with respect to EEG asymmetry at 
frontal lobe sites using EEG measures while at rest. In this study, participants who were high in 
self-reported depressed mood exhibited significantly lower self-report scores of depressed mood. 
However, studies thus far have not examined changes in right frontal alpha asymmetry compared 
to left frontal alpha when a CVG is used as the intervention. By further examining left versus 
right sided changes in alpha under similar CVG intervention conditions, future researchers may 
be able to confirm more precise changes in alpha asymmetry, related to CVG interventions.  
Thus far, most studies that have examined changes in alpha EEG functioning have taken 
place during research study settings. There is a growing body of research that is indicating “pre-
exposure EEG” or EEG measurements prior to starting treatment may help capture trait aspects 
of psychological dysfunction (Cao et al., 2019). Gathering pre-exposure EEG may potentially 
help predict the effects of particular antidepressants in an individual, helping create a more 
efficient process for treatment (Cao et al., 2019). By examining EEG patterns before, during and 
after treatment regimens, practitioners may shortcut the process of matching a correct medication 
with a client as they examine neurophysiological data, rather than self-report data alone (Cao et 
al., 2019).  
Objectivity in Measuring Mental-Health Outcomes 
Neuropsychiatric disorders, which include mental disorders such as depression are having 
an increasing impact worldwide, with this category being the third ranked cause of disability for 
persons aged five and older (NIMH, 2020). The call to action to address these disorders has 
elicited the help of technological innovation to assist with treatment and diagnosis. This is the 
fundamental focus of the newly defined field of research called, behaviomedics (Valstar, 2014). 
The general aim of behaviomedics is to apply automatic analysis and synthesis of affective and 
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social signals to aid in objectively diagnosing, monitoring and treating medical conditions that 
alter one’s affective and socially expressed behavior (Solomon et al., 2015). This new field 
includes research in several subjects like affective computing which seeks to determine ways that 
science can create emotionally aware technologies including automatically analyzing affect and 
expressive behavior (Solomon et al., 2015). Additionally, utilizing computer software to analyze 
big data sets to generate treatment selection algorithms could largely impact the mental-health 
field (Fekadu et al., 2018). This process of generating custom algorithms would allow for 
practitioners to find and advise the best treatment for a given client and will allow for health care 
delivery to become more efficient (Fekadu et al., 2018). 
 By definition, mood disorders are directly related to affective state, thus, affective 
computing promises to be a good approach to depression analysis (Solomon et al., 2015). While 
EEG may not be perceived as a form of affective computing, it is also a method that seeks to 
provide a layer of objectivity to the previously, mostly subjective process of mental-health 
disorder diagnosis and treatment. As efficacy for studies that include such objective measures 
continue to grow, the hope is that eventually such objective methods will become integral to 
clinical practice. Other new developments in the journey to find the most effective course of 
treatment for mental-health conditions includes advances in genetic testing (Pandarakalam, 
2018). Tools such as genetic testing for detection of mental-health conditions such as mood 
disorders have been established in physical medicine but not psychiatric care (Pandarakalam, 
2018). Genotype testing may eventually provide information regarding individuals who may be 
at heightened risk for diagnosis like depression, as well as predicting effective treatment 
outcomes (Serretti et al., 2011). Additionally, the invisibility of depression as well as subtle and 
flagrant discrimination and stigma towards individuals with mental-health conditions creates 
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complexities for treating practitioners to accurately find the best course of treatment. Newer 
imaging techniques such as functional MRI, EEG and other brain scan technologies may support 
efforts to find reasons why some people respond to treatment and others do not. These brain-
based assessment tools may help provide practitioners with more individualized, objectively 
measured data that can better target decisions such as antidepressant selection and tailoring 
intervention choices to each individual separately (Pandarakalam, 2018).  
Depression Specific Alternative Intervention and Videogame Research 
With such high rates of recurrence through pharmacological approaches, novel treatment 
strategies for treating depression are needed (Cuijpers, Huibers, & Furukawa, 2017). Treatment-
resistant depression is not uniformly defined, which may confuse not only diagnosis but advised 
treatment options as well (Trevino et al., 2014). One estimate is that TRD affects 20-30% of all 
individuals with MDD (Fekadu et al., 2009). As with any research, in order to produce reliable 
outcomes along a variable, the variable must be clearly defined.  
The most common method of first-line treatment for depression is pharmacological 
intervention using antidepressant medication, however, it is estimated that 53% of clients with 
clinical depression show non-response to the first-line prescribed medication and 67% show non-
remission of symptoms (Warden et al., 2007). In order for such individuals to experience 
alleviation of depression symptoms, the client may require supplemental pharmacological, non-
pharmacological and exploratory interventions (Johnston et al., 2018). Some studies have 
suggested a complementary approach to depression treatment should be added in conjunction 
with pharmacological measures including: cognitive behavioral therapy (CBT), neurostimulation 
techniques, and aerobic exercise as a behavioral treatment strategy (Wiles et al., 2013; Trivedi et 
al., 2011). 
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To further examine the use of CVGs as an intervention for mental-health treatment, 
future research should consider investigating the effectiveness of CVGs along with other 
medications. Traditionally, many antidepressant medications and other therapies have 
compliance issues as well as side effects that may discourage continued use by clients (NIMH, 
2020). One unique quality of this study was that the intervention, CVG, was not specific to 
healthcare or depression. The findings from this study involving the use of CVGs to help 
alleviate symptoms of depression point to the potential use of other non-medical specific 
interventions such as video games to be developed and used for more clinical focused 
interventions. To the extent of this researcher’s knowledge, video game programmers are not 
generally trained in healthcare specific fields, however games they have developed may help less 
the burden of depression symptoms for some individuals. In the future, the application of other 
non-medical specific interventions, specifically around videogames should be investigated. 
Additionally, it is recommended that future studies further examine different prescribed 
protocols of CVG play as different frequencies of play, intensities and durations of play may 
cause either more or less significant effects on symptoms of depression. 
As expanse into the use of complimentary forms of treatment for symptoms of depression 
continues to grow, future researchers should consider different types of CVGs utilizing other 
prescribed protocols. The protocol used in this study was defined as playing 30 minutes of the 
video game of choice for three times per week. While there was strong PHQ-9 evidence to 
follow this protocol, future research should be examined to experiment with other potential 
prescriptions of play that may produce more impactful results.  This would allow researchers to 
focus on particular elements of prescriptive play that may be helpful including:  Number of times 
played per week, practice skills and length of each session. There are several ways in which 
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game programmers and players may work together to further develop similar games. For 
example, players may convey to developers what they would like in a game and developers may 
take these ideas and combine them with their technical skills to deliver the requested game or 
something similar (Russoniello et al., 2013). While this process of intervention development is 
not unfamiliar, the uniqueness of CVGs are their instant feedback, their nature of being fun to 
play, are inexpensive and readily available.  
Chapter Summary 
The purpose of this study was to examine if prescribed CVG play could reduce symptoms 
of depression in a study group as compared to the comparison group that did not participate in 
any intervention. In order to carry out this study, three research questions were developed and 
analyzed using a series ANCOVA analyses. In addition to addressing research questions, 
descriptive statistics were reported for dependent variables as well as participant demographics. 
Finally, psychometric properties were evaluated for the independent variables used in this study. 
All findings were discussed, including (a) limitations, (b) clinical implications, and (c) 
recommendations for future research.  
There were multiple limitations identified in the current study. These limitations were 
relevant to the research design, instrumentation, and statistical analyses. The research design 
employed in the current study was a quantitative, ex post facto examination of archival data. 
Accordingly, limitations included issues related to secondary data analysis and the inability to 
make causal inferences. Limitations to instrumentation focused on the issues of self-report 
measures, and lack of sophisticated instrumentation to accurately measure needed EEG variable 
data as it prohibited accuracy in EEG alpha wave data collection, measurement and evaluation. 
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Although there were limitations, findings from the current study have critical 
implications for counseling practitioners, recreational therapists, and researchers. The use of 
CVG play offers counseling practitioners the additional homework and intervention modality to 
provide clients with a low-cost, easily accessible intervention between clinical visits or as an 
intervention to compliment other counseling care. Recreational therapists by profession use 
recreational activities, games and leisure interventions to provide rehabilitation and alleviation of 
disabilities and disorders. Expanding the use of CVG play into recreational therapy practice 
further offers a low-cost, accessible form of intervention that can also be tracked, monitored and 
documented remotely. Additionally, the more than three-point average difference from Time 1 to 
Time 3 within the study population strongly supported the significant image CVG play may have 
on reducing overall symptoms of depression as documented on the PHQ-9 scores. While EEG 
recordings did not show similar significant impacts, it is advised in the future recommendations 
section that further analysis using proper EEG instrumentation be conducted so re-test for 
correlations and significance on EEG alpha wave data.  
Future recommendations for research primarily focused on expanding research into 
finding additional objective methods to detect and treat depression. Some future suggestions 
found in the literature include genetic testing for mental-health diagnoses and further 
examination of EEG and other imaging methods to examine the structure and chemical make-up 
of the brain. Lastly, this research supports the use of CVG interventions for helping to reduce 
symptoms of mental-health related diagnoses including depression and anxiety. It was 
recommended that future research expand in the area of CVG use as well as other progressive 
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